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An orthopaedic medical device refers to a part, implant, prosthetic or orthotic which is used to address 
damage to the body's musculoskeletal system, primarily by providing stability and mobility. 
Orthopaedic medical devices play a role in injury-related disorders, which have been highlighted as a 
key element of the quadruple burden of disease in South Africa.  
In this thesis, orthopaedic devices are conceptualised as a technological field and a technological 
innovation system (TIS) framework is applied to understand orthopaedic device development in South 
Africa. Knowledge development and knowledge diffusion are fundamental components of any 
innovation system. The thesis hypothesises that the functions “knowledge development” and 
“knowledge diffusion through networks” of the orthopaedic devices TIS are influenced by contextual 
factors. The objectives of the study are: to identify the actors who generate knowledge for 
orthopaedic device development and to characterise the relationships between them; to identify 
focus areas of orthopaedic device development; to provide insight into the drivers and barriers to 
knowledge development and diffusion in the TIS; and to identify the contextual factors that influence 
knowledge dynamics in the TIS. These objectives are investigated using social network analysis based 
on bibliometric data (scientific publications and patents), keyword networks, a review of institutions, 
and a set of case studies where the primary data source are interviews with actors.  
Actors producing knowledge were from the university, healthcare, industry and science council 
sectors, although science councils played a small role. International actors were shown to bring new 
ideas into the TIS. The networks were fragmented, illustrating that knowledge diffusion through the 
networks was limited. This was especially the case in the patent networks as many actors patent in 
isolation. The keyword networks highlighted unrealised collaboration potential between actors based 
on their common research interests. The case studies revealed features of cross-sector interaction for 
orthopaedic device development not evident from network analysis based on bibliometric data.  
Drivers of knowledge development and knowledge diffusion were: inter-sectoral collaboration; the 
availability of resources; the affordability of available devices; and the positive externalities of allied 
TISs. The main barrier to knowledge development and diffusion was in the form of barriers to inter-
sectoral collaboration. These include unmatched expectations from partners in collaboration, 
different views on intellectual property ownership, and burdensome university administrative 
processes. The orthopaedic devices TIS was structurally coupled to the embedded TIS and sectoral 
contexts, and externally linked and structurally coupled to its political context. Knowledge 
development and diffusion was found to be positively enhanced by innovation in the additive 
manufacturing TIS, with shared structural elements and resources. Knowledge development and 
diffusion was influenced by sectoral dynamics of the university, healthcare and industry sectors.  
This thesis makes the following contributions. First, it applies the TIS framework to a new focus area, 
namely medical device development, in a developing country context. Second, it makes two unique 
methodological contributions: it presents an index to capture the extent of sectoral collaboration in a 
network; and it develops a method for determining the collaboration potential of actors in a network 
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The term “orthopaedics” refers to a branch of medicine concerned with the correction of deformities 
of the musculoskeletal system (The American Heritage Science Dictionary, 2011). While orthopaedics 
may be easy to define, the orthopaedic burden of disease could be classified under different causes. 
The “Revised Burden of Disease Estimates for the Comparative Risk Factor Assessment, South Africa 
2000” (Bradshaw, Schneider, & Groenewald, 2006) includes an estimate for morbidity and non-fatal 
injuries due to a disease, i.e. years lived with disability (YLD). Of the top 20 leading causes of YLD, four 
categories are addressed by the orthopaedics speciality: interpersonal injuries (ranked 3rd), falls 
(ranked 8th), osteoarthritis (ranked 12th) and road traffic accidents (ranked 16th). Injury-related 
disorders have been highlighted as one of the four elements of the quadruple burden of disease in 
South Africa (Mayosi, et al., 2009). An orthopaedic medical device is a part, implant, prosthetic or 
orthotic that is used to address injuries or diseases of the musculoskeletal system. The primary 
purpose is to provide stability and mobility. 
South Africa’s medical device industry is made up of many small players (600 to 700 companies) and 
a handful of large multinational corporations (MNCs), with very little known about the value of local 
manufacturing and about who is producing what (Trade & Industrial Policy Strategies, 2018). The 
market however is dominated by large MNCs, with approximately 90% of all products being imported 
(Deloitte, 2014). Sixty-eight percent of local medical devices companies are solely distributing 
imported devices, and 26% of local medical devices companies manufacture devices locally (Trade & 
Industrial Policy Strategies, 2018). Approximately 90% of the local manufacturers also act as 
distributors of imported devices, suggesting that it may be difficult to act as a local manufacturer (only) 
in the current South African market (Trade & Industrial Policy Strategies, 2018). Total imports for the 
medical device industry was valued at ZAR11.07 billion, and total exports at ZAR1.08 billion, in 2013 
(Deloitte, 2014). The latter figure shows some local activity and opportunity in the South African 
medical device market. It is however not clear what percentage of the export figure represents 
products manufactured locally in South Africa, as it could also include re-export value, where suppliers 
use South Africa as an export gateway. Most exports are to other African countries (KPMG, 2014). Of 
the ZAR13.05 billion of products imported in the period 2004-2013 in the category “Surgical 
Appliances and Surgical Supplies”, 65% (ZAR8.5 billion) comprised products listed as “orthopaedic 
appliances” (Deloitte, 2014). These “orthopaedic appliances” were grouped as “artificial joints”, 
“other artificial parts of the body, not elsewhere specified” and “other appliances which are worn or 
carried or implanted in the body, not elsewhere specified.” In 2016, “orthopaedics and prosthetics” 
medical devices accounted for 11% of the medical device market in South Africa (Department of Trade 
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and Industry, 2018a). Of the top ten groups of medical devices most imported into South Africa in 
2013, four were classified as orthopaedic devices, with a combined value of ZAR1.8 billion. Of the top 
ten groups of most exported medical devices, only one was classified as orthopaedic devices, with a 
value of ZAR50 million. These figures indicate the substantial value of imported orthopaedic devices. 
They also suggest that the supply of such devices by the domestic medical device market in South 
Africa may be limited. This study investigates the orthopaedic devices innovation system in South 
Africa and how such an innovation system may address the South African orthopaedic burden of 
disease. In this study, the orthopaedic devices innovation system is analysed using a technological 
innovation system (TIS) framework (described below). The starting point of the TIS is the technology, 
in this case orthopaedic devices, and the emphasis is on interacting agents.  The orthopaedic devices 
TIS co-exists with the National System of Innovation (NSI). An NSI is described by Metcalfe (1995) as 
“the set of distinct institutions which jointly and individually contribute to the development and 
diffusion of new technologies and which provides the framework within which governments form and 
implement policies to influence innovation processes”. The starting point of the NSI is usually a 
geographic area (Hekkert, Suurs, Negro, Kuhlmann, & Smits, 2007), a country.  
Thus, the TIS and the NIS offer different perspectives on, and consider different aspects of, innovation. 
The use of the TIS as a framework in this study enables a focus on orthopaedic devices, with the aim 
of identifying factors that may support orthopaedic device innovation in South Africa. 
1.1 Technological innovation systems as a framework for the study 
A technological innovation system (TIS) has been defined as a “network of agents interacting in a 
specific economic/industrial area under a particular institutional infrastructure or set of 
infrastructures” which “is involved in the generation, diffusion, and utilisation of technology” (Carlsson 
& Stankiewicz, 1991). The TIS comprises structure and functions. The structure comprises actors, 
networks and institutions of the TIS. Functions refer to core processes of the innovation system to 
move the technology forward. Hekkert et al. (2007) refer to seven functions of the TIS, including 
“entrepreneurial experimentation and production”, “knowledge development”, “knowledge diffusion 
through networks”, “guidance of the search”, “market formation”, “resource mobilisation” and 
“counteract resistance to change/legitimacy creation”.  
As this study is concerned with the development of orthopaedic devices, the functions “knowledge 
development” and “knowledge diffusion through networks” are explored. A study of these functions 
would reveal the existing capabilities within the TIS. Knowledge development is described by Bergek 
et al. (2008a) as learning and involving activities in which learning takes place. Indicators of knowledge 
development include the number of scientific publications and patents produced by actors of the TIS 
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(Hekkert, Negro, Heimriks, & Harmsen, 2011). Knowledge diffusion through networks relates to the 
exchange of information within and between actors in the networks. Indicators of knowledge 
exchange include the types of knowledge exchange occurring in the network as well as the number of 
networks (Hekkert, Negro, Heimriks, & Harmsen, 2011).  
Several authors have emphasised the importance of examining context in TIS analysis. Technology 
evolves differently in different contexts, resulting in TIS outcomes that are context-specific. Bergek et 
al. (2015) posited that TIS-contextual factors could present in several forms, including: the effect of 
different TISs in which the focal TIS is embedded; the sectors of which the TIS forms a part; 
geographical factors; and political factors. In this thesis, the author argues that “knowledge 
development” and “knowledge diffusion through networks” of the orthopaedic devices TIS in South 
Africa are influenced by TIS-contextual factors. This is achieved by regarding orthopaedic device 
development in South Africa as a technological innovation system and applying the TIS framework to 
guide the study. The orthopaedic devices TIS in this project, is therefore defined as the networks of 
actors who interact under a set of institutional infrastructures and are involved in the generation, 
diffusion and use of orthopaedic devices in South Africa. By identifying TIS-contextual factors, this 
study highlights drivers and obstacles for the orthopaedic devices TIS in South Africa.  
1.2 Aims and objectives 
The aim of the study is to investigate knowledge dynamics in the orthopaedics devices TIS and the 
effect of the South African context on knowledge development and exchange in the TIS. The specific 
objectives of this thesis are:  
1. To identify the actors who develop knowledge in the orthopaedic devices TIS in South Africa 
and to characterise the relationships between them. 
2. To identify the focus areas of orthopaedic device development in South Africa. 
3. To provide insight into what drives and hinders “knowledge development” and “knowledge 
diffusion through networks” in the orthopaedic devices TIS in South Africa. 
4. To identify the TIS-contextual factors that influence “knowledge development” and 
“knowledge diffusion through networks” in the orthopaedic devices TIS.  
This study has a quantitative and a qualitative component. The actors who develop knowledge in the 
orthopaedic devices TIS are identified using bibliometric data of scientific publications and patents 
and are related using co-authorship and co-inventorship as a proxy for collaboration. Using social 
network analysis (SNA) techniques, relationships between actors are quantified and knowledge 
diffusion in the networks is characterised. The research focus areas are identified through keyword 
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networks; further relationships between actors are established through the consideration of their 
cognitive distance. The analysis of actor-collaboration and keyword networks comprises the 
quantitative component of the study. The institutions that impact orthopaedic device innovation in 
South Africa are reviewed, providing evidence for the political context in which the orthopaedic 
devices TIS is embedded. Case studies exploring knowledge development and diffusion dynamics 
present actor experiences of their participation in the orthopaedic devices TIS. The case studies reveal 
how actors are structurally coupled to the embedded TIS and the sectors to which they belong. The 
institutional review and the case studies comprise the qualitative component of the study.  
This research contributes towards the knowledge base on TIS by identifying contextual factors that 
affect the TIS for orthopaedic medical devices in South Africa. In doing so, it responds to the lack of 
literature on application of the TIS framework in developing countries, and it expands the set of 
technological fields to which the TIS framework has been applied. 
1.3 Thesis structure 
A literature overview is presented in Chapter 2 and the conceptual framework for the project is 
presented in Chapter 3.  Chapter 4 presents the social network analysis methodology to be employed 
in Chapters 5, 6 and 7. The scientific base for orthopaedic device development in South Africa, which 
has been published in Scientometrics (Salie, de Jager, Dreher, & Douglas, 2019) is presented in Chapter 
5. The technological base of orthopaedic device development in South Africa is presented in Chapter 
6, through the analysis of actor-collaboration networks from patent bibliographic data. In Chapter 7, 
the research areas, and actors’ interests within the scientific base, of the orthopaedic devices TIS are 
explored through keyword networks. Chapter 8 reviews the institutions that impact the orthopaedic 
devices TIS in South Africa. Chapter 9 presents case studies of the orthopaedic devices TIS.  The 






2. Literature overview 
In this thesis, it is hypothesised that “knowledge development” and “knowledge diffusion through 
networks” of the orthopaedic devices technological innovation system (TIS) in South Africa is 
influenced by TIS-contextual factors. In this chapter, the pertinent literature is reviewed. The chapter 
starts by introducing the biomedical innovation system and its relation to the medical devices and 
healthcare ecosystems in South Africa. The concepts of knowledge and learning are introduced and 
the TIS framework and its knowledge functions are reviewed.  The chapter ends with a critical review 
of the literature and highlights the gap that this study aims to address.   
2.1 The biomedical innovation system 
Medical device development involves different sectors, each of which plays a different role in 
innovation. The healthcare sector identifies patient needs, has access to patients and their data and 
ensures that  suitable technology reaches the patient; universities and science councils are platforms 
for research and development, and have advanced or specialised resources, instrumentation and 
expertise; and industry focuses on the development, production and commercialisation of 
technologies (Lander, 2014; Chimhundu, de Jager, & Douglas, 2015; de Jager, Chimhundu, Saidi, & 
Douglas, 2017). Collaboration between these sectors enables knowledge transfer and the sharing of 
capital across sectors, while ensuring that technologies match patient needs and ultimately reach the 
market. Through collaboration, organisations can create social networks, gain complementary 
expertise and share resources, which often results in the integration of knowledge, efforts and 
capabilities, and enhances productivity (Powell, Koput, & Smith-Doer, 1996).  
In a study of the British research system, Hicks & Katz (1996) identified two clusters of organisations 
– one cluster linked to industry, and the other cluster linked to healthcare facilities – which could serve 
as a source of technical opportunity and sites of application. In the healthcare facilities cluster, the 
site of application was hospitals, which were connected to sources of biomedical technical 
opportunity, i.e. non-profit organisations, special health authorities, and through them, research 
councils and universities. Hospitals were the site at which much of biomedical research activity in the 
UK research system was ultimately applied. The analysis suggests the co-existence of a biomedical 
innovation system with the more commonly acknowledged industry-oriented system. The biomedical 
system, however, is quite different: hospitals contribute more substantially to the science base than 
does industry, and access to patients is needed for biomedical research. Hicks & Katz conclude that 
better knowledge of the biomedical system would support insights into its innovation activities and 
its contributions to the UK science base. 
24 
 
Lander & Atkinson-Grosjean (2011) and Lander (2013) deem the biomedical innovation system to be 
the clinical pathway of innovation. The biomedical innovation system relies on public sector 
institutions, including universities and hospitals, as well as private sector industry actors (Lander & 
Atkinson-Grosjean, 2011). Lander (2013) showed that the infection and immunity network in 
Vancouver, Canada, is dominated by interactions between two non-commercial sectors, i.e. 
universities and hospitals. They highlighted the roles of different sectors in research and development, 
and showed that alternate innovation pathways, dominated by the public rather than the private 
sector, exist and are successful. Lander & Atkinson-Grosjean (2011) showed that translational science 
occurs between the university and academic hospitals in biomedical innovations; this translation is 
often not recognised because the university and the academic hospital are considered to be a single 
entity.  
The South African Medical Research Council (SAMRC) and PATH1 (South African Medical Research 
Council and PATH, 2014) investigated the development of an ecosystem to support a medical devices 
and diagnostics industry for South Africa. They interviewed different stakeholders – government, 
healthcare, industry, research organisations (including science councils) and private investment 
organisations, and made recommendations aimed at building the local medical devices and diagnostic 
industry, reducing the country’s trade deficit, improving access to healthcare, and reducing 
unemployment by developing local business opportunities through innovation. Many of the 
recommendations required government engagement and initiatives that government would need to 
pursue to create a favourable ecosystem for the local medical devices and diagnostics industry to 
flourish. The success of the medical device and diagnostics industry was said to lie within different 
stakeholders having a unified vision and collaboration among the different stakeholders towards that 
vision. Lack of alignment within the current ecosystem was identified as a barrier to existing innovation 
processes, where innovations arising from universities were not being translated to commercial 
products. Contributing factors reported were the many research focus areas within the university 
healthcare space and the lack of commitment to South Africa’s healthcare and health technology 
requirements. Current innovation incentives were also reported to be misaligned and therefore 
unable to maximise the market impact of research and development through to commercialisation. 
In universities and science councils, research was publication driven, rather than focused on product 
development. The lack of incentives to procure locally manufactured devices, and the inability of 
government sponsorship for device development to translate into preferential treatment in the public 
healthcare space, were also cited.  
 
1 PATH is a global team of innovators working towards health equity; services include advising and working with 
different stakeholders to solve health issues (PATH, 2020).  
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The South African medical device innovation ecosystem, adapted from Bunn (2018), is presented in 
Figure 1. 
 
Figure 1: The South African medical device innovation ecosystem, adapted from Bunn (2018) 
The South African medical device innovation ecosystem comprises stakeholders from different 
sectors. Industry associations, the South African Medical Device Industry Association (SAMED) and the 
Medical Device Manufacturers South Africa (MDMSA), are addressing import substitution of medical 
devices into South Africa.  SAMED is an industry association, comprising members from local 
companies and multinational corporations (MNCs), which oversees medical device policies, 
innovation, and ethical principles and practices among its members within South Africa (South African 
Medical Technology Industry Association, 2018).  The MDMSA is an industry association of companies 
that manufacture medical devices in South Africa (Medical Device Manufacturers Association of South 
Africa, 2015). These industry associations engage with government departments, such as the 
Department of Trade and Industry (dti) to support the domestic medical device industry. There are bi-
directional flows between (local and global) needs and (local and global) markets. Public and private 
healthcare, health professionals, and national and provincial departments of health are responsible 
for identifying the local needs. The local needs also inform the devices to be developed for 
local/regional markets. Local and global needs are fed to the innovators – science councils, 
universities, not-for-profit organisations, local manufacturers and start-ups – which are self-funded or 
funded through various mechanisms of the Department of Science and Technology (DST), SAMRC, the 
Technology Innovation Agency (TIA), the Industrial Development Corporation (IDC), venture capitalists 
and international donors.  The end-users in global markets identify global needs; the global needs 
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inform the devices to be developed for global markets. Developments addressing local and global 
needs feed to the MDMSA, and after several regulatory processes, feed into the local and international 
markets.   
Trade & Industrial Policy Strategies (2018) investigated the Johannesburg health cluster, providing a 
motivation to develop a medical devices cluster for the City of Johannesburg. In the report, medical 
device manufacturers and suppliers were positioned as healthcare service providers to the South 
African health cluster as described in Figure 2.  
 
Figure 2: The health cluster, as described in Trade & Industrial Policy Strategies (2018). Activities in the purple space are core 
cluster activities aimed at providing healthcare to patients. Pink boxes, below the purple box, are facilitators to the healthcare 
cluster. Yellow boxes lying within the purple space are providers of healthcare. Blue boxes are the providers of healthcare 
services.   
Core cluster activities provide healthcare to patients. The providers (medical practitioners, specialist 
input services and allied medical practitioners) of the core cluster services interface with the patient 
either through hospital or ambulatory care. Government, universities/research organisations, 
institutions and associations, and medical insurance schemes do not form part of the core activities; 
however, they are facilitators that enable and direct healthcare to patients within the health cluster. 
The report also focussed on problems faced within the existing medical device industry and on what 
would enable its growth. Two key emergent growth opportunities were uncovered: mass production 
at the lower-end medical consumables market (import substitution) and high-end, high-value new 
product development (for local and export markets). The report found that many of the constraints 
within the medical device industry could only be alleviated with government interventions.  
27 
 
The main difference between the biomedical innovation system described by Hicks & Katz (1996), 
Lander & Atkinson-Grosjean (2011) and Lander (2013), and the South African medical devices 
innovation ecosystem (Bunn, 2018), is that in the latter, members of the healthcare sector are not 
regarded as innovators; their role appears to be limited to identifying local needs in medical device 
innovation and being the users of such devices.  This is despite the scientific evidence provided by 
Hicks & Katz (1996), Lander & Atkinson-Grosjean (2011) and Lander (2013), which identifies the 
healthcare actor as critical in the biomedical innovation system. Hicks& Katz (1996) showed that 
hospitals were the site of application, and that hospitals contributed towards the scientific base for 
biomedical innovation and are an even bigger contributor to the science base than industry. The 
health cluster put forth by Trade & Industry Policy Strategies (2018) identifies the critical role of other 
actors, like medical insurance companies, which facilitate or hinder the implementation of developed 
devices in the local market. According to the General Household Survey of 2014 (Statistics South 
Africa, 2015), medical insurance coverage in South Africa was at 18.1% in 2014. This puts medical 
insurance companies in a gate-keeping position where they can accept or refuse costs delegated to 
them. Thus, the available South African frameworks that capture or allude to the medical devices 
innovation system (Figures 1 and 2) do not capture the roles of all the actors in the innovation system, 
nor do they illustrate a co-ordinated innovation system. 
To investigate the performance of an innovation system, several frameworks exist. These include the 
National System of Innovation (Lundvall, 2016), the Sectoral System of Innovation and Production 
(Malerba, 2002), Technological Innovation Systems (Hekkert, Suurs, Negro, Kuhlmann, & Smits, 2007; 
Bergek, Jacobsson, Carlsson, Lindmark, & Rickne, 2008a), the Triple Helix Model of Innovation 
(Leydesdorff & Erkowitz, 1998) and the Quadruple Helix Model of Innovation (Carayannis & Campbell, 
2009), among others. The technological innovation system (TIS) framework is used in this research 
project as it places the development of technology in a central position, and it explores how the actors, 
networks and institutions perform functions necessary for the technology to develop. Central to this 
framework is knowledge development and exchange. While the TIS conceptual framework use in this 
project is presented in Chapter 3, literature on knowledge development and exchange is reviewed in 
the next section.  
2.2  Knowledge development and exchange 
2.2.1 Knowledge development 
Van Raan (2004) distinguishes two different types of knowledge: basic, which relates to 
understanding, or applied, which relates to use. This knowledge could be codified – sometimes 
referred to as explicit knowledge – or tacit. Tacit knowledge has a technical and cognitive component; 
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the technical component refers to “know how” while the cognitive component is implicit, formed by 
mental models and beliefs that shape the way the individual perceives the world (Nonaka & Takeuchi, 
1995). Examples of codified knowledge include patents and publications. Tacit knowledge is more 
personal and may be hard to communicate or share with others (Nonaka & Takeuchi, 1995); examples 
include formal and informal contacts and networks, shared technical facilities, human resources and 
mobility, and spin-off or start-up companies (Tijssen, 2004). Nonaka & Takeuchi (1995) developed a 
theoretical framework of organisational knowledge creation based on knowledge conversion between 
tacit and codified knowledge. Four modes of knowledge conversion were described, including 
socialisation (tacit to tacit), externalisation (tacit to codified), combination (codified to codified) and 
internalisation (codified to tacit). Tijssen describes a sequence of five stages in knowledge creation 
and utilisation: creation, dissemination, acquisition, storage and absorption of knowledge. While the 
results of these stages may be codified, the entire process results mainly from human actions and 
interaction generating tacit knowledge. Knowledge development builds on what has already been 
learned or is already known. As Powell et al. (1996) put it: “Knowledge facilitates the use of other 
knowledge. What can be learned is crucially affected by what is already known”.  
Forms of basic and applied knowledge are scientific and technological knowledge, respectively. With 
scientific knowledge, communication of the research results is part of the scientific endeavour. This 
usually takes the form of scientific publications, like journal articles. However, it is not the only 
communication channel. Acceptance of a paper for publication in a well-known refereed journal is an 
indication that it reports meaningful research (Braun, 2004). The citation of a publication is an 
acknowledgement of research, usually by other scientists, and citation has been used as an indicator 
to illustrate how new research builds from older publications. Journal articles are not the main vehicle 
for scientific knowledge in all research fields (van Raan, 2004). Patents provide details on the 
technological characterisation of a patented invention (Gittelman, 2008) and have been used as 
output-based indicators of technological knowledge (Park & Park, 2006). The number of patents, or 
patent count, has been adopted as a measure of the amount of technological knowledge produced by 
an organisation or country (OECD, 2001; Lach, 1995). Similar to the citation of journal articles, patent 
citation shows how new technologies are related to previously patented technologies.  
Knowledge is coupled to learning. Typically, two modes of learning are distinguished: the science, 
technology and innovation (STI) mode and the doing, using and interacting (DUI) mode.  The STI mode 
relies on formal processes of research and development that explicitly produce codified knowledge, 
while the DUI mode focuses on learning via informal interaction within and between organisations 
where the end result is building competencies, usually associated with tacit elements (Jensen, 
Johnson, Lorenz, & Lundvall, 2016). The STI mode is usually applied in research fields associated with 
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analytical processes that identify natural principles such as, for example, chemical, pharmaceutical, 
biotechnology and nanomaterials; it requires investment into research and development activity to 
generate knowledge, and is therefore associated with new and high technology industries (Gonzalez-
Pernia, Parrilli, & Pena, 2012). Knowledge is acquired through the DUI mode by finding solutions to 
problems that arise and is tacit and often highly localised (Jensen, Johnson, Lorenz, & Lundvall, 2016). 
The DUI mode is an experience-based learning mode and promotes the translation of scientific 
knowledge inputs into knowledge that drives outputs associated with engineering-based and 
manufacturing industries (Asheim & Coenen, 2005). The two modes of learning are not mutually 
exclusive; elements of both are present in almost all innovation activity, and strategies that promote 
innovation need to consider both (Jensen, Johnson, Lorenz, & Lundvall, 2016).  
Associated with the STI and DUI modes of learning, is the distinction of product innovation and process 
innovation. Product innovation refers to goods or services that are new or significantly improved 
regarding their characteristics or use (Parrilli & Heras, 2016). Process innovation refers to the 
implementation of a new or significantly improved technique, equipment, production or delivery 
method, and/or software (Parrilli & Heras, 2016) and is expected to yield efficiency and product gains 
through the introduction of better performing production processes (Gonzalez-Pernia, Parrilli, & Pena, 
2012). Process innovation may be further delineated according to technological or non-technological 
innovation, where technological innovation refers to the definition above, and non-technological 
innovation refers to commercialisation and organizational innovations.  
2.2.2 Knowledge exchange 
Organisational learning is a function of both access to knowledge and the ability to use and build on 
such knowledge (Powell, Koput, & Smith-Doer, 1996). To stay current in an evolving research field 
where know-how is critical,  requires that organisations be involved in the research process and be 
experts in both in-house research and in collaborative research with partners from various sectors 
(Powell, Koput, & Smith-Doer, 1996). In the innovation systems literature, “knowledge exchange” has 
become almost synonymous with “collaboration” or “partnership”. However, collaboration or 
partnership is one mechanism of knowledge exchange, and other forms of knowledge exchange do 
exist. The technological innovation systems function “knowledge diffusion through networks” of 
Hekkert et al. (2007) extends to learning by DUI. 
Powell et al. (1996) refer to two types of learning associated with collaboration. The first type is 
strategic and based on risk vs return; the decision to collaborate is dependent on factors such as the 
size of the organisation and its position in industry, technological sophistication, resource constraints 
and previous collaborations. It also appears to depend on the specific types of skills or resources 
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exchanged (Hennart, 1988; Pisano, 1989; Parkhe, 1993). The second type is a process of social 
construction (Brown & Duguid, 1991), where the learning is associated with the conditions under 
which it is learned.  The sources of innovation are not limited to one organisation, instead, innovation 
occurs where firms, universities, research laboratories, and other actors in the innovation chain, meet. 
Social networks matter because face-to-face contacts between knowledge developers are necessary 
to transfer knowledge which escapes codification. This knowledge includes skills, which may be 
facilitated though practical demonstration, and scientific and technical jargon necessary for 
engagement (Breschi & Lissoni, 2004). While the DUI mode may be inherent in organisational 
operations, Jensen et al. (2016) point out that the DUI mode can also be intentionally adopted through 
building structures and relationships that enhance and utilise doing, using and interacting, such as, for 
example, project teams, problem-solving groups, and personnel rotation that promotes knowledge 
exchange. A mechanism to emphasise this localised knowledge, and diffuse it more broadly, is through 
interaction with external actors. Organisational knowledge creation in Japanese companies, described 
by Nonaka & Takeuchi (1995), refers to their capacity to create new knowledge, disseminate it through 
the company, and embody this knowledge in its products, services and systems.  Here, knowledge is 
sought outside the organisation from suppliers, customers, distributors, government and competitors 
and this knowledge becomes part of the organisation’s knowledge base, feeding into the development 
of new products and technologies. The knowledge is then transferred outside the organisation in the 
form of the product or technology. This internal-external cycle encourages continuous innovation in 
Japanese organisations. 
The STI mode supports interactions with new knowledge producers, like universities and public 
research organisations, which generate codified knowledge that can be exploited by industry to 
produce innovations (Fitjar & Rodriguez-Pose, 2013). In fact, university-industry collaboration is an 
important manifestation of the STI mode of learning (Gonzalez-Pernia, Parrilli, & Pena-Legazkue, 
2015). Gonzalez-Pernia et al. investigated the separate and combined effects of STI and DUI modes of 
learning on companies collaborating with universities, other scientific knowledge producers 
(technology centres, research laboratories, and consulting services) and DUI partners such as 
customers, suppliers and competitors. They found that company partnerships with universities, 
without engaging other STI and DUI partners, were weak for product innovation, while simultaneous 
STI and DUI partnerships, were found to be linked to a higher probability of product innovation. 
Process innovation was found to be more likely with the simultaneous engagement of other STI 
partners (not universities) and DUI partners. Their findings highlight the importance of combining 
strengths and complementarities of different partners through the innovation chain.  
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2.2.3 Knowledge development and exchange in biomedical innovation systems 
The idea of innovation being a linear process of ideas born in universities, developed into new 
products by industry and then used by clinicians in healthcare facilities, is an oversimplification of the 
iterative process of discovery and development in medical research (Academy of Medical Sciences, 
2010). Moon (2004) showed that the great mechanical innovations in history were as a result of both 
technological evolution and complex social networks, and that new technological products were 
usually preceded by other emergent technologies. In medical device development, actors from 
different sectors collaborate, and each actor plays a different role in the collaboration. This networking 
is necessary because it results in knowledge transfer and sharing of capital across sectors, while 
ensuring that developed technologies meet patient needs and reach the market. This interaction could 
also be measured, within limits, using codified indicators of knowledge development, i.e. scientific 
publications and patents (Hekkert, Negro, Heimriks, & Harmsen, 2011). Co-authorship of scientific 
publications and co-inventorship of patents, which serve as proxies for collaboration, have been used 
in social network analysis (SNA) studies to quantify knowledge exchange between actors. Newman 
(2001) used co-authorship of scientific publications to illustrate scientific collaboration networks. 
Fleming & Marx (2006) illustrated that collaborations recorded in patent data captured personal and 
professional ties between inventors. 
The SNA literature using scientific publications, patents, or a combination of both, is abundant. In the 
latter the focus is often on university-industry interaction and the translation of basic science to 
commercialising technologies. Within this body of literature, work on medical device development is 
limited and therefore literature on medical and biomedical applications more broadly, is reviewed 
here. These include biotechnology (Powell, Koput, & Smith-Doer, 1996), tissue engineering (Murray, 
2002), cancer research centres (Long, Cunningham, & BraithWaite, 2012; Long, Cunningham, Wiley, 
Carswell, & Braithwaite, 2013), medical research (Chinchilla-Rodriguez, Benavent-Perez, De Moya-
Anegon, & Miguel, 2012), infection and immunity (Lander & Atkinson-Grosjean, 2011; Lander, 2013; 
Lander, 2014) and medical devices (Chimhundu, de Jager, & Douglas, 2015; de Jager, Chimhundu, 
Saidi, & Douglas, 2017). 
Powell et al. (1996) mapped the emerging biotechnology industry to explain the extensive inter-
organisational collaboration in that field. They put forward that, “when the knowledge base of an 
industry is both complex and expanding, and the sources of expertise are widely dispersed, the locus 
of innovation will be found in networks of learning, rather than individual firms.” They found that the 
age of a company was not a predictor for network behaviour. Growth was a process that required 
time; organisational growth stemmed from the initiation of collaborations and was stimulated by 
centrality. Centrality was produced by research and development ties, experience and diversity. This 
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central connectedness cycled back to intensify a company’s commitment to exploration through its 
network.  
Murray (2002) investigated the communication between science and technology networks in cartilage 
tissue engineering. Using interviews, patents, scientific publications, and archival analysis, Murray 
showed distinct scientific and technological networks, with bidirectional communication between the 
two networks. Bibliometric indicators showed that a few key scientists published in both domains, 
while industry actors did not really participate in scientific publications. The interviews, however, 
highlighted considerable overlap between the two networks, not captured in bibliometric data. 
Reasons for this overlap included the involvement of key scientists in patenting and technology 
development, forming start-up companies, consulting, mentoring and informal advice. In particular, 
Murray found that academic scientists actively shape the co-evolution of patent and publication 
networks.  
Long et al. (2012) and Long et al. (2013) investigated the importance of actors’ position and strategic 
activities in a translational cancer research network. Translational research centres were a strategy 
developed to overcome gaps between clinicians and biomedical researchers. Gaps included 
administrative structures for shared resources, social structures in hospitals and universities which 
facilitate collaboration, and mechanisms for information and knowledge transfer between biomedical 
and clinical disciplines. Using online surveys and semi-structured interviews, their network analysis 
revealed that key network actors were a well-connected group with positions in the network that 
denoted high centrality and brokerage potential. 
Chinchilla-Rodriguez et al. (2012) investigated international collaboration in medical research in Latin 
America and the Caribbean. Their study aimed to determine the countries’ capacity to engage in 
scientific collaboration both intra- and extra-regionally, as a means of identifying the countries that 
hold central and strategic positions in collaboration networks, and determining the countries 
benefitting most from the relationship dynamic in terms of productivity. They found that all countries 
in the region tended towards internationalisation. The network was found to be occupied by three 
dominant trios of countries, which were the region’s largest publication producers, with low 
collaboration rates. Thus, countries with the largest outputs had low international collaboration rates, 
and collaboration would not seem to affect publication production in such countries. In contrast, 
smaller countries had relatively high collaboration rates, and satellite countries had small output with 
high collaboration rates. International collaboration enhanced visibility, however, not all countries 
were equally effective in this way, and not all countries benefitted from collaboration to the same 
degree. Using citation analysis, the authors showed that the most productive countries used 
knowledge generated domestically or by their neighbours.  
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More recently, collaboration for medical device development has been investigated in South Africa. 
Chimhundu et al. (2015) investigated the types of collaboration within and between sectors in 
cardiovascular medical device (CMD) development in South Africa and the extent of collaboration 
within and between sectors, and analysed collaboration trends for the period 2000 to 2014. A network 
analysis was performed, with co-authorship data obtained from scientific publications to indicate 
collaboration across four sectors, i.e. industry, universities, healthcare services, and science councils 
and facilities. Two networks were defined, namely local (South African organisations only) and global 
(South African and foreign organisations). Results showed that the university and healthcare sectors 
were the most active in CMD development in the global network. The most prevalent type of inter-
sectoral collaboration was between the university and healthcare sectors. The CMD development 
network was found to be improved by the presence of foreign organisations, as the global network 
absorbed some of the local actors that were isolated in the local network; foreign actors thus provided 
alternative pathways for knowledge exchange. Results further showed considerable unrealised 
collaboration potential in both networks and that university actors played a considerable role in 
determining the behaviour of the network.  
De Jager et al. (2017) investigated the medical device development landscape in South Africa. SNA 
using co-authorship of scientific publications was used to identify organisations and sectors active in 
medical device development in South Africa, quantify the extent of intra- and inter-sectoral 
collaboration, and investigate the influence of international actors. The central actors were seven 
South African organisations. Four were from the university sector, two were from the healthcare 
sector (both academic hospitals) and one was from the science and support sector. Universities 
collaborated extensively both intra- and inter-sectorally. Universities formed hubs in the network that 
could facilitate knowledge exchange and potentially help to establish new collaborations. The 
healthcare sector actors also collaborated extensively with each other. This practice may be attributed 
to many healthcare actors present in the network being academic hospitals which may have mimicked 
university behaviour. Small sectors, like the science and support sectors, were involved extensively in 
inter-sectoral collaboration, while larger sectors did not necessarily engage as extensively in inter-
sectoral collaboration. Even though international actors were found to have a presence, local actors 
collaborated more extensively with each other than with international actors. De Jager et al. further 
investigated the presence of “translational collaboration”, defined as collaboration across three 
sectors – university, healthcare and industry – which are considered to be essential if biomedical 
discoveries are to be translated into clinical practice (Academy of Medical Sciences, 2010). Only 7 % 
of the publications of the dataset were due to translational collaboration. The authors suggested that 
34 
 
this might be an indication that the biomedical innovation system in South Africa was not fully utilising 
innovation pathways described in Lander & Atkinson-Grosjean (2011).  
Sooryamoorthy (2010) also identified government as a contributing sector in medical research in 
South Africa. The trends seen in Chimhundu et al. (2015) and de Jager et al. (2017) reflect the 
contributions by different sectors to scientific output in South Arica more generally. In 2013, 90% of 
South Africa’s research output had at least one author from the university sector, while only 10% of 
research output was from the science council sector and 0.9% from the business sector (National 
Advisory Council on Innovation, 2014). The National Advisory Council on Innovation report showed 
that industry and science councils collaborated mainly with universities; however, there was a low 
level of research collaboration between industry and science councils, and businesses undertook 
limited research. Universities appeared to be the driving force in intersectoral collaboration producing 
more co-authored articles with other universities, science councils and industry, compared to the 
number of co-authored publications among the other sectors combined. Additionally, most 
international collaborations involving South African researchers were with developed countries. 
2.3 Summary 
In this literature review, the concepts of codified and tacit knowledge were introduced, the STI and 
DUI modes of learning were described, as were organisational knowledge and learning. The South 
African medical device innovation system was considered in the context of the literature on 
biomedical innovation systems. There is some discrepancy between the biomedical innovation system 
described in the literature (by Hicks & Katz (1996) and Lander (2013)) and that presented in recent 
reports from South African organisations. Frameworks describing the South African medical device 
innovation system were found lacking in terms of recognising healthcare actors as knowledge creators 
and in not recognising all actors who facilitate knowledge development processes.  
Quantitative studies on medical device innovation systems are available, while qualitative enquiry to 
investigate innovation system dynamics, such as the learning processes that occur for knowledge 
development and exchange and the interactions between actors that enable such learning, are 
lacking.   
Central to innovation system frameworks are knowledge development and exchange. A fundamental 
point made by Powell et al. (1996) is that expertise is widely dispersed and the locus of innovation is 
found in networks of learning and not in individual organisations. Thus, the technological innovation 
systems framework, given its emphasis on networks, may present a route to examining how 
knowledge is developed and exchanged among actors in medical device innovation systems.  The 
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literature review has also highlighted the potential of social network analysis in identifying knowledge 





3. Overall conceptual framework 
This chapter presents the overall conceptual framework applied in the study. Certain elements of this 
conceptual framework are presented in Section 5.3, as Chapter 5 contains a verbatim account of a 
publication (Salie, de Jager, Dreher, & Douglas, 2019). There are therefore areas of overlap between 
this chapter and Section 5.3, which are included here in order to present a complete conceptual 
framework.  
A technological innovation system (TIS) is a “network of agents interacting in a specific 
economic/industrial area under a particular institutional infrastructure or set of infrastructures” which 
“is involved in the generation, diffusion, and utilisation of technology” (Carlsson & Stankiewicz, 1991). 
TIS structures include actors, institutions and networks which contribute to the generation, diffusion 
and utilisation of a new technology.  
A structural analysis can answer the following questions: “Which parties develop knowledge?”, 
“Where are the knowledge producers located?”, “How much knowledge is being developed?” and 
“What types of organisations are involved in knowledge production?” (Hekkert, Negro, Heimriks, & 
Harmsen, 2011).  Structural analysis is useful because it enables the identification of actors and 
networks in the TIS, the sectors and countries to which they belong and their relationships. Hekkert 
et al. (2011) concisely described the elements of the structure of the TIS, namely actors, networks, 
institutions and technology. The actors are individuals or organisations contributing to the TIS through 
the generation, utilisation and diffusion of the technology. The network is the interaction between 
the actors of the TIS. Institutions are the human-derived constraints, such as policies, laws and rules, 
that shape the interactions of the TIS and influence the behaviour of the actors (organisations) 
(Hekkert, Negro, Heimriks, & Harmsen, 2011). The technology enables and constrains the activities of 
innovation system actors and therefore forms part of the innovation system. Functions are core 
processes in a TIS that are complementary to the structure (Hekkert, Suurs, Negro, Kuhlmann, & Smits, 
2007). Hekkert et al. (Functions of innovation systems: A new approach for analysing technological 
change, 2007) and Bergek et al. (2008a) each describe seven functions of a TIS, with slightly different 
formulations. The functions described by Hekkert et al. (2007), are used in this research project, and 
are presented in Table 1. The functions of interest are “knowledge development” and “knowledge 






Table 1:The functions of the TIS as described in Hekkert et al. (2007) 
Function Description 
F1: Entrepreneurial 
experimentation and production 
Activities relating to the commercialisation of a technology.  
F2: Knowledge development Activities in which learning takes place.  
F3: Knowledge diffusion through 
networks 
Learning through the exchange of information within and between 
networks.   
F4: Guidance of the search Activities that positively affect the visibility and clarity of specific 
desires among technology users. 
F5: Market formation Activities for the creation of markets where new technologies may 
grow. 
F6: Resource mobilisation The mobilisation of resources for the development of the innovation 
system. 
F7: Legitimacy creation OR 
Counteract resistance to change 
Activities related to advocacy for enhancing stakeholder support for 
the new technology. 
 
Bergek et al. (2008a) compress the knowledge functions into “knowledge development and diffusion”. 
They introduce the function “development of positive externalities”, which reflects the development 
or strengthening of one function in the TIS in stimulating or positively influencing the development of 
other structural components or functions in the TIS. Both Hekkert et al. (2007) and Bergek et al. 
(2008a) present comprehensive frameworks to analyse TISs.  
Knowledge development and diffusion are said to be “at the heart of the TIS” (Bergek, Jacobsson, 
Carlsson, Lindmark, & Rickne, 2008a). Bergek et al. describe knowledge development involving 
activities in which learning takes place. “Knowledge diffusion” describes the exchange of information 
within and between networks; it extends to activities of learning involving use and interaction (Blum, 
Bening, & Schmidt, 2015). 
Several authors have emphasised the role of context in TIS analyses. Although the TIS framework is 
universally applicable (Bergek, Jacobsson, Carlsson, Lindmark, & Rickne, 2008a; Hekkert, Suurs, Negro, 
Kuhlmann, & Smits, 2007), technology development proceeds differently in different contexts, 
producing context-specific TIS outcomes. In addition, context is not static, but changes over time. 
Delineating favourable contexts enables the identification of opportunities that favour the 
development of new technologies (Bergek A. , et al., 2015). The way in which the TIS is linked to its 




Figure 3: Relationship of the TIS to its context. 
On the right-hand side of Figure 3 is the context of the TIS. Bergek et al. (2015) describe three types 
of contexts. The first type is the surrounding and related TIS where the context may be the result of 
how geographical or technological boundaries between the focal TIS and others are drawn (the 
embedded TIS). This means that other TISs that are dependent on the focal TIS, or other TISs on which 
the focal TIS is dependent, may influence its development. The focal TIS may therefore be embedded 
in the development of other TISs, or vice versa. The second type is related to pre-existing 
infrastructure and institutions (sectoral and geographical). Sectors and countries may already have 
established infrastructure and institutions which influence the TIS. When a new TIS develops, actors 
may come from already established sectors or countries, which may have habits and formal 
institutions which the new TIS may adopt, or adapt to its context, or challenge and change. The TIS is 
therefore influenced by the sectoral and geographical context, and it may influence the sectoral and 
geographical contexts. The third context type is political and related to the provision of system-level 
assets. This may present in the form of political support for technology-specific policies. On the left-
hand side of Figure 3 is the TIS, which comprises the structure (actors, networks and institutions) and 
functions (F1 to F7). The TIS interacts with the context in one of two ways: “structural couplings” or 
“external links”. Structural couplings are shared elements (actors, networks, institutions, technology) 
between a TIS and a specific context structure. External links are influences or resources or assets that 
are shared between a TIS and a specific context that may impact the development of the TIS; these 
external links are not affected by TIS-internal processes. External links may be distant forces affecting 
macro-level developments; external links may also be close to the TIS, such as national innovation 
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policy, market conditions, etc. The distinction between external links and structural couplings can be 
determined by the ability of the actors to influence the underlying contextual elements. If the actors 
can’t influence the underlying contextual elements, then the interaction is externally linked; if the 
actors can, then it is structurally coupled.  
When the TIS is contextually linked to an embedded TIS, there is an interdependence in the interaction 
of the two technologies (or technological fields). Different technologies may compete and 
complement each other in different ways and the coevolution of these inter-related TISs will influence 
the dynamics in each of them, as follows (Bergek A. , et al., 2015). Each TIS may form an important 
context for other TISs. The TIS-TIS interactions may be vertically- or horizontally-related. The focal TIS 
may require resources provided by other TISs. The development of up-stream TISs may influence the 
focal TIS positively or negatively. Up- or down-stream TISs (vertical relationships) may become 
bottlenecks for “knowledge development” in the focal TIS if complementary technologies are not 
developing at the same pace as the focal TIS. The focal TIS may also produce products required by 
downstream TISs. The development of the focal TIS then influences downstream TISs, and may affect 
certain functions, like “guidance of the search”. TISs may be horizontally related if they share the same 
inputs and have complementary assets, or they have similar outputs as that of the focal TIS. Resultant 
interactions could be in the form of competition for resources, or structural couplings of actors and 
institutions.  
The dynamics of a given TIS are intertwined with the structure and dynamics of the sector(s) of which 
it is part. Sectors are composed of the same type of structural elements as TISs, but they rely on a 
larger set of technologies in different stages of maturity and on several different TISs, to provide their 
overall function (Bergek A. , et al., 2015). In sectoral systems of innovation and production, institutions 
shape the interaction between actors in terms of processes of communication, exchange, co-
operation, competition and command (Malerba, 2002). Sectors provide a stable context; individual 
TISs either have to adapt to this context, or they have to try to change it to their own benefit (Bergek 
A. , et al., 2015). Many TISs are part of several sectors. Interactions do not only occur in the sector in 
which the focal TIS is mainly embedded, but also with other sectors to which it is related. In particular, 
actors that enter an emerging TIS often come from other sectors. Because of such structural couplings, 
sectoral dynamics in adjoining sectors can influence the functional dynamics of the focal TIS. 
Coenen et al. (2012) emphasise the geographical context of TISs. They explain that space affects 
relationships, i.e. the distance between actors affects how they interact – regular interactions 
between actors result in more solid connections, institutions and networks. Their geographical 
analysis allows for the understanding of a phenomenon with space-specific impacts. The absence of a 
conceptualisation of space results in an underestimation of the coupling structures between the TIS 
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and the sectoral and contextual systems (Rochracher, Truffer, & Markard, 2010). It also results in an 
under-conceptualisation of relationships between different sub-system structures. By understanding 
how the TIS is coupled to its spatial context, case-specific findings in the literature could be made more 
general and comparable. The geographical context of TISs has been highlighted by several studies in 
recent years (Binz, Truffer, & Coenen, 2014; Wieczorek, Hekkert, Coenen, & Harmsen, 2015; Murphy, 
2015). Binz et al. (2014) developed an analytical framework, incorporating indices and spatial 
classifications, to evaluate the geographical or spatial dimension of the TIS and map the dynamics of 
the knowledge functions in membrane bioreactor (MBR) technology. They performed a network 
analysis of the actors over time to identify relevant actor locations and spatial levels of the TIS. Spatial 
levels may refer to local, sub-national, national, regional or international delineations. The authors 
explain that the spatial set-up of the TIS is specific to the technology in focus, and to the resources 
and relationships between actors involved in driving that technology.  
The political context in which the TIS is embedded is important to its development as it may impact 
the manner in which institutions are aligned. Government strategy and policy could result in actors in 
the TIS aligning their institutions to synchronise with those of government, and enable the provision 
of specific resources that are necessary for further maturation of the TIS (Bergek A. , et al., 2015). 
Bergek et al. highlight the importance of the political context, and the analysis of the political context, 
of the TIS for its development. Political support may present in the form of financial resources for 
research and development, formation of markets, legitimacy creation for the technology which may 
positively impact on the entry of new actors to the TIS, which may bring resources to the TIS. The 
analysis of the political context of the TIS should characterise the political system, including the way 
in which it may constrain or enable further development of the TIS. 
It has been pointed out that the TIS approach has enjoyed limited application in developing world 
contexts and that examination of emerging TISs in developing countries would contribute to 
conceptual development of the TIS framework (Blum, Bening, & Schmidt, 2015; Tigabu, Berkhout, & 
van Beukering, 2015a). Coenen et al. (2012) suggest that actors may have substantially different access 
to resources at different geographical levels, contrary to the assumptions of a “global opportunity set” 
(Carlsson, Jacobsson, Holmen, & Rickne, 2002) in which all actors are assumed to have equal access 
to external resources. This is evident in studies applying the TIS framework in developing and least 
developed country settings. Schmidt & Dabur (2014) delineated a “national TIS” and “international 
TIS” in their framework for the diffusion of biomethanation in India. They found that the role of the 
international TIS only contributed to a few functions, but these functions were the most developed in 
the TIS and relevant in the removal of barriers that were less rooted in national institutions. Blum et 
al. (2015) used the TIS approach to derive policy recommendations to increase the diffusion rate of 
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remote electric mini-grids in Laos. In delimiting their spatial contexts, they drew three geographical 
levels - local, national and international. They found that the low diffusion rates were due to 
institutional mismatches within and across geographical levels as well as hampered flows of resources 
across the geographical levels. Their geographical classification allowed for the identification of 
bottlenecks at geographical interfaces, which was important in understanding the functions in the 
Laotian context. Tigabu et al. (2015a) investigated the development of a bio-digestion TIS in Rwanda 
and mapped the dynamics of the bio-digestion TIS to understand how its functions influence the 
diffusion of the technology and to understand the determinants of the functioning of the TIS, so that 
ultimately, insight into policy measures could be generated. A process analysis was performed, where 
activities and processes related key actors, and their collaborations and institutions were analysed 
from a historical perspective.  Tigabu et al. (2015b) performed a comparative analysis of the diffusion 
of biogas between Kenya and Rwanda. They showed that the pattern of accumulation of TIS functions 
may determine the rate of diffusion of the technology, and argued that it shapes technology diffusion 
in least-developed countries. Kebede & Mitsufuji (2017) used the TIS framework to discuss the 
diffusion of solar photo voltaic (PV) systems and the build-up of associated PV TIS in Ethiopia. They 
delineated a TIS into a research & development (R&D)-based TIS and a diffusion-based TIS. A diffusion-
based TIS was defined as actors, networks and institutions “that interact and contribute to the 
diffusion of an existing technology along with building absorptive and innovative capacity for further 
improvement and diffusion of the technology”. In a diffusion-based TIS, the emphasis of context 
involves relying on the introduction of technology from industrialised countries, where the aim may 
be to adapt and use the technology, and for the generation of further innovations over time. Kebede 
& Mitsufuji adapted function indicators to be more suitable to the developing country. As an example, 
in the knowledge development function, the usual indicator is the number of scientific publications 
and patents related to the technology. These indicators are more suited to the R&D-based TIS than to 
the diffusion-based TIS. Indicators for knowledge development used in the diffusion-based TIS 
context, where learning by doing, using and interacting was more prevalent, included feasibility 
studies, market assessment, testing new business models, and the adoption of technology from 
developed countries. 
3.1 Application of the conceptual framework in this research project 
The orthopaedic devices TIS in South Africa is investigated in this project, with orthopaedic devices 
considered the technological field. In particular, this project investigates the functions “knowledge 
development” and “knowledge diffusion through networks” of the orthopaedic devices TIS. Actors 
who contribute towards scientific knowledge production in the TIS are identified through scientific 
publications and actors who contribute towards technological knowledge production are identified 
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through patents. Actor-collaboration networks are drawn based on bibliometric data on co-authorship 
and co-inventorship. These publications serve as indicators of “knowledge development” while the 
actor-collaboration networks represent “knowledge diffusion through networks”. By only considering 
the contribution of South African knowledge creators, a geographical boundary is drawn which sets 
the limits to the analysis of the TIS, although international actors that collaborate with national actors 
are considered. As medical device development involves inter-sectoral collaboration, the way in which 
the TIS is linked to its sectoral context is also considered. A spatial and sectoral analysis of knowledge 
development and exchange in the TIS is performed using the framework presented in Binz et al. 
(2014). The analysis as it pertains to scientific knowledge production is presented in Chapter 5, and 
the analysis as it pertains to technological knowledge production is presented in Chapter 6.   
To identify the focus areas of orthopaedic device development in South Africa, a keyword network 
analysis is performed. This keyword network analysis stems from a different conceptual framework 
which relates actors based on their cognitive distance. The framework, presented in Chapter 7, 
presents a methodology that may capture knowledge diffusion dynamics in actor-collaboration 
networks.  
A review of the institutions to which the actors of the TIS subscribe to may reveal norms, standards, 
laws and regulations of the TIS. It may also reveal institutional alignment of the TIS to its political 
context. An institutional review, presented in Chapter 8, along with the actor-collaboration networks 
in Chapters 5 and 6, identify the structure of the orthopaedic devices TIS. Case studies, using 
interviews as the primary data source, present actor experiences of knowledge development and 
exchange in the TIS, and present the way in which knowledge is developed and exchanged for 
orthopaedic device development in the South African context.    
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4. Social network analysis 
Social network analysis (SNA) is employed to address objective 1 of the thesis: “to identify the actors 
in the orthopaedic devices technological innovation system (TIS) in South Africa and to characterise 
the relationship between them”. The SNA in this thesis is performed using bibliometric data of 
scientific publications and patents. Scientific publications and patents are considered formal (i.e. 
codified) indicators of knowledge development in an innovation system (Hekkert, Negro, Heimriks, & 
Harmsen, 2011).    
In this chapter, an overview of the methodology employed in the subsequent SNA-related chapters 
(Chapters 5, 6 and 7) is presented. This chapter is a step-by-step account of the methodology to 
identify actors of the TIS, and to characterise relationships between them. As scientific publications 
and patents are different knowledge indicators, the actor-collaboration networks are defined and 
constructed separately, and are presented in Chapters 5 and 6, respectively. SNA has its roots in graph 
theory. While the keyword networks of Chapter 7 also lie in this domain, the nature of the networks 
differs from those in Chapters 5 and 6, and distinctions are presented in Chapter 7.   
4.1 Sourcing bibliometric data 
Search terms were used in Scopus and Thomson Reuters Web of Knowledge (WoK) to find journal 
articles and conference proceedings (jointly “scientific publications”), and in TotalPatent from 
LexisNexis to find patents that demonstrate orthopaedic device development. Conference 
proceedings may not be subject to the same level of peer review as journal articles (Franco, Malhotra, 
& Simonovits, 2014); however, only conference proceedings that have been captured by Scopus and 
WoK have been included in this study. Only full-text conference papers are captured by Scopus; 
conference papers in the Scopus database are selected on relevance and quality of the conference 
relative to the subject field (Elsevier, n.d.). Clarivate has specific criteria upon which conference 
proceedings are considered for the WoK database and its Conference Proceedings Citation Index; it 
includes considerations regarding basic publishing standards, content, copyright and conference date 
(Clarivate, 2019). 
The search phrases for the Scopus and Thomson Reuters WoK are provided in Appendix A, and the 
search phrase for TotalPatent is provided in Appendix B.  The searches were performed for the period 
2000 to 2015. The year 2000 was chosen as a start date because from the year 2000 there is a steady 
increase in scientific activity captured in the Scopus and Thomson Reuters WoK relating to orthopaedic 
device development in South Africa.   
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Search results were manually assessed to determine if the scientific publications and patents 
contributed to orthopaedic device development in South Africa. The retrieval of bibliometric data 
from scientific publications and patents differed. Each process is described below including the way 
author or inventor affiliation was established.  
4.1.1 Scientific publications 
Scientific publications retrieved using the search phrases were screened against the following criteria 
to be retained in the dataset: 
1. Publications had to show evidence of development of an orthopaedic device, based on the 
definition of an orthopaedic device. 
2. The publication had to have at least one author affiliated with a South African organisation.  
3. Retrospective clinical studies which showed the performance of orthopaedic devices were 
included, as clinical performance of the orthopaedic device could lead to ancillary studies for 
further device modification and development. 
4. Morphometric studies that were explicitly performed to bridge the gap between structural 
anatomy and device development, were included, as these studies directly contribute to the 
development of the device. 
5. New applications of an existing device were included, as a new application was considered to 
contribute to the device development through broadening the scope of application of the 
device. This did not extend to new surgical techniques developed for existing devices.  
6. Publications related to dental, orthodontic or maxillo-facial research were excluded. However, 
where publications showed extension to orthopaedic applications, they were retained.  
7. Publications relating to tissue engineering were largely excluded, except where they explicitly 
showed an extension to orthopaedic device development.  
8. Publications related to sports science were included only if they contributed to the 
development of an orthopaedic device but were excluded if the developed device was solely 
for improved sports performance.  
Once the full list of publications was finalised, author-affiliation data were extracted from publications 
and used to draw actor-collaboration networks. The relationships that may arise in the actor-
collaboration network are best illustrated through an example. Figure 4 shows an excerpt of the 
author affiliation details from Truscott et al. (2007), one of the publications included in the scientific 
publication dataset. This publication has seven authors affiliated with five organisations. Organisations 
are of interest in the actor-collaboration networks. Each organisation appearing in the dataset was 
given an abbreviation. In this example, the organisations were Central University of Technology (CUT), 
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University of Cape Town (UCT), Groote Schuur Hospital (GSH), Vincent Palotti Hospital (VPH) and 
Loughborough University (LU).  
 
Figure 4: Author affiliations for the publication by Truscott et al. (2007).  
Authors and affiliations appeared in different forms in the dataset. The following list explains how 
consistency was achieved across the dataset for incorporation into the actor-collaboration networks: 
1. Departmental affiliations were not considered; only parent organisations were retained. An 
exception was the case of academic hospitals. Also, private hospitals belonging to a hospital 
group (e.g. Life Healthcare, Netcare, MediClinic) were considered as individual hospitals. This 
was thought to better reflect inter-organisational collaboration. 
2. In the case of a publication from a single author having a single affiliation OR multiple authors 
having a single affiliation, the publication results from knowledge created within a single 
organisation.  
3. In the case of a single author having multiple affiliations, each organisational affiliation was 
retained, co-authorship between those organisations was considered to have taken place. 
Using the example above of Figure 4, Keith Hosking works at both GSH and VPH, and the 
knowledge he created and possessed, was exchanged between these organisations.  
4. Where university-affiliated authors had listed their clinical department (i.e. authors who were 
clinical academic staff), the associated academic hospital was also assigned a node. Figure 5 
is an excerpt of the author-affiliated data from Janson & Rossouw (2013). The authors are 
from the Department of Surgery at the University of Stellenbosch (SUN), which is located at 
Tygerberg Academic Hospital (TAH). The resulting actor-collaboration network would show a 
collaboration between SUN and TAH. As in 3, above, knowledge was assumed to have been 




Figure 5: Author affiliations for the publication by Janson & Rossouw (2013). 
4.1.2 Patents 
Each patent retained in the data set had to show evidence of orthopaedic device development, with 
the primary inclusion criterion of at least one inventor listing a South African address. On patents, 
inventors are only required to provide a full name and an address. Organisational affiliations of 
inventors could not simply be extrapolated from organisational affiliations as could be done with 
scientific publications, as patent data do not link the inventors to their affiliations.  
To overcome some of the biographical shortcomings of patents, a series of steps was followed to 
determine the affiliation of the inventor at the time of first application, i.e. at the priority date. Figure 
6 is an excerpt of the first page of a patent by Plugmacher et al. (2011) in the study dataset and is used 




Figure 6: An excerpt from a patent by Plugmacher et al. (2011). 
The following steps were taken in extrapolating inventor data to organisational data: 
1. The inventor name was cross-checked against names of authors in the scientific publication 
dataset. If the inventor was also an author of a scientific publication published at the time of 
patenting, then the affiliation listed on the scientific publication was used. This approach is 
similar to that of Tijssen (2004) who matched inventor names to authors of scientific 
publications in the Science Citation Index (SCI) database and had success in finding affiliations 
for inventors who were active in science-based technical areas. The “same time” refers to a 
one-year window with the priority date of the patent application at its centre.  
2. A Google Scholar search of the inventor was performed. If the inventor had a Google Scholar 
profile listing their publications, then the publications were screened to retrieve all affiliations 
within one year of the priority date of the patent.  
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3. A LinkedIn search of the inventor was performed. If the inventor had a LinkedIn profile, the 
“Experience” section of the inventor’s profile was viewed to establish their affiliation at the 
priority date of the patent.   
4. A Google search of the inventor was performed. Google searches often resulted in links to 
social and academic networking platforms, including Facebook and ResearchGate. In the case 
of clinicians, often the clinician’s practice would be found. In these instances, inventors were 
contacted (via email, social and academic networking messaging platforms, or phone calls) to 
confirm their affiliations at the priority date of the patent.   
5. Where multiple affiliations were retrieved per inventor in the above steps, all affiliations for 
that inventor were captured.  
Several factors must be considered when dealing with patent data. A patent is applied for, and 
granted, at different times. This time lag underscores the importance of choosing the appropriate date 
in a patent analysis (Hinze & Schmoch, 2004). Hinze & Schmoch suggest that the patent’s priority date 
is most closely related to the time of invention and recommend this date to be used in patent analyses 
to reflect the applied research and development activities of companies and research organisations. 
For this reason, the priority date of the patent was used in this research.  
Another factor considered in patent analysis is the assignment of countries of origin. Hinze & Schmoch 
(2004) described three options. First, the country can be assigned as that of the office to which the 
priority application was submitted; all patent databases record the priority country. Second, the 
inventor country information could be used for country assignment. It is assumed that the location of 
the research and development organisation generally coincides with the inventor’s country of 
residence. The third option is the applicant country. This last option is less clearly defined. Some 
international groups have the parent company apply for all patents, and in other instances, the 
affiliated organisations appear as applicants. In this research, the inventor country information was 
used.  
The patent family must also be considered in patent analysis. A patent family contains a set of patent 
documents which refer to the same technical topic (Michel & Bettels, 2001). An applicant usually 
makes a first filing at a patent office of their choice. The first filing is linked to the priority date. The 
applicant may file extensions of the same technical topic in other countries within one year of the 
priority date. In this research, patent families were considered as a unit. Inventor data at the priority 
date were recorded.  
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4.2 Drawing actor-collaboration networks 
Actor-collaboration networks were generated using UCINet 6 (Version 6.573) (Borgatti, Everett, & 
Freeman, 2002) and NetDraw (Version 2.152) (Borgatti, 2002). UCINet is a software package used for 
SNA, and NetDraw, which is embedded within UCINet, is a software package to draw social network 
diagrams (Analytic Technologies, 2010). NetDraw’s spring embedded algorithm was used to draw the 
network and nodes were manually manipulated to best illustrate network dynamics and relationships. 
A spring-embedded algorithm is used to sort randomly placed nodes into a desirable and legible layout 
for better visual representations (InfoVis Cyberinfrastructure, 2004). In the actor-collaboration 
network, the organisations to which the authors and inventors were affiliated are the nodes (actors). 
Each instance of co-authorship or co-inventorship is an edge between nodes. The thickness of the 
edge is weighted according to the number of co-authored publications or co-invented patents 
produced by the two nodes that it connects. Edges are undirected as co-authorship and co-
inventorship are reciprocal relationships. The nodes and edges combine to form components. Two 
nodes are part of the same component if there is a path connecting them. Where the publication was 
co-authored or the patent was co-invented by individuals of the same organisation, the 
“collaboration” is represented by a self-reflecting tie.  
Once the full list of publications was finalised, author- and inventor-affiliation data were extracted 
from scientific publications and patents and used to draw actor-collaboration networks using UCINet 
and NetDraw. The input file for UCINet was a node matrix which related nodes in the network. 
Following from the example of Plugmacher et al. (2011) (Figure 6), the following inventor-affiliations 
were established: Robert Plugmacher was found to be affiliated with Klinik und Poliklinik fur 
Orthopadie und Unfallchirurgie (KPOU), Gert Becker was found to be affiliated with Saspine, a South 
African medical device manufacturer, and Peter Van Asselt was found to be affiliated with Design 4 
Spine (D4SBV) at the time of patenting. The resulting matrix required for UciNet is shown in Table 2. 
Table 2: Node matrix illustrating collaboration in Plugmacher et al. (2011) 
 D4SBV Saspine KPOU 
D4SBV 0 1 1 
Saspine 1 0 1 
KOPU 1 1 0 
 
NetDraw requires an attribute file, which assigns attributes to nodes. Each node was assigned 
attributes based on the sector to which it belonged and on its geographical location. All South African 
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organisations were attributed “national” and all organisations who were not located in South Africa 
were attributed “international”.  Each node was assigned to one of the following four sectors: 
1. Healthcare, which includes all hospital types, including academic hospitals, clinics and 
specialised healthcare facilities.  
2. University, which includes all forms of higher education organisations, such as universities, 
universities of technology, colleges, etc.  
3. Science council, which includes research organisations other than universities.  
4. Industry, which includes individuals and organisations whose aim is to take products to 
market, usually to make a profit.  
The attribute file for the Plugmacher et al. (2011) example would resemble Table 3 below, and the 
actor-collaboration network diagram could be drawn as in Figure 7. The assignation of attributes to 
respective nodes is represented in the shapes and colours in the actor-collaboration network. The 
attributes also allow for further analysis based on location and sector.  
Table 3: Attribute file illustrating attributes ascribed to nodes of Table 2 
*node data   
ID Location Sector 
D4SBV International Industry 
Saspine National Industry 
KPOU International Healthcare 
 
Figure 7: Simple actor-collaboration network diagram illustrating co-inventorship for Plugmacher et al. (2011). 
Each organisation appearing on a scientific publication or patent has been counted only once, 
regardless of the number of authors or inventors affiliated with that organisation. Furthermore, where 
one author or inventor was affiliated with several organisations, a link was created between those 
organisations.  
In order to build the actor-collaboration network, all the publications which formed part of the 
network dataset were needed:  the affiliation data had to be built into a matrix; the attribute data of 
the nodes in the network had to be built into a file. The actor-collaboration networks were analysed 
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in UCINet and network metrics were calculated to analyse the networks quantitatively. The following 
three chapters (Chapters 5, 6 and 7) use the methodology that has been described in this chapter and 
may have elements that differ according to their distinct analyses. 
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5. The scientific base for orthopaedic device development in South 
Africa: spatial and sectoral evolution of knowledge development 
This chapter presents verbatim a journal article (Salie, de Jager, Dreher, & Douglas, 2019) which has 
been approved by the Doctoral Degrees Board to be included in this thesis. The article has been 
formatted to match the rest of the thesis.  
The chapter investigates the scientific base for orthopaedic device development in South Africa. It 
partially addresses objective 1 of the study “to identify the actors in the orthopaedic devices TIS in 
South Africa and to characterise the relationship between them” by identifying the actors that 
contribute towards the scientific base, and using social network analysis, relating the actors to each 
other based on co-authorship of scientific publications. Methods employed in this chapter allow for 
examination of the spatial and sectoral evolution of knowledge development in the TIS. Through 
understanding the development of knowledge in orthopaedic device innovation and an assessment 
of how well the functions of the TIS are performing, the capacity of the innovation system is revealed. 
By highlighting trends in the TIS on the spatial and sectoral levels, the chapter partially addresses 
objective 3 of the study “to provide insight into what drives or hinders knowledge development and 
knowledge diffusion through networks of the orthopaedic devices TIS” and objective 4 “to identify the 
TIS-contextual factors that influence knowledge development and knowledge diffusion through 
networks in the orthopaedic devices TIS”.   
As this chapter provides concise explanations of the methodology employed in the study, a more 
detailed explanation has been presented in Chapter 4. The conceptual framework as it applies to the 
entire project has been presented in Chapter 3, but elements are presented in Section 5.3. This 
chapter only presents selected timeframes of the evolution of the TIS over time. All twelve timeframes 
of the evolution network are presented in Appendices D and E. The scientific publications on which 
the networks are based, are presented in Appendix F. A postface discussion is presented in Section 
5.8.  
5.1 Abstract 
We assess knowledge development and knowledge diffusion for orthopaedic device innovation in 
South Africa over the period 2000-2015. A structural network analysis is performed on bibliometric 
data using co-authorship on scientific publications as an indicator of collaboration between different 
organisations. We apply a Technological Innovation System (TIS) framework, quantitatively assessing 
the TIS functions “knowledge creation” and “knowledge diffusion” in their spatial and sectoral 
contexts. Network metrics (degree and betweenness centralities), and empirical TIS analyses are used 
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to describe the knowledge functions of the TIS. Our results show that scientific knowledge 
development has increased as time has progressed, and that university and healthcare sectors have 
largely been responsible. Results further indicate that, for the national healthcare and national 
industry sector actors, ties to university and science council actors support scientific knowledge 
creation. The collaboration networks were found to be sparse, and disjointed, with many actors largely 
unreachable, indicating barriers to knowledge exchange between actors. Initially the network 
displayed spatial elements of an internationalised TIS, but over time, the spatial typology changed to 
that of a nationalised TIS. This shift may be a positive one, as South African research and development 
activity shifts towards being driven by local actors and towards medical devices which address the 
South African burden of disease.  
5.2 Introduction 
Orthopaedic devices comprise a substantial component of medical device imports to South Africa, 
with up to 65% of all surgical appliances imported between 2004 and 2013 comprising products 
categorised as “orthopaedic appliances” (Deloitte, 2014). The export value of orthopaedic devices 
from South Africa is low in comparison. This suggests that the domestic orthopaedic market is not able 
to supply devices as needed and may present opportunities for local manufacture of orthopaedic 
devices, to replace imports. A characterisation of the nature and extent of innovation activity for 
orthopaedic devices in South Africa would form a basis from which to develop this area of activity. 
Medical device development involves different sectors – university, healthcare, industry (Lander & 
Atkinson-Grosjean, 2011; Lander, 2013) and science councils2 and other supporting sectors, including 
government and non-government organisations (Chimhundu, de Jager, & Douglas, 2015; de Jager, 
Chimhundu, Saidi, & Douglas, 2017) – each of which plays a different role in the innovation network. 
Collaboration between these sectors results in knowledge transfer and access to different forms of 
capital across sectors, while ensuring that developed technologies address patient needs and reach 
the market (Lander, 2014). An understanding of collaboration in orthopaedic device development 
networks could inform strategies to promote knowledge exchange between actors, to enhance 
research, development and commercialisation.  
 
2 The term “science council” is widely used in South Africa. Scholes et al. (Science councils in South Africa, 2008) 
described the term as being shorthand for a variety of public sector, not-for-profit research and development 
organisations, which have been established by statutes, and are dependent on public funding. Organisations in 
the science council sector typically conduct fundamental and applied industrial research, are involved in the 
experimental development of innovative technologies, and provide training, consulting and other services 
(National Treasury, 2014).  
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We investigate the scientific base for orthopaedic device development, focussing on collaboration for 
the creation and exchange of scientific knowledge. Our approach lies in conceptualising orthopaedic 
devices as a technological field, and applying a technological innovation system (TIS) framework to 
assess the development of aspects of the orthopaedic device TIS over time. We employ social network 
analysis as an analytical framework to analyse knowledge creation and knowledge diffusion among 
actors in the network, focusing on the spatial and sectoral context. An understanding of the 
development of knowledge in orthopaedic device innovation, and an assessment of how well the 
functions of the TIS are performing, reveal the capacity of the TIS. An analysis of the spatial and 
sectoral context of knowledge creation of the TIS may be used to inform policy to encourage 
development of orthopaedic devices which addresses local needs. 
5.3 Conceptual framework 
A TIS has been defined as a “network of agents interacting in a specific economic/industrial area under 
a particular institutional infrastructure or set of infrastructures” which “is involved in the generation, 
diffusion, and utilisation of technology” (Carlsson & Stankiewicz, 1991). TIS structures include actors, 
institutions and networks which contribute to the generation, diffusion and utilisation of a new 
technology. A structural analysis can answer the following questions: “Which parties develop 
knowledge?”, “Where are the knowledge producers located?”, “How much knowledge is being 
developed?” and “What types of organisations are involved in knowledge production?” (Hekkert, 
Negro, Heimriks, & Harmsen, 2011).  Structural analysis is useful because it allows for the identification 
of actors and networks in the TIS, the countries and sectors to which they belong and their relation (if 
any) to each other. “Functions” refer to core processes in a TIS, complementary to the structure 
(Hekkert, Suurs, Negro, Kuhlmann, & Smits, 2007). Hekkert et al. (2007) and Bergek et al. (2008a) both 
describe seven functions of a TIS, but their formulations differ slightly. The functions described by 
Hekkert et al. (2007) include entrepreneurial activities; knowledge development; knowledge diffusion 
through networks; guidance of the search; market formation; resource mobilisation; and creation of 
legitimacy.  Bergek et al. (2008a) compress the knowledge functions into “knowledge development 
and diffusion”, and introduces the function “development of positive externalities” which is 
dependent on the other six functions. Both publications present comprehensive frameworks to 
analyse TISs. Knowledge development and diffusion are said to be “at the heart of the TIS” (Bergek, 
Jacobsson, Carlsson, Lindmark, & Rickne, 2008a). “Knowledge development” is described by Bergek 
et al. as learning, and involves activities in which learning takes place. “Knowledge diffusion” relates 
to the exchange of information within and between networks and extends to activities of learning 
involving interaction and use (Blum, Bening, & Schmidt, 2015). 
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Several authors have recently stressed the importance of considering context in TIS analysis. While 
the TIS framework may be universally applicable (Bergek, Jacobsson, Carlsson, Lindmark, & Rickne, 
2008a; Hekkert, Suurs, Negro, Kuhlmann, & Smits, 2007), technology develops differently in different 
contexts, resulting in the context-specific TIS outcomes. Context is also not static, and changes over 
time. Identifying favourable contexts allows for the identification of favourable opportunities for the 
development of new technologies (Bergek A. , et al., 2015). The dynamics of a given TIS are intertwined 
with the structure and dynamics of the sector(s) of which it is part. Sectors are composed of the same 
type of structural elements as TISs, but they rely on a larger set of technologies in different stages of 
maturity and on several different TISs, to provide their overall function (Bergek A. , et al., 2015). They 
may exhibit high degrees of institutionalisation in terms of well-defined division of labour and stable 
network relationships and technological infrastructures (Malerba, 2002; Smith & Raven, 2012). A 
sector therefore provides quite a stable context, to which individual TISs either have to adapt or which 
they have to try to change to their own benefit. Many TISs are part of several sectors. Interactions do 
not only occur in the sector in which the focal TIS is mainly embedded, but also with other sectors to 
which it is related. In particular, actors that enter an emerging TIS often come from other sectors. 
Because of such structural couplings, sectoral dynamics in adjoining sectors can influence the 
functional dynamics of the focal TIS. 
Coenen et al. (2012) emphasise the geographical context of TISs. They explain that space affects 
relationships, i.e. the distance between actors affects how they interact – regular interactions 
between actors result in more solid connections, institutions and networks. Their geographical 
analysis allows for the understanding of a phenomenon with space-specific impacts. The absence of a 
conceptualisation of space results in an underestimation of the coupling structures between the TIS 
and the sectoral and contextual systems (Rochracher, Truffer, & Markard, 2010). It also results in an 
under-conceptualisation of relationships between different sub-system structures. By understanding 
how the TIS is coupled to its spatial context, case-specific findings currently found in the literature 
could be made more general and comparable. The geographical context of TISs has been highlighted 
by several studies in recent years (Binz, Truffer, & Coenen, 2014; Wieczorek, Hekkert, Coenen, & 
Harmsen, 2015; Murphy, 2015).   
It has been pointed out that the TIS approach has enjoyed limited application in developing world 
contexts and that examination of emerging TISs in developing countries would contribute to 
conceptual development of the TIS framework (Blum, Bening, & Schmidt, 2015; Tigabu, Berkhout, & 
van Beukering, 2015a). Coenen et al. (2012) suggest that actors may have substantially different access 
to resources at different geographical levels , contrary to the assumptions of a “global opportunity 
set” (Carlsson, Jacobsson, Holmen, & Rickne, 2002) in which all actors are assumed to have equal 
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access to external resources.  This is evident in studies applying the TIS framework in developing and 
least developed country settings. Schmidt & Dabur (2014) delineated a “national TIS” and 
“international TIS” in their framework for the diffusion of biomethanation in India. They found that 
the role of the international TIS only contributed to a few functions, but these functions were the most 
developed in the TIS and relevant in the removal of barriers which were less rooted in national 
institutions. Blum et al. (2015) used the TIS approach to derive policy recommendations to increase 
the diffusion rate of remote electric mini-grids in Laos. In delimiting their spatial contexts, they drew 
three geographical levels - local, national and international. They found that the low diffusion rates 
were due to institutional mismatches within and across geographical levels as well as hampered flows 
of resources across the geographical levels. Their geographical classification allowed for the 
identification of bottlenecks at geographical interfaces, which was important in understanding the 
functions in the Laotian context.  
Binz et al. (2014) developed an analytical framework, incorporating indices and spatial classifications, 
to evaluate the geographical or spatial dimension of the TIS and map the dynamics of the knowledge 
functions in membrane bioreactor (MBR) technology. They performed a network analysis of the actors 
over time to identify relevant actor locations and spatial levels of the TIS. Spatial levels may refer to 
local, sub-national, national, regional or international delineations. The authors explain that, while 
technology and technological fields may span across countries, the spatial set-up of the TIS is specific 
to the technology in focus, and to the resources and relationships between actors involved in driving 
that technology.  
Newman (2001) shows how the network structure of scientific communities has implications for the 
diffusion of information. He found “small-world” properties – high clustering, and low average path 
length – to be a crucial feature of a functional scientific community. A high clustering coefficient means 
that actors are highly connected, while a short average path length means that the distance between 
actors is small, usually only a few actors. Binz et al. (2014) assert that small-world networks increase 
TIS creative output as they combine local and trustful collaborative innovative processes with ties to 
more distant, complementary ideas. 
5.3.1 Focus of the study 
We examine the TIS for orthopaedic device development in South Africa. We identify the structure of 
the TIS by drawing collaboration networks based on bibliometric data, particularly co-authorship of 
scientific publications.  
These publications serve as indicators of “knowledge development” while the collaboration networks 
represent “knowledge diffusion”. By only considering South Africa, a geographical boundary is drawn 
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which sets the limits to the analysis of the TIS, although international actors that play a role in the 
national TIS are considered. The technological field is orthopaedic devices. We are concerned with the 
development of new devices, or the extension of functionality of existing devices. The spatial context 
arises from the collaboration of South African organisational actors with each other and with 
international actors. We are concerned with the functions “knowledge development” and “knowledge 
diffusion through networks” described by Hekkert et al. (2007).   
As medical device development involves inter-sectoral collaboration, we draw from the ideas of TIS-
sectoral interaction from Bergek et al. (2015). We perform an empirical analysis of the focal TIS using 
the framework presented by Binz et al. (2014), which relies on social network analysis. While 
geographic delimitation is of interest in our orthopaedic device development network, drawing 
boundaries between sectors is also of interest in understanding the behaviour of actors from different 
sectors. We have created distinct national and international boundaries, as in Schmidt & Dabur (2014). 
Here, we assess knowledge development and diffusion in the orthopaedic device development 
network in South Africa, in terms of its relative “goodness” as a desirable network (Bergek, Jacobsson, 
Carlsson, Lindmark, & Rickne, 2008a). 
5.4 Methodology 
A bibliometric study was used to investigate the network of actors involved in orthopaedic device 
development in South Africa. Using author affiliation listed on scientific publications, we were able to 
identify the organisations that contribute to orthopaedic device development in South Africa. Co-
authorship on scientific publications served as an indicator of collaboration between authors from 
different organisations. The primary inclusion criterion for a scientific publication was affiliation of at 
least one author to a South African organisation. Once the organisations were identified, we could 
determine their location and sector, which were used for further analysis, described below.  
5.4.1 Definition of an orthopaedic device 
We developed a definition for an orthopaedic medical device using a similar approach to that of 
Chimhundu et al. (2015) for cardiovascular medical devices. We started with the medical device 
definition of the Global Harmonisation Task Force (Global Harmonisation Task Force, 2012) which is 
endorsed by the WHO, and modified it for orthopaedic devices (modifications are shown in bold): 
An [orthopaedic] medical device means any instrument, apparatus, implement, machine, appliance, 
implant, in vitro reagent or calibrator, software, material or other similar or related article, intended 
by the manufacturer to be used, alone or in combination, for human beings for one or more specific 
purposes of  diagnosis, prevention monitoring, treatment or alleviation of disease[s associated with 
the musculoskeletal system]; the compensation for an injury; the investigation, replacement, 
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modification or support of [the musculoskeletal system]; or for providing information for diagnostic 
purposes by means of in vitro examination of specimens [of the musculoskeletal system]; and does 
not achieve its primary intended action in or on the body[’s musculoskeletal system] solely by 
pharmacological, immunological or metabolic means.  
The definition informed the search terms used in Scopus and Thomson Reuters Web of Knowledge 
(WoK) to find journal articles and conference proceedings for the period 2000-2015. These search 
terms are presented in Appendix A. Search results were manually assessed to determine if the articles 
contributed to orthopaedic device development.  
5.4.2 Collaboration networks 
The collaboration networks were generated using UCINET 6 (V 6.573) (Borgatti, Everett, & Freeman, 
2002) and NetDraw (V 2.152) (Borgatti, 2002). In the network, the actors are the organisations to 
which the co-authors are affiliated; each actor is represented as a node. The actors were classified 
into four sectors – universities, healthcare, industry and science councils. While it is easy to classify 
national actors as belonging to the science council sector, international actors were classified with 
caution. Actors that have been designated as international science councils, are those that conduct 
research, but are not of the university sector, and not explicitly a healthcare organisation. Examples 
include the French National Institute for Health and Medical Research (FNIHMR) - a publicly funded 
research institute in France, and the National Institute of Research and Development for Theoretical 
Physics (NIRDTP) – a publicly funded Romanian organisation involved in basic and applied research.  
In the collaboration networks, each publication is represented as an edge between collaborating 
nodes. The size of the node is scaled to the degree (discussed later) of the node. The thickness of the 
edge is weighted according to the number of co-authored publications produced by the two nodes 
that it connects. The nodes and edges combine to form components. Two nodes are part of the same 
component if there is a path connecting them. The network as a whole may consist of several 
components. Co-authorship of a publication by individuals of the same organisation is represented 
with a self-reflecting tie. While these publications do not display collaboration, they do indicate 
activity towards orthopaedic device development, and have thus been included in the analysis. We 
used a five-year moving window to assess our publication dataset. Eslami et al. (2013) assumed the 
life-span of network links based on co-authorship to be five-years, based on previous studies and on 
the argument that information exchange takes place between co-authors for some time during a 
collaboration. 




The degree centrality is a measure of the number of collaborations in which the node is involved, 
thereby serving as an indicator of how active the node is. It is calculated as the number of ties between 
a given node and other nodes in the network, including any self-reflecting ties the node may have. As 
we are comparing networks, we report normalised degree centrality. The normalised degree 
centrality, as reported in Equation 6, is the node’s degree, 𝑢(𝑦), divided by the maximum possible 




 … Equation 6  
Betweenness centrality 
Betweenness centrality is a measure of how often a node lies on the shortest path between two other 




𝑥≠𝑦≠𝑧  … Equation 7 
Nodes with high betweenness centrality are considered to influence the flow of information across 
the network. As we are comparing networks, we report normalised betweenness centrality. The 
normalised betweenness centrality is the node’s betweenness centrality divided by the maximum 




 … Equation 8 
5.4.3 TIS analytical framework 
Binz et al. (2014) present metrics and typologies to analyse networks spatially. This section draws 
strongly from their analytical framework, and allows us to characterise the innovation network in 
terms of a spatial topology. Three broad network patterns are described by Binz et al.:  
1. Localised – where innovation is based on processes emerging in largely unrelated subsystems 
in the network, and the network may be localised regionally or nationally. We have localised 
at the national level. 
2. Globalised – where innovation spans actors from different countries. 
3. Multi-scalar – where the actor network incorporates both national and international ties. This 
set-up essentially represents a small-world network, efficiently connecting tight clusters of 




Binz et al. (2014) developed a nationalisation index, to measure the level of cooperation within vs 
outside national borders. It is based on the external-internal (E-I) index by Krackhardt & Stern (1988), 
and is defined as the ratio of links among actors inside one country to links with actors outside that 
country. We have applied the nationalisation index of Binz et al. to compare the number of ties among 
South African actors, Li, to the number of ties South African actors have with actors in other countries, 




 … Equation 9 
This index measures the dominance of national over international ties. If most actors are cooperating 
in a national context, the index would be positive and tend towards one. If national and international 
cooperation are equally present, the index would be close to zero. If international cooperation is 
dominant, the index would be negative, and tend towards -1. 
Sectorisation index 
Adapted from Binz et al.’s nationalisation index, we present the sectorisation index, S, as shown in 
Equation 10, which compares the number of collaborations between South African actors within the 
same sector (i.e. universities, healthcare, industry or science councils), 𝑠𝑖, to that with South African 




 … Equation 10 
n-clan analysis 
Binz et al. (2014) use n-clan analysis to identify subgroups within components of the network. N-clans 
are defined as subgraphs in which the largest (geodesic) distance between any two nodes is not 
greater than “n”. Based on this description, two nodes may form part of the same subgroup, even if 
they have not collaborated. By using n-clan analysis to identify subgroups in the orthopaedic device 
collaboration network, we can assess the network spatially to determine whether the network has 
national, global or multi-scalar dimensionality. 
As in Binz et al. (2014), “n” is equal to 2, implying that all nodes are separated by no more than one 
other node in the subgroup. The n-clan function in UCINET requires that a minimum number of actors 
in a subgroup be set. We have set this to be the diameter of the network, which is the maximum 
geodesic distance in the network (within a component) (Hanneman & Riddle, 2005). Thus all nodes 
that meet the definition of the n-clan subgroup will be included.  
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Binz et al. (2014) present a typology of spatial TIS set-ups, based on the nationalisation index as well 
as the extent of cohesiveness of the network’s subgroups. The cohesiveness of subgroups refers to 
the formation and interrelation of subgroups. The cohesiveness of the network is assessed by 
visualising the overlap of n-clan subgroups. The typologies may be:  
1. Nationalised innovation networks – no cohesive subgroups and nationalisation index 𝑁 > 0  
2. International innovation networks – no cohesive subgroups and 𝑁 < 0 
3. Nationalised TIS – internal cohesive subgroups, weak overlap of subgroups and 𝑁 > 0 
4. Internationalised TIS – external cohesive subgroups, weak overlap of subgroups and 𝑁 < 0 
5. Multi-scalar TIS – internal and external cohesive subgroups, weak overlap of subgroups and 
𝑁 ≈ 0 
6. Global TIS – internal and external cohesive subgroups, strong overlap of subgroups and 𝑁 ≈
0 
Our network structures were analysed spatially using these typologies.  
5.5 Results 
In our manual assessment of the search results, publications were eliminated if their title and abstract 
did not show evidence of the development of an orthopaedic device. Where it was unclear from these 
sources whether the publication did indeed show evidence of orthopaedics device development, the 
first author read the publication to determine if the publication fell in the scope of orthopaedic device 
development. The publication had to clearly illustrate what “device” was being developed and it had 
to illustrate “development”.  
The Scopus search yielded 59 publications which met the inclusion criteria. The Thomson Reuters WoK 
search yielded 20 publications, of which four were not included in the Scopus results. Consequently, 
a total of 63 publications were retained for use in the bibliometric study. Ninety-nine actors were 
identified from the publications. Table 4 presents a spatial and sectoral breakdown of the actors. One 
hundred and ninety-eight unique authors were identified in the 63 publications. Of these authors, 99 
had South African affiliations, 88 had international affiliations, seven had listed both South African and 
international affiliations, two had not listed their affiliations, and one publication did not distinguish 
affiliations when listing authors. The network is dominated by actors from the university and 
healthcare sectors, jointly accounting for almost 80% of the actors. There is a large international 
presence in the network, with more than 60% of all actors representing international organisations. 




Table 4: Sectoral breakdown of actors in the orthopaedic device development network. 
Sector National International Total 
Universities 11 29 40 
Healthcare 14 24 38 
Industry 7 7 14 
Science Councils 4 3 7 
 36 63 99 
 
Seven of the 63 publications arose from internal collaboration within the same organisation. Six of 
these were from the university sector, and one from the healthcare sector. All the actors who had 
publications resulting from internal collaboration, were high degree actors (discussed later). 
For the period 2000-2015, 12 overlapping timeframes were distinguished, starting from 2000-2004 
(1st timeframe) and ending at 2011-2015 (12th timeframe), and assessed. For each timeframe, the 
number of national and international actors, and the number of scientific publications for that period 
were counted (see Figure 8). There is a gradual increase in the number of publications produced by 
actors as time progresses. The total number of actors increases over time. The number of national and 
international actors are similar in the early timeframes. There is a sudden increase in international 
actors in the sixth timeframe (2005-2009), resulting in an increase of the total number of actors. 
Beyond the sixth timeframe, the number of international actors is slowly decreasing, and the number 
of national actors steadily increasing. The number of national actors exceeds the number of 
international actors in the latter years. Selected timeframes of the orthopaedic device development 
network are presented in Figure 9. Each actor is represented by a node in the network. Full names of 




Figure 8: Number of publications and number of national and international actors in each of the timeframe networks of the 

































































































































Figure 9: Orthopaedic device development network of South Africa for selected timeframes (a) 2000-2004 (b) 2005-2009 and 
(c) 2011-2015. All national nodes are blue, and all international nodes are maroon. Nodes are shaped according to sector 




The publication dataset of the bibliometric study showed low initial levels of publication in the early 
years, with no publications in 2001 and 2004. This may be the result of the fledgling orthopaedic device 
development network at that time, with very few actors – 15 in the first timeframe – able to make 
contributions to the network. As time progresses, there is an increase in the rate of knowledge 
production, determined by the increasing rate of publications.  
For each of the 12 timeframe networks, the top three actors with the highest degree centrality values 
are reported.  Where fewer than three actors are reported, several actors in the network would have 
been tied for the third position. Once the top actors were identified, the degree centrality for all time 
periods were extracted to assess actor evolution over the 12 timeframes. These results are presented 
in Figure 10. They are reported in this way for two reasons. The first is to show who the high-degree 
actors are for a specific timeframe (vertical axis). The second is to show the evolution of these high-
degree actors over time (horizontal axis). 
 
Figure 10: Highest-ranked actors by degree centrality. A list of actor abbreviations and their full names can be found in 
Appendix C 
In the first timeframe, Groote Schuur Hospital (GSH) is the highest degree actor. In the next four 
timeframes, the highest degree actors are the University of Cape Town (UCT) and Vincent Palotti 
Hospital (VPH). In the sixth (2005-2009) and seventh (2006-2010) timeframes, the highest degree 
actors are University of Witwatersrand (WITS), Charlotte Maxeke Johannesburg Academic Hospital 
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high degree actors up to the tenth timeframe (2009-2013). In the last two timeframes, UCT, the 
University of Stellenbosch (SUN) and Morningside MediClinic (MMC) are the highest degree actors. 
Most of these high-degree actors are from the national university and national healthcare sectors. The 
only exception is the AOCID, which is classified as an international science council. 
The actors having highest betweenness centrality over the 12 timeframes are presented in Figure 11. 
This metric is presented similarly to degree centrality in Figure 10, where the highest ranked actors by 
degree centrality are presented along the vertical axis, and the evolution of these actors over time can 
be seen across the horizontal axis. While all actors present in a network has degree centrality, not all 
actors lie between other actors, and hence, not all have betweenness centrality. We report as many 
as five top betweenness centrality actors per timeframe in Figure 11.  
 
Figure 11: Highest-ranked actors according to betweenness centrality over the 12 timeframes. A list of actor abbreviations 
and their full names can be found in Appendix C. 
The actors having high degree centrality also have high betweenness centrality, i.e. all the actors that 
appear in Figure 10 also appear in Figure 11. There are two more actors in Figure 11 than Figure 10 – 
the University of Leeds (ULEED) and the University of Pretoria (UP). In the first timeframe (2000-2004), 
GSH and UCT are the actors with highest betweenness centrality. In the second (2001-2005) and third 
(2002-2006) timeframes, UCT and VPH have betweenness centrality, and here, the value captures 
their role in the main component of the network. The addition of WITS and CMJAH to the network in 
the fourth timeframe (2003-2007) results in two distinct network components (see Figure 9) forming 
the UCT/VPH component and the WITS/CMJAH component. Over time the WITS/CMJAH component 
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2013)) and shrinks (timeframe 11 (2010-2014) and 12 (2011-2015)). The UCT/VPH component shrinks 
over time, with a slight increase in the last timeframe. The AOCID and the University of Leeds (ULEED) 
also have betweenness centrality in the WITS/CMJAH component. MMC enters the network in the 
seventh timeframe (2006-2010), but only gains betweenness centrality in the tenth timeframe (2009-
2013). As the SUN component grows in the later years, so too does the betweenness centrality of SUN. 
The network is dynamic and the actors change over time, particularly the international actors, many 
of whom only appear on one publication. The national actors appear to evolve – their collaboration 
choices and role within the evolutionary networks change. As an example, UCT shows growth in terms 
of increasing its degree centrality in the first five timeframes, followed by a period of decreasing 
degree centrality over the next five timeframes, and then increasing degree centrality in the last two 
timeframes. The actor SUN demonstrates more consistent growth. SUN first presents in the fifth 
timeframe (2004-2008) as a self-reflecting tie, illustrating internal collaboration. As time goes by it 
increases its degree centrality and betweenness centrality, by collaborating with other actors and 
across other sectors. By the eleventh timeframe (2010-2014), SUN has the second highest degree and 
betweenness centralities, creating a knowledge hub within the network. The evolution of most of the 
national actors (WITS, CMJAH, UP, GSH, VPH) across the timeframes is similar. These evolving actors 
are from the university and healthcare sectors and display co-dependence on the actors to which they 
have strong ties, as an example, the evolution of GSH with UCT. 
Science councils are slowly introduced into the network, first presenting in the sixth timeframe (2005-
2009), with international actors only. National science councils only present in the ninth timeframe 
(2008-2012). Across all timeframes, there is no instance of collaboration between the science council 
and industry sectors.  
The Nationalisation Index is presented in Figure 12. Across all timeframes there is neither a strong 
tendency towards internationalisation (-1) nor towards nationalisation (+1). Till the ninth (2008-2012) 
timeframe, there is a preference for international collaboration, with a mostly negative index. There 





Figure 12: Nationalisation index of the orthopaedic device development networks over the 12 timeframes 
We used 2-clan analysis to identify cohesive subgroups in the networks, and how these subgroups 
overlap. Subgroup overlap presents greater opportunity for knowledge diffusion across the network. 
Over the 12 timeframes, the number of 2-clans is ever increasing, with two 2-clans in the first 
timeframe, and ten in the last timeframe. The 2-clan subgroups of the selected timeframes are 
presented in Figure 13, where the overlap of subgroups is indicated by actors belonging to more than 
one subgroup. Considering Figure 12 and Figure 13 together, the spatial typology of each network was 
assessed. According to the classifications presented in Binz et al. (2014), the first three timeframes 
can be classified as being an internationalised TIS based on their negative nationalisation index and 
weak overlap of subgroups. The nationalisation index of the fourth timeframe (2003-2007) is positive, 
but very close to zero (N=0.05), and this network is classified as being a multiscalar TIS. From the fifth 
(2004-2008) to the tenth (2009-2013) timeframe, the networks are classified as internationalised TIS. 
In the last two timeframes, the networks have nationalised TIS typology due to their positive 
nationalisation index and no overlap in subgroups. It is worth pointing out that in all timeframes, a 
TIS, rather than an innovation network, is present, as there are always cohesive subgroups in each 
timeframe network.   
The international actors of the orthopaedic device development network come from 14 different 
countries. These include the United Kingdom (UK), Italy (ITA), the United States of America (USA), 
Switzerland (SWI), Germany (GER), Austria (AUST), Belgium (BEL), Romania (ROM), Netherlands (NED), 
China (CHI), Australia (AUS), France (FRA), India (IND) and Spain (SPA). The UK appears in all 12 
timeframes. In the first timeframe (2000-2004), international actors are from Italy and the UK. In the 

























































































































the fifth timeframe (2004-2008), joining the USA and the UK. There is an influx of European actors into 
the network from the sixth timeframe (2005-2009), originating from Germany, Switzerland, Austria, 
Italy, Belgium and Romania. China enters in the seventh timeframe (2006-2010) and Australia in the 
tenth timeframe (2009-2013). As the number of European actors grows over time, the number of 
American actors decreases; the USA is absent in the last two timeframes. India and France join the 
network in the eleventh timeframe (2010-2014), and Spain in the last timeframe (2011-2015). By the 
eleventh timeframe, the number of European countries present is higher, but the number of actors is 
lower. There are no collaborations with actors from other African countries. There are also no 
collaborations with actors from South American countries. On the national front, most of the national 
actors in the first six timeframes belong to overlapping 2-clan subgroups. From the eighth timeframe 
(2007-2011), national 2-clan subgroups, i.e. comprising only South African actors, start forming. There 
is one national 2-clan subgroup in timeframes eight, nine and ten; three national 2-clan subgroups in 
the eleventh timeframe; and five national 2-clan subgroups in the last timeframe. These national 2-






Figure 13: 2-clan subgroups for selected timeframes (a) 2000-2004 (b) 2005-2009 and (c) 2011-2015. 2-clan subgroups are 
drawn across the diagonal, national actors are drawn below the diagonal and international actors above the diagonal.  
International actors are grouped according to the countries in which they are located. Overlap of subgroups can be seen 
where nodes belong to more than one 2-clan group. A list of actor abbreviations and their full names can be found in Appendix 
C. Isolated actors shown in the top left-hand corner form part of the timeframe network, but do not belong to any 2-clans. 
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The sectorisation indices are presented in Figure 14. A positive index indicates a sector’s preference 
to participate in intra-sector collaborations, while a negative index indicates a tendency for 
involvement in inter-sector collaboration. An index of zero implies equal preference for intra-and 
inter-sectoral ties. All national sectors prefer inter-sectoral collaboration, however the degree of inter-
sectoral collaboration differs greatly. The national healthcare sector shows strong preference for 
national inter-sectoral collaboration throughout all timeframes. This is different from the behaviour 
of the university sector, which shows preference for intra-sectoral collaboration from the second 
(2001-2005) to fifth (2004-2008) timeframes, and then again in the latter years. This is emphasised by 
the disjoint components (See Figure 9 and Figure 13) in later timeframes, driven by national 
universities. The industry sector is always involved in inter-sectoral collaboration. The national 
industry actors, however, are only involved in inter-sectoral collaboration till the ninth (2008-2012) 
timeframe when they start interacting with other national industry actors. National science councils 
were seen to enter the network in the ninth (2008-2012) timeframe and show evidence of 
collaborating with other national science councils as well as inter-sectorally. These trends suggest that 
for national healthcare and national industry sector actors, ties to university and science council actors 
promote scientific knowledge creation.  
 

























































































































We have shown that the rate of scientific publication output in orthopaedic device development in 
South Africa increases over the 12 timeframes. Makhoba & Pouris (2016) have argued that increased 
scientific output in South Africa in recent years could be due to concerted efforts made by the 
government to promote scientific publication. One such effort is the New Funding Framework which 
provides cash incentives to higher education organisations for each publication produced. 
In our network, most of the actors, and therefore the knowledge creators, belonged to the university 
and healthcare sectors. Our results confirm the suggestion by Lander (2013) that the “biomedical 
innovation system”, the clinical pathway of innovation, is dominated by interactions between two 
non-commercial sectors i.e. universities and hospitals. Shown using normalised degree centrality as 
an indicator for knowledge development – actors who publish more are likely to have more 
connections in the network – the key actors contributing to knowledge development are national 
research-intensive universities (UCT, WITS and SUN) and national healthcare facilities (VPH and 
CMJAH), which show strong ties (by repeat collaborations) to the national universities. The strong ties 
may be the result of single authors listing multiple affiliations, for instance when an author is affiliated 
with both the university and an associated academic hospital.  
Some of our findings are consistent with those of Chimhundu et al. (2015) for cardiovascular medical 
devices (CMD). They defined two types of networks, i.e. local (South African organisations only) and 
global (South African and foreign entities). Universities and healthcare services were found to be the 
most active sectors in CMD development between 2000 and 2014 in the global network. The CMD 
development network was found to be improved by the presence of foreign entities, as some of the 
entities isolated in the local network, were absorbed into the global network by their presence; thus, 
foreign institutions created alternative pathways for knowledge transfer. Their results further showed 
there was substantial unrealised collaboration potential in both networks and that the universities 
played a substantial role in dictating the behaviour of the network. Our results differ from those of 
Chimhundu et al. (2015) who found that inter-sectoral collaboration increased over time. While our 
study shows a general preference among all sectors for inter-sectoral collaboration, the national 
science councils and universities tend toward intra-sectoral collaboration with other national actors 
in the latter timeframes. This suggests knowledge development rather than diffusion activity. Our 
findings also differ from those of Chimhundu et al. in terms of the role of international nodes. The 
isolated components in our network are consistent over all periods – international nodes did not link 
previously disconnected national actors, and the absence of international nodes did not hinder 
knowledge development. This confirms the assertion of Binz et al. (2014) that the spatial set-up of the 
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TIS is specific to the technology in focus (orthopaedic devices vs CMD), and to the resources and 
relationships between actors involved in driving that technology.   
We showed that over all the timeframes, the interaction of actors resulted in a TIS typology, rather 
than an “innovation network” typology. This means that the actors are not creating knowledge in 
isolation. Those actors who have published by internal collaboration were found to be key actors, 
having high degree and betweenness centrality. The network evolves from having an internationalised 
TIS typology in the first three timeframes, multi-scalar TIS typology in the fourth timeframe (2003-
2007), internationalised TIS typology from the fifth to the ninth timeframes, and then having 
nationalised TIS typology in the last three timeframes. Binz et al. (2014) suggest that the 
internationalised TIS typology could be a result of the TIS being driven by different international 
networks, e.g. multinational companies. This is certainly plausible in the network presented here with 
the presence of large industry sector actors Medtronic (MEDT), DePuy, Howmedica Europe (HE) 
(which had been a part of Pfizer), and Aesculap AG (AAG). Coenen et al. (2012) suggests that globally 
active actors depend on places to which they are structurally coupled to advance their own agendas. 
In the last timeframe, the national universities were the knowledge developers, creating small 
components of activity in the network. There are 11 national universities in the last timeframe 
network, belonging to nine of the ten components. The components however are disjoint, and 
diffusion is impaired. Further study is needed to determine the motivation for the more recent 
preferential collaboration among national actors, after initial international collaboration, and the role 
of international actors in driving collaboration.  
While we have used the tools provided by Binz et al. (2014), our area of interest and spatial scales 
differ. Using co-authorship on scientific publications of MBR technology as an indicator of 
collaboration, Binz et al. were able to describe different phases of the MBR TIS, on a global scale, for 
the period 1990 to 2009. We have found the Binz et al. methodology to be valuable in understanding 
knowledge creation dynamics at a national and sectoral level.  
The limitation of describing a network as having small world properties, is that a network can only 
truly be considered small world if all the actors are connected, i.e. all actors lie in the same component. 
Several authors, including Eslami et al. (2013) and Fleming et al. (Small worlds and regional innovation, 
2007), have worked around this limitation, by considering only the largest component in the network 
in their analysis. We have not performed our analysis in this way, because for many of our timeframes, 
the number of actors in the largest component is only a fraction of the actors in the network. As an 
example, only 16 of the 51 actors (31%) present in the last timeframe belong to the largest component. 
Our network briefly displays multi-scalarity in the fourth (2003-2007) timeframe, but for the most part 
has internationalised TIS typology, with nationalised TIS typology in more recent times. In the fourth 
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timeframe, 12 of the 23 actors (52%) form part of the largest component. Therefore, even at the point 
where the network displays multi-scalar traits, a small world analysis on the largest component would 
miss the influence of half the actors in the network. We have found the framework of Binz et al. 
especially useful in analysing our network, as it presents a methodology for analysing knowledge 
development and diffusion in networks that lack small-world properties. 
Throughout the period of our study, many actors are unreachable from each other in the network due 
to disconnected components. While knowledge is certainly being developed, and being developed at 
an increasing rate, knowledge is not being diffused with increasing efficiency. Thus, learning is taking 
place in the absence of interaction and use.  While there are tight clusters of activity driven by national 
university and healthcare actors, the key university actors – UCT, WITS, SUN – never collaborate with 
each other. While further analysis is required to ascertain reasons for this, Pouris & Ho (2014) have 
posed that the government subsidy system aimed at incentivising publication at South African 
universities, penalises co-authorship with other institutions and in fact disincentivises collaboration. 
If the reason for collaboration is to access capital, and that capital shapes the interactions within 
scientific fields (Lander, 2014), it appears that national universities have become more established, 
have better access to resources, and have become attractive collaborators, in later years. While 
universities and science councils both serve as research platforms in the network, there is an obvious 
preference for the healthcare sector to collaborate with the university sector. National science council 
actors only enter the network very late, and may not be experienced in orthopaedic device 
development, and may therefore not be an attractive collaboration choice in this TIS. Furthermore, 
the mandates of science councils may not necessarily be aligned to medical (or orthopaedic) device 
development, and their contribution to the network may be a reflection of their primary research 
focus. Bergek et al. (2015) explained that the dynamics of the TIS are related to the structure and 
dynamics of the sectors of which it is part, which may open or close markets for the new technologies. 
Our TIS could be displaying the consequences of existing sectoral dynamics.  
The broader context of the orthopaedic devices TIS includes efforts towards the promotion of medical 
device development in South Africa. The South African Department of Trade and Industry (dti) 
commissioned an investigation of medical device industry in South Africa (Deloitte, 2014), with the 
aim of gaining insights for strategy and policy interventions to support long term growth of this 
industry. Stakeholder collaboration and the introduction and enforcement of effective regulatory 
policy were elements identified as necessary for growth of the medical device industry. Medical device 
regulations have since been introduced, effective since December 2016 (Department of Health, 2016). 
Codes of practice encouraging ethical principles among medical device manufacturers have been in 
practice since 2012 (SAMED). There are government incentives for investment into medical device 
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development in South Africa, including support for: business development in both the healthcare and 
education sectors; manufacturing of medical devices; seed funding and patenting; foreign investment 
through a foreign investment grant; and developing innovative and competitive products or processes 
(SAMED). The TIS functions affected by these incentives should be examined. Another area for further 
exploration, is the impact of the promotional interventions on the knowledge functions of the 
orthopaedic device development TIS; the work presented in this paper would form the foundation for 
such a study. 
5.6.1 Limitations of the study 
As the network was investigated using a bibliometric study, institutions and sectors that publish 
scientific output are favoured, i.e. universities and academic healthcare facilities. This may explain 
why these institutions are more prominent in the network. Alternative outputs which also show 
collaboration for orthopaedic device development, such as patents, have not been captured and 
presented here, but may be more representative of collaboration trends in the industry sector, and 
will be analysed in a future study.  
An analysis of a TIS should include examination of international influence because a spatially limited 
part of a global TIS cannot be understood or assessed without an understanding of the global context 
(Bergek, Jacobsson, Carlsson, Lindmark, & Rickne, 2008a). We present the role of international actors 
in the South African network but do not assess the global orthopaedic device innovation TIS, of which 
the South African TIS forms part.  
5.7 Conclusions 
We have identified the organisations contribute to the scientific base of orthopaedic device 
development in South Africa, the sectors to which they belong, and characterised the interaction 
between national and international actors by performing a spatial and sectoral analysis. We have 
shown that knowledge has been created at an increasing rate over time. We have further shown that 
the diffusion of knowledge is inefficient. We could present this in two (positive) ways. The first is that 
the TIS has the capacity to produce knowledge. Secondly, the sparsity of the network is an opportunity 
for collaboration, as the actors creating knowledge have been identified, and have, through this study, 
been made visible. The shift towards a nationalised TIS may be important in the developing country 
context, if the aim is to build national knowledge-generation capacity and address diseases and 
conditions that are nationally relevant. We have further shown that, at a national level, there is a great 
difference in preference for inter-sectoral collaboration among actors from different sectors, and that, 
for national healthcare and national industry sector actors, ties to university and science council actors 
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support scientific knowledge creation. Further study is needed to explore any causal links between 
these network features and the context of South Africa as a developing country. 
We have expanded the application of social network analysis to TIS, which was demonstrated by Binz 
et al. (2014), to a different knowledge field and to the early stages of a TIS in a developing country 
setting. We have adapted the tools proposed by Binz et al. to consider the technology in focus in a 
national context, and included a sectorisation index. Thus, we have extended the tools presented by 
Binz et al. into a methodology for assessment of the knowledge functions of an emerging TIS. 
This study will in future be complemented by an analysis of the patenting activities of the actors. An 
understanding of knowledge development and diffusion through social network analysis of 
publications and patents will form the basis for case studies for further examination of knowledge 
dynamics for orthopaedic device innovation in South Africa. 
5.8 Post-face discussion 
This section discusses additional considerations that have arisen related to the actor-collaboration 
networks based on scientific publications, since publication of Salie et al. (2019). 
The discussion (Section 5.6) and conclusions (Section 5.7) are based on a relatively small dataset, 
comprising 63 publications, presenting actor collaboration networks with only 99 organisational 
actors. These networks, though small, are similar in size to the national actor-collaboration networks 
that have been examined for cardiovascular medical devices (Chimhundu, de Jager, & Douglas, 2015) 
and medical devices (de Jager, Chimhundu, Saidi, & Douglas, 2017) in South Africa. Chimhundu et al. 
performed an analysis on 123 journal articles, resulting in networks comprising 155 organisational 
actors; de Jager et al. performed an analysis on 171 scientific publications, resulting in networks 
comprising 116 organisations. The conclusions drawn of networks being sparse and actors being 
unreachable in the scientific publications network, illustrating barriers to knowledge exchange 
displayed in these networks, is based on the scientific publication dataset only. Further work in later 
chapters on the patent actor-collaboration networks and case studies provides a more holistic picture 
of knowledge development and exchange of actors in the TIS. Additionally, the effect of sectoral 
dynamics on knowledge development and exchange is further explored in the case studies. The 
findings and conclusions of this Chapter are considered in Chapter 10 within the broader context of 
the analyses present in the chapters that follow.  
The actor-collaboration networks based on scientific publications were shown to have a large 
international presence. Participation of national actors in large international projects may potentially 
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crowd them into large networks with increased visibility. Kahn (2018) has described the impact on 
measuring collaboration of participation in mega science projects in BRICS countries, and the 
increased visibility of these publications due to their high citation rates; such crowding in may result 
in publications with hundreds of contributing authors, many of whom will never meet each other. In 
the scientific publication networks, the greatest number of organisations linked by one publication is 
12. The networks are therefore unlikely to be influenced by the crowding-in resulting from mega 
science projects.  
The multiple affiliations due to the joint assignation of clinical academics to a university and an 
academic hospital, contributed to the strong ties between the university and healthcare sectors in the 
scientific publication networks. Lander & Atkinson-Grosjean (2011) highlighted that these connections 
are often overlooked in biomedical innovation studies, where the two organisations are considered a 
single entity, with the result that the relational flow between the organisations that is important for 
translational sciences, is not recognised.  
Clinicians are the de facto “users” of orthopaedic devices and the healthcare actors provide a demand-
side input into the innovation system. The demand side of the innovation system would consider users 
of the devices and their experiences and preferences related to a device, and whether it meets the 
(clinical) need; this would feed back into the innovation process. In the actor-collaboration networks, 
the strong presence of the healthcare sector actors suggests that the (potential) users are active 
participants in the innovation system. Their role within the innovation system is further described in 








6. The technological base for orthopaedic device development in 
South Africa: spatial and sectoral evolution of knowledge 
development  
In this chapter, the technological base for orthopaedic device development in South Africa is explored 
through patent bibliometrics. The chapter begins by describing how patents are used as an indicator 
for collaboration in technological innovation, and then presents the results of the social network 
analysis using patent data of orthopaedic inventions stemming from South Africa. The discussion later 
in the chapter relates the patent and scientific publication actor-collaboration networks (the latter 
having been presented in Chapter 5), which together contribute to the structure of the orthopaedic 
devices technological innovation systems (TIS) in South Africa. 
6.1 Patents as indicators of collaboration for technological innovation 
A patent is a legal document claiming intellectual property (IP) protection, which gives the patent 
owner certain rights in exchange for public disclosure of the invention. In order for a patent application 
to be granted it has to meet all three of the following criteria: (1) novelty, (2) inventive activity, and 
(3) industrial applicability (Michel & Bettels, 2001). Because a patent must show novelty, it has been 
used as an economic indicator of the rate and direction of technological progress and innovation 
(Andersen, 2004). Patents, however, do not capture innovation in the economic sense, where a new 
or improved product or service has been commercialised into a market. The fact that an invention has 
been patented, does not mean that it will have commercial success. Patenting is used in this project 
to illustrate a form of knowledge development and exchange in the innovation chain. Patents and 
scientific publications represent different dimensions of innovation, and combined analysis may assist 
in the evaluation of knowledge transfer between scientific discovery and technological outcome. 
Fleming & Marx (2006) illustrated that collaborations recorded in patent data captured personal and 
professional ties between inventors. Co-inventors may have collaborated intensively over extended 
periods of time towards novel inventions (Singh, 2005). Patents, therefore, serve as tools indicative of 
a collaborative event (Balconi, Breschi, & Lissoni, 2004) and could be exploited to map social ties 
among inventors (Breschi & Lissoni, 2004). Several authors have used co-inventorship of patents as a 
proxy for collaboration in network analysis studies. To the author’s knowledge, the first true attempt 
was presented by Balconi et al. (2004). Balconi et al. mimicked the approach used by Newman (2001), 
which examined social networks arising from co-authorship in scientific publications, by linking co-
inventors of patents in a network. Newman derived implications for knowledge exchange in the 
network from the structure of the network. Functional scientific networks were found to have “small 
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world” characteristics, i.e. high clustering and low average path length. High clustering implied that 
actors were highly connected, and short average path length meant that the distance between actors 
was small. Small world networks increased creative output as they linked local collaborative 
innovation to more distant, complementary ideas (Binz, Truffer, & Coenen, 2014). Balconi et al. (2004) 
found that, except for a few technological fields, networks of inventors were more fragmented than 
networks of scientists. In the cases where network fragmentation was less pronounced between 
scientists and inventors, this was possibly related to technologies where scientific input was important 
for the commercialisation of those technologies. An objection raised against co-inventorship to 
illustrate knowledge exchange among inventors is that inventorship only reflects a small subset of the 
knowledge exchange that takes place for technological development; examples of other types of 
knowledge exchange are personal contacts with non-inventors, which may include academic 
researchers and technologists (Breschi & Lissoni, 2004). 
Social network analysis (SNA) literature using scientific publications, patents, or a combination of both, 
is abundant. In the latter the focus is often on university-industry interaction and the translation of 
basic science to commercialising technologies. Within this body of literature, work on medical device 
development is limited. To the authors knowledge, the only such study was performed by Murray 
(2002), who investigated the communication between science and technology networks in cartilage 
tissue engineering. Murray discovered that one of the motivations for tissue engineering applications 
was grounded in the need to find real solutions to an existing medical problem i.e. real solutions for 
organ failure. Bibliometric indicators showed that a few key scientists published in both domains; also, 
industry actors did not really participate in scientific publications. Interviews conducted for Murray’s 
study, however, highlighted overlap between the two networks, not captured in bibliometric data. 
Reasons for this overlap included the involvement of key scientists in technology development and 
patenting, forming start-up companies, consulting, mentoring and informal advice. Through these 
activities, scientists become active participants in both the scientific and the technical community.    
The conceptual framework employed in this chapter has been presented in Chapter 3, and the 
methodology implemented in this chapter has been presented in Chapters 4 and 5.      
6.2 Results 
The search phrase used to extract patents showing evidence of orthopaedic device development by 
South African inventors (individuals or organisations), is shown in Appendix B. The definition of an 
orthopaedic medical device (see Section 5.4.1) was used to develop the search phrase. A TotalPatent 
search was performed on 12 June 2018 and yielded 1,926 results. Patents were manually examined 
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to extract those related to orthopaedic devices, which had priority dates between 1 January 2000 and 
31 December 2015. Seventy-three patents having unique names and showing evidence of orthopaedic 
device development by inventors having a South African address, were retained. 
Inventor affiliation data for 11 of the 73 patents could not be established. Some inventors had no 
internet presence at all. For some patents, affiliation data for some of the inventors, but not all, were 
obtained. These patents were excluded from the dataset. The results reported here are from 62 
patents filed between 2000 and 2015. Fifty-seven organisational actors were identified; Table 5 
presents a spatial and sectoral breakdown of the actors. Thirty-five (61%) of the actors are South 
African. The organisations are represented in fairly equal numbers from the university, healthcare and 
industry sectors. National and international university actors are represented in similar numbers. The 
number of national healthcare and industry actors present is twice that of their international 
counterparts.   
Table 5: Spatial and sectoral breakdown of inventors who patent in orthopaedic device development in South Africa 
Sector National International Total 
Universities 7 9 16 
Healthcare 14 7 21 
Industry 14 5 19 
Science Councils 1 0 1 
Total 35 22 57 
 
For the period 2000-2015, 12 overlapping timeframes were assessed, starting from 2000-2004 (1st 
timeframe) and ending at 2011-2015 (12th timeframe). For each timeframe, the number of national 
and international actors and the patents for that period were counted (see Figure 15). There is a 
gradual increase in the number of patents produced by actors as time progresses, peaking in the 9th 
(2008-2012) timeframe. The total number of actors increases over time; the number of national actors 
is always greater than the number of international actors. There is a sudden increase in the number 
of international actors in the ninth timeframe (2008-2012). Selected timeframes of the orthopaedic 
device development network are presented in Figure 16. Each actor is represented by a node in the 
network. Full names of the actors along with their abbreviations are presented in Appendix F. The 






































































































































Figure 16: Orthopaedic device development actor-collaboration network of South Africa based on patents for (a) 2000-2004, 
(b) 2005-2009 and (c) 2011-2015. Nodes are sized according to weighted degree centrality. Thickness of edges have been 
weighted to tie strength.  
83 
 
In the 2000-2004 timeframe (Figure 16a), 13 patents were produced by inventors affiliated to ten 
organisations. In this timeframe, only one international organisation is present – Spinal Motion Inc. 
(SMI). SMI was, at the time of patent priority date, an American partner to domestic company 
Southern Medical (SM).  The network component to which SMI and SM belong (i.e. the group of nodes 
of which SM and SMI and connected by edges), is largely involved in the development of spinal disc 
arthroplasty3. The other components in the first timeframe are all from patents arising from within 
the same organisation. In the 2005-2009 timeframe (Figure 16b), 22 patents were produced by 
inventors affiliated with 15 organisations. The SM/SMI component evolves – some previous actors 
have disappeared, and new actors appear. The patents of this component comprise inventions in 
spinal fusion devices and disc and lower-arm arthroplasty. The rest of the actor-collaboration network 
comprises either single-node or two-node groups, where the inventors were either from a single 
organisation, the inventors were from two different organisations, or the single inventor was affiliated 
with two organisations. An example is the UCT/GSH component, where the (single) inventor is 
affiliated to both the University of Cape Town (UCT) and one of its academic hospitals, Groote Schuur 
Hospital (GSH). The 2011-2015 timeframe (Figure 16c) comprises 25 patents from inventors affiliated 
with 38 organisations. The single-node CMO (Custom Med Orthopaedics) has repeat patents for 
orthopaedic instrumentation involving inventors only affiliated with its own organisation. Three 
components in this network have greater international presence – inventor(s) from Saspine are 
collaborating with inventors affiliated with international healthcare and international industry 
organisations; inventor(s) from Tshwane University of Technology (TUT) are collaborating with 
inventors affiliated with international universities; and inventors from Stellenbosch University (SUN) 
and Stellenbosch MediClinic (SMC) are collaborating with inventors affiliated with international 
university, healthcare and industry organisations. While UCT appears to have a central role in this 
network, it is largely in that position because of the multiple affiliations of its inventors.  
Across all timeframes, there are inventors who chose to patent in isolation. Apart from the Council for 
Scientific and Industrial Research (CSIR), these inventors are largely from the national healthcare and 
national industry sectors. These isolated inventors from the national healthcare sector are almost 
exclusively affiliated with private healthcare facilities, including Netcare Jakaranda Hospital (JH), Life 
Wilgeleugen Hospital (LWH), Netcare Pinehaven Hospital (PH), Netcare Parklands Hospital 
(ParklandsH), Netcare Unitas Hospital (Unitas) and Zuid-Afrikaans Hospital (ZAH). The actor-
collaboration network contains many actors who have patented only once. On the other end of the 
spectrum, there are a few actors who patented many inventions. SM/SMI contribute to 21(34%) of 
 
3SM is a South African company and has SMI is its American partner. The SM/SMI partnership is occasionally due 
to one individual having both affiliations, but mostly, there are inventors from both companies.  
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the 62 patents; their parent company, Southern Implants (SI), contributes to a further three patents. 
CMO contributes to six patents. This is consistent with Balconi et al. (2004), who found that very few 
inventors produce a high number of patents, while most inventors produce just one.  
Figure 17 presents the evolution of high degree centrality actors of the patent actor-collaboration 
network over the 12 timeframes. If an actor had the highest degree in any timeframe, its degree 
centrality over all 12 timeframes is reported. In some cases, pairs/groups of actors are presented 
because they are so closely related. This deviates from their presentation in the scientific publication 
actor-collaboration networks of Chapter 5. It is presented in this way because in some instances the 
nodes are solely due to the dual-affiliations of the inventors, as in the case of WITS/CMJAH and 
UP/SBAH, or in other cases, inventors have worked together on multiple patents and some have dual 
affiliations. This is the case for SM/SMI. SM/SMI are high degree actors for the first eight timeframes, 
with their degree centrality decreasing as time progresses. WITS/CMJAH and UP/SBAH are high degree 
actors in the first five timeframes. Their degree centrality values are identical and decreasing. These 
pairs are only present in the first five timeframes and result from university-affiliated clinicians who 
co-invent patents with the SM/SMI pair. Nine actors, UMIN, TI, SUN, SMC, OSV, LTU, LOC, GU and 
GUH, are high degree actors in the last four timeframes. They collaborate on a 2013 patent for a set 
of femoral implants for knee prosthesis. Their presence is due to the number of inventors listed on 




Figure 17: Actors having high degree centrality in the patent actor-collaboration networks 
Figure 18 presents the evolution of actors having high betweenness centrality. In the entire period, 
only four actors have betweenness centrality. This includes the SM/SMI pair, UCT and Saspine. These 
actors have very limited potential to influence the flow of knowledge in the network; this influence is 
































































































































Figure 18: Normalised betweenness centrality for patent actor-collaboration networks 
The nationalisation index of the patent actor-collaboration networks is presented in Figure 19. The 
nationalisation index is positive for the first five timeframes, but it is ever decreasing. As the network 
grows, the collaborations become more internationalised, with a negative index between the sixth 
(2005-2009) and the 11th (2010-2014) timeframes. Beyond the fifth timeframe, the index increases to 
zero, and then edges positively, suggesting that collaborations become nationalised again. However, 
the index is very close to zero beyond the seventh timeframe, suggesting that the collaborating actors 












































































































Figure 19: Nationalisation index of the patent actor-collaboration networks across all 12 timeframes 
No 2-clan networks were drawn for the patent actor-collaboration networks as it was apparent from 
the actor-collaboration networks in Figure 16 that very few timeframes, or rather components within 
timeframes, would meet the requirements to be part of the 2-clan analysis.  
The international actors of the patent actor-collaboration network are from nine different countries, 
including France (5 actors), the United States of America (4 actors), the United Kingdom (3 actors), 
Belgium (2 actors), Australia (2 actors), Canada (1 actor), Germany (1 actor), the Netherlands (1 actor), 
and India (1 actor). Canada is the only country appearing in the patent actor-collaboration network 
that did not appear in the scientific publication actor-collaboration network.  
The sectorisation indices of the local healthcare, university and industry sectors, for the patent actor-
collaboration networks across the 12 timeframes, are presented in Figure 20. A positive index 
indicates a sector’s preference to participate in intra-sectoral collaborations, while a negative index 
indicates a tendency for involvement in inter-sectoral collaboration. In Figure 20, the sectorisation 
index is -1 across all timeframes expect for the last one.  
Overall, collaborating actors from the national university and industry sectors are largely involved in 
inter-sectoral collaboration with other national organisations. Across all timeframes, the national 


























































































































actors. This is also the case for the national healthcare sector, except in the very last timeframe, where 
there is a link between two national healthcare actors, GSH and VPH.   
 
 
Figure 20: Sectorisation indices of the patent actor-collaboration network across the 12 timeframes 
 
6.3 Discussion 
The Intellectual Property Rights from Publicly Financed Research and Development Act, Act 51 of 
2008, led to the establishment of the National Intellectual Property Management Office (NIPMO) and 
the Intellectual Property Fund in South Africa. The Act provides for more efficient utilisation of 
intellectual property resulting from publicly financed research and development, and for the 
establishment of technology transfer offices (TTOs) at publicly financed research organisations (e.g. 
universities and science councils). Public organisations like universities, academic hospitals and 
science councils are bound by the Act, while the Act does not apply to private sector actors from the 
healthcare and industry sectors.  
Patenting activity from South African universities prior to the Act was low, with a total of only 24 
patents emanating from South African universities in 2008 (Alessandrini, Klose, & Pepper, 2013); by 
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Muchi, 2018). The effects of the Act appear to not (yet) have increased patenting in the orthopedic 
devices TIS. Seven national university actors appear in the patent actor-collaboration networks. 
However, the number of inventors affiliated with national universities in any given timeframe is very 
low, the highest number being four.   
The Act may however have changed certain behaviours of actors in the TIS. The university-affiliated 
clinicians (from UP/SBAH and WITS/CMJAH) who collaborate in the SM/SMI components have their 
patents assigned to the SM/SMI conglomerate. In this way, university-affiliated clinicians may serve 
as consultants to industry and transfer their IP rights to the industry actor, on agreed-upon terms. 
These are earlier patents (between 2000 and 2008) and patenting activity may not yet have been 
affected by initiatives undertaken by universities to promote patenting. The inventors who have gone 
through national university channels to patent, i.e. where the university was the assignee on the 
patent, include inventors from SUN, VUT, TUT and UCT. All these patents have been filed since 2008.  
Each of the national university actors has formalised structures for the protection of IP emanating 
from university research. In the UCT component, the UCT/GSH link is due to university-affiliated 
clinicians who have patented inventions in their own capacity4, even though the clinician had been 
affiliated with both organisations. This appears to be a practice by clinicians, especially orthopaedic 
surgeons, who can be remunerated for consultation services and earn royalties on inventions (South 
African Orthopaedic Association, 2019). There does however exist opportunity for university TTOs to 
identify inventions by university employees, create an entrepreneurial culture among university-
affiliated clinicians (and the university at large), and encourage employees to disclose inventions to 
the university and pursue university IP processes. Owen-Smith & Powell (2001) found that a crucial 
first step in the university environment is to convince academics to disclose their potentially valuable 
innovations to the TTOs. The perception of local patenting processes among academics and the 
meanings that academics attach to their IP colour their decisions to disclose these innovations (ibid). 
Owen-Smith & Powell suggest that creating an entrepreneurial culture among academics is a key step 
in successful technology transfer. In South African universities, successful technology transfer efforts 
lie in proactive engagement by the TTOs with inventors (Alessandrini, Klose, & Pepper, 2013) and 
effective and trustworthy relationships between TTO staff and inventors (Sibanda, 2009).  
While national university actors produced many scientific publications related to orthoapedic device 
development, national university actors have been involved in relatively few patents. It could be that 
university faculty are not incentivized in the same way to patent as they are to produce scientific 
publications. Academics who patent are listed as inventors on university patents and can earn 
 
4 These clinicians were both the inventors and assignees listed on the patent.  
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royalties therefrom. Incentives available to produce scientific publications may bring more immediate 
gain, in the form of promotion and the subsidy from the Department of Education and Training’s 
Research Outputs Policy. The Department of Higher Education and Training has changed the incentive 
structure, effective in the 2021-22 financial year, to give equal weighting to innovations such as 
patents and scientific publications under the recognised research outputs for which universities may 
earn subsidies (Department of Higher Education and Training, 2018).   
The Act and its Regulations have been criticised for their approach to IP protection, which may present 
obstacles to scholarly publishing (Gray, 2009). Rapid publication of new research relating to potentially 
patentable inventions may be delayed to prevent compromising the novelty requirement for 
patentability; routine delays may affect scientific publication rates, making South African academics 
less competitive in open knowledge exchange (Ncube, Abrahams, & Akinsanmi, 2013).  
The number of clinicians from the private healthcare sector in the orthopaedic devices TIS who patent 
in their own capacity is noteworthy. Of the 14 national healthcare actors present in the patent actor-
collaboration network, ten are from the private healthcare sector. The actors from the private 
healthcare sector mainly operate on their own or with one other actor, contributing to the large 
number of separate components in the network (SMC is the exception). These private healthcare 
actors are largely from the three big private healthcare providers in South Africa, i.e. Netcare Group, 
Life Healthcare and Mediclinic. Medical practitioners, such as doctors and specialists, are not 
employed by the private healthcare groups in South Africa (Health Professions Council of South Africa, 
2016b). A common business model employed in private hospitals has the medical practitioner working 
from, but not employed by, the hospitals; these hospital-based practitioners either deal only with 
inpatients admitted to the hospital, or have a dual business model where they treat private, 
ambulatory, in-care and hospital patients (Trade & Industrial Policy Strategies, 2018). Even though 
these doctors are not employed by the large private healthcare provider groups, there exists 
opportunity for private healthcare groups to facilitate and exploit innovations arising from clinicians 
affiliated with the private healthcare group.  
There are a few ways in which the scientific publication actor-collaboration network (Chapter 5) and 
the patent actor-collaboration networks presented here differ. First, the scientific publication actor-
collaboration network comprises actors largely from the university and healthcare sectors, with very 
few industry and science council sector actors present. In the patent actor-collaboration network, the 
inventors are affiliated with organisations from the university, healthcare and industry sectors in 
almost equal proportion, and the science council sector is mainly absent. Only one science council 
actor, the CSIR, appears early in the network, contributing to a single patent. 
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Second, the scientific publication actor-collaboration network had a large international presence, 
whereas the patent actor-collaboration network is made up mainly by inventors affiliated to South 
African organisations. Third, the key actors identified in the scientific publication actor-collaboration 
network were found to be national research-intensive universities and their associated academic 
hospitals. The key actors identified in the patent actor-collaboration network are a pair of industry 
actors who patent many innovations, and an inventor affiliated to a private healthcare facility, who 
has ties to university, healthcare and industry sector actors. In the scientific publication actor-
collaboration network, only seven national industry actors and seven international industry actors 
were identified. In the patent actor-collaboration networks, 14 national industry actors (11 not 
previously identified in the scientific publication actor-collaboration network) and five international 
industry actors (four not previously identified in the scientific publication actor-collaboration network) 
were identified. These national industry actors are largely small, medium and micro enterprises; two 
of these are university spin-outs, both from UCT. Of the international industry actors, Tornier Inc. (TI), 
now merged with Wright Medical Group to form Wright Medical Group N.V. (Healio, 2014), is the only 
large corporation.   
It is recognized that South African business makes a very small contribution to scientific knowledge 
output in South Africa (National Advisory Council on Innovation, 2014; National Advisory Council on 
Innovation, 2016). Industry actors who do patent may well be doing research that they prefer not to 
publish. As Breschi & Lissoni (2004) highlighted, patent inventorship only reveals a tiny subset of the 
activity towards development. Nonetheless, the patent actor-collaboration network analysis has 
identified actors, especially those in the industry sector, who were not identified in the scientific 
publication actor-collaboration network, including key contributors to the technological knowledge 
base, the SM/SMI pair.    
The patent actor-collaboration networks are sparse, with many single-actor and double-actor 
components. In the case of single actor components, the benefits of inter-sectoral collaboration are 
absent in the development of devices. In the case of double-actor components, translational 
collaborations do not occur. The SM/SMI component is the main component participating in 
translational collaborations; however, its key role in the patent actor-collaboration network may be 
attributable to factors beyond its participation in such collaborations, which cannot be assessed 
through network analysis.  
As seen in the sectorisation index, national intra-sectoral collaboration is absent. Intra-sectoral 
collaboration takes place between national and international actors in the patent actor-collaboration 
network; but within South Africa, South African universities are not patenting jointly, healthcare actors 
are not patenting jointly, and industry actors are not patenting jointly. The presence of intra-sectoral 
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collaboration at an international scale, and not a national scale, suggests some benefit of international 
ties within the same sector offer over local ties. These could include access to foreign markets, access 
to different patient demographics, access to specialized infrastructure and resources, and access to 
patenting expertise.  
Patra & Muchie (2018) found that approximately 20% of South African university patents were 
collaborative. Approximately 40% of these collaborative patents were with national science council 
actors, and approximately 17% were with international multinational companies. Joint patents with 
national industry actors were very low. Patenting between national universities and national industry 
actors is low in the orthopaedic devices TIS as well as more broadly in South Africa. In a study by Ncube 
(2013), one university warned that provisions in the Act would result in a loss of industry-contracted 
research due to requirements for permissions from NIPMO and the uncompetitive nature of the full-
cost model, while another university considered the full-cost model a necessary approach to 
university-industry collaboration. According to the full-cost model, if a private entity or organisation 
covers the full cost (both direct and indirect) of research and development in collaboration with a 
public research organisation, the project is not considered to be publicly financed, and the provisions 
of the Act no longer apply (NIPMO, 2019). Knowledge is a localised phenomenon and knowledge 
exchange among the same set of co-located actors lose value over time; as the value of knowledge 
and the recombination thereof fades (Boschman & Frenken, 2010), collaboration with outside 
partners becomes important to prevent over-embeddedness (Breschi & Lenzi, 2015). Patenting only 
captures a small proportion of links relevant to knowledge exchange, although the network of 
collaborators is the most immediate and influential environment from which inventors draw ideas and 
information (Breschi & Lenzi, 2015).  
Twenty-three organisations appear in both the scientific publication and the patent actor-
collaboration networks – 11 from the university sector, eight from the healthcare sector, three from 
the industry sector and one from the science council sector. Many, but not all, organisations that 
appear in both networks, have the author and inventor as the same person. This suggests that there 
is some translation of scientific knowledge to commercial applications. Some patent-paper pairs are 
present in the actor-collaboration networks, i.e. the same idea described in different ways, resulting 
in a patent and journal paper (Murray, 2002). The paper would usually describe experimental results, 
whereas the patent would define utility and claims of inventiveness. Examples of such pairs from the 
university sector include paper and patent of the TUT-component on a mechatronic system for 
assisting an individual attaining a standing position. In the scientific publication actor-collaboration 
network, some of these TUT component inventors co-author a series of papers on the biomechanics 
of knee and ankle trajectories. The inventors of a patent by the SUN/SMC pair on the method for 
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designing a knee prosthesis in the patent actor-collaboration network, are co-authors of several 
papers on the development and testing of patient-specific knee implants. There are several such 
examples, and it is evident that the orthopaedic device development network arises from the 
interaction between science and technology spheres.  
6.3.1 Limitations of the study 
Eleven of the 73 patents had incomplete inventor affiliation data and were subsequently omitted from 
further analysis in this research project. This means that many organisational actors may not have 
been identified. The second limitation is that the organisational affiliations associated with each 
inventor relied on the methodology described in Chapter 4. The inventors themselves did not provide 
their affiliations, and some affiliations may have errors. The multiple affiliations of the inventor 
captured at the priority date may not have been associated with work carried out at all of those 
organisations; this may result in the network presenting collaborative ties where there were none, or 
not formally. Multiple affiliations due to the joint assignation of university and hospital by clinical 
academic contributed toward the strong ties between the university and healthcare sectors in the 
scientific publication actor-collaboration networks.  
Both the scientific publication and patent actor-collaboration networks were small, developed from 
63 and 62 publications respectively, presenting networks of 99 and 57 organisations respectively. 
These networks, though small, are similar in size to those presented by Chimhundu et al. (2015) and 
de Jager et al. (2017).  
6.4 Conclusion 
The goal of any innovation system is to develop, apply and diffuse new technological knowledge 
(Hekkert, Suurs, Negro, Kuhlmann, & Smits, 2007). The organisations contributing to the technological 
knowledge base for orthopaedic device development in South Africa and the sectors to which they 
belong have been identified and the nature of the relations among them have been characterised.  
While technological knowledge is being created at an increasing rate over time, knowledge diffusion 
among actors is in the network is limited.   
The patent network complements the scientific publication network presented in Chapter 5. The 
combined analysis presents an overview of knowledge generating capabilities and activities of the 
actors contributing to the orthopaedic devices TIS. Overlap between the two domains has been 
highlighted. Notable differences between the two networks is the small patenting contribution of 
national university actors, who were the main contributors of scientific knowledge production, as well 
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as the significant contribution made by private healthcare actors patenting in isolation. The results of 
the chapter would be enhanced by further exploration of translation between science and technology 
in the orthopaedics devices TIS. 
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7. Keyword networks 
In this chapter, keyword networks are used to identify the orthopaedic devices being developed, the 
areas of innovation, and the underlying cause, disease or anatomy addressed by the devices. The 
objectives of the chapter are to: 
1. Identify the areas of interest in orthopaedic device development in South Africa and the links 
between these areas of interest. 
2. Highlight the collaboration potential that exists for actors of the orthopaedic devices TIS based 
on common areas of interest.  
The chapter begins with a literature overview of keyword networks and their applications, which 
extends to capturing the relationships between social and cognitive interaction in different types of 
scholarly networks. The conceptual framework and methodology as it has been developed for this 
chapter is then presented. This chapter makes unique methodological contributions in the 
development of tools to relate actors in a network based on their intellectual similarity in a particular 
context.  
7.1 Background literature 
Keyword networks (also referred to as co-word networks5)  are approaches to reveal inter-related 
areas of knowledge. Keywords listed on scientific publications have been used as a data source in 
network analysis; by applying traditional network metric analysis, such studies have achieved several 
different aims. Choi et al. (2011) investigated the organisation and evolution of knowledge and 
research themes in five major journals. Important keywords were identified by their frequency of 
appearance on publications and their centrality in the network. They found that, in their context, the 
more popular a keyword became, the more frequently it was used by researchers in future 
publications, and the more often it was associated with other keywords. They inferred that keywords 
having a central position in the network usually become connected to many neighbouring keywords 
based on a process of preferential attachment. The latter occurs when new nodes attach preferentially 
to existing nodes in the network that are already well-connected (Barabasi & Albert, 1999). In the Choi 
et al. study, central keywords played a role in integrating distinct clusters of highly connected 
keywords into a unified network. Yi & Choi (2012) investigated the organisation and evolution of 
scientific knowledge by exploring the mechanisms underlying observed patterns of keyword networks. 
The study compared keyword networks to citation networks and showed that keyword network 
 




analysis could be used as an alternative to citation network analysis. Citation networks were typically 
small-world networks (i.e. they had high clustering coefficients with short path lengths), had power-
law degree distribution, and had hierarchical structure. The structure of keyword networks differed 
from that of citation networks as keyword networks were not small-world networks (i.e. they had high 
clustering coefficients without short path lengths), they were scale-free (power-law degree 
distribution with a scaling factor between 2 and 3) and had a hierarchical structure (due to scale-free 
topology and high clustering co-efficient).  
By investigating the number of connections of keywords to others, Yi & Choi established a power-law 
between the nodal degree and its cumulative distribution.  This power-law distribution takes the form 
of 𝑥−𝛾; the probability of a keyword having 𝑥 connections is proportional to 𝑥−𝛾, where 𝛾 is a scaling 
factor. Most keywords would have a small number of connections, and certain keywords would have 
many connections. Yi & Choi showed that 𝛾 had a value between 2 and 3 in all their application areas. 
The implication of this range is that the keyword network optimises the association of keywords at 
low cost in terms of the number of links due to the role of hub keywords (Sole, Corominas-Murtra, 
Valverde, & Steels, 2010). The definition of a scale-free network is that 𝛾 has a value between 2 and 
3. Outside of this range, the network may become too disconnected (𝛾 > 3) or too dense (𝛾 < 2).  
Using keywords listed on conference proceedings, Santonen & Conn (2016) used keyword networks 
to investigate how different keywords were interlinked with each other to illustrate the 
interrelationship between research fields. Khan & Wood (2015) used keyword networks to uncover 
emerging themes in the information technology management domain.  
Keyword networks potentially lie in the same domain as co-citation networks. Co-citation is 
considered to be a proxy for intellectual similarity (Small, 1973). Co-citation networks are based on 
the number of times two publications are cited together in other publications; co-citation networks 
indicate clusters of related scientific work (van Raan, 2004). They differ from keyword networks in that 
they may relay cognitive and social network relations, whereas keyword network analysis may only 
reveal the cognitive relations.  
Yan & Ding (2012) explored the similarity between six different types of scholar networks and 
investigated the use of hybrid network approaches to identify research areas. The six networks 
included: bibliographic coupling, citation, co-citation, topical, co-authorship and co-word. Co-citation, 
bibliographic coupling and co-word networks were referred to as similarity-based networks and 
focussed on identifying research topics. Factors that contributed to the similarities among networks 
included edge types (real vs. artificial) and network types (social networks vs. information networks). 
Co-authorship networks were found to have the lowest density and number of links among all the 
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networks, which suggested that real social connections were harder to establish than similarity 
approximations. Co-word networks were found to be most similar to bibliographic coupling networks. 
Yan & Ding also identified two types of similarity dimensions among the six networks: “citation-based 
vs. non-citation based” and “social vs. cognitive”.  One of the recommendations of their study was to 
use hybrid networks to comprehensively capture complex research communication and interaction. 
A proposed hybrid model, which explored the second similarity dimension “social vs. cognitive”, 
combined co-authorship and co-word networks.  
Khan & Wood (2016) explored the use of social network analysis in the information technology domain 
at the individual, organisational, country, source (i.e. journal) and keyword level in an attempt to 
answer the question “What is the network structure of information technology management 
knowledge infrastructure?” For the period 1995-2014, they found this domain to be highly 
fragmented, with new nodes (individuals and organisations) entering the network preferentially 
attaching themselves to established nodes in the network. They were able to establish unique 
characteristics of the information technology management community, showing that the community 
comprised several distinct schools of thought in which different hypotheses were pursued by 
individuals in the same organisation, who did not collaborate.  
Vida (2018) investigated the effect of distance on co-authorship of scientific publications and its 
impact on the formation and intensity of relationships. Three different types of distances influencing 
the formation of scientific collaborations were identified: geographic, social and cognitive. Vida 
measured geographic distance by the physical distance between co-authors, social distance through 
co-authorship, and cognitive distance through author bibliographic coupling based on common 
references (co-citation) between pairs of scientific publications. Vida used the common journal article 
to inform the co-citation network. Khan & Wood (2016) used source co-citation, where the source was 
the journal in which the article was published, and constructed a source bibliographic coupling 
network. Vida (2018) proposed a way to measure pure cognitive distance (illustrated in Equation 11) 
of an author. The cognitive distance is a measure of the similarity of the knowledge base of researchers 
(Yan & Ding, 2012), as assessed by relations such as co-citation, bibliographic coupling, co-word 
occurrences and common topics (Vida, 2018).  
𝑃𝑢𝑟𝑒 𝑐𝑜𝑔𝑛𝑖𝑡𝑖𝑣𝑒 𝑑𝑖𝑠𝑡𝑎𝑛𝑐𝑒 = 𝐹𝑢𝑙𝑙 𝑐𝑜𝑔𝑛𝑖𝑡𝑖𝑣𝑒 𝑑𝑖𝑠𝑡𝑎𝑛𝑐𝑒 − 𝑆𝑜𝑐𝑖𝑎𝑙 𝑑𝑖𝑠𝑡𝑎𝑛𝑐𝑒… Equation 11 
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In Equation 11, the full cognitive distance is established from a similarity matrix derived from the 
number of shared references between author pairs6. The social distance is established from a 
similarity matrix containing the number of co-authored publications for each pair of authors. Pure 
cognitive distance identifies potential future collaborations, since those authors who are close to each 
other in the cognitive dimension, work in the same research domain but are not (yet) connected by 
co-authorship (Vida, 2018).  
The establishment of pure cognitive distance in Vida’s approach is comprehensive, yet cumbersome; 
all author pairs for the given dataset would need to be established based on common citations, as well 
as co-authorship relations of authors. It is proposed here that the keywords listed on scientific 
publications be used as an indicator of cognitive distance and that keyword networks could similarly 
be used to highlight collaboration potential within co-authorship networks.    
7.2 Conceptual framework 
This conceptual framework is based on the literature described above. The keywork network is used 
to relate keywords listed on scientific publications using network theory. Network theory is rooted in 
graph theory and involves the mapping and visualizing of different relationships (e.g. co-authorship or 
co-words) among “nodes” of the graph (Wasserman & Faust, 1994). While network theory has been 
used extensively to characterise relationships among actors in a network, this study uses network 
theory to uncover relationships between keywords (or areas of innovation), similarly to the 
approaches presented in Choi et al. (2011)  and Santonen & Conn (2016). The keyword network is 
used to establish key research areas in the publication set, links between different keywords, and 
relationships described in previous literature, such as preferential attachment and the formation of 
research domain hubs.  
Based on the approach of Vida (2018), the cognitive distance between authors of scientific 
publications is established. In the approach presented in this thesis, the keyword an author lists on a 
scientific publication is an indicator of their research focus area. By relating keywords that appear on 
a scientific publication, a network of research focus areas can be formed. By linking authors to 
keywords listed on the same scientific publication within a network, an analogue to Vida’s full 
cognitive distance is established. The difference here is that keywords, rather than co-citation, are 
used as the relationship linking authors. Collaboration potential in the network can then be calculated 
by subtracting the social component, which has already been established in the co-authorship 
 
6 The author pairs were derived from a set of scientific publications which meet the inclusion criteria; the set of 
scientific publications was in Economics and Physical Geography with at least one author affiliated to a 
Hungarian organisation (Vida, 2018).  
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networks, from the full cognitive component, namely the author-keyword network. To the author’s 
knowledge, no previous keyword network study has attempted to connect author affiliations to the 
keywords listed on the same publication for this purpose. This thesis therefore adds a new approach 
to the set of tools available for analysing relationships in keyword network analysis.  
7.3 Methodology 
Using the dataset of scientific publications used to inform the scientific publication networks of 
Chapter 5, keyword networks were generated from keywords listed on the publications. Three types 
of keyword networks, namely a keyword-only network, a two-mode keyword-actor network, and a 
collaboration-potential network, were drawn and analysed; these are described below. These 
networks depict cognitive links between actors and are useful in illustrating the collaboration-
potential which exists for actors in the scientific publication actor-collaboration network, based on 
common research interests.  
7.3.1 Keyword-only network 
Each keyword is represented as a node in the network, and an edge between two nodes indicates that 
those nodes appear on the same scientific publication. Metrics of interest were degree centrality and 
betweenness centrality, which have been described in Chapter 4. The popularity of a keyword, as 
described in Choi et al (2011), was investigated.  Popularity is based on frequency of use of keywords, 
i.e. how often they appear in publications.   
To determine if the keyword-only network displayed small world properties, the clustering co-efficient 
and the average path length were calculated, and a hierarchical dendrogram drawn. In a small world 
network, the clustering co-efficient is high and the average path length is low. The clustering co-
efficient7 is a measure of the degree to which nodes in the network cluster together and is calculated 
by Equation 12 (Wasserman & Faust, 1994). The clustering co-efficient is calculated by the number of 
closed triplets in a network divided by all the triplets (which may be open or closed) in the network. 
The term “triplet” here refers to three nodes in the network that are connected by either two edges 
(open) or three edges (closed).  
𝐶 =
𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑐𝑙𝑜𝑠𝑒𝑑 𝑡𝑟𝑖𝑝𝑙𝑒𝑡𝑠
𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑎𝑙𝑙 𝑡𝑟𝑖𝑝𝑙𝑒𝑡𝑠
 … Equation 12  
 
7 In this project the clustering co-efficient refers to the global clustering co-efficient of the network. This is not 
to be confused with local clustering co-efficient of the node, which is not used.  
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The average path length8 is calculated using Equation 13 (Nykamp, n.d.) and measures the average 




 ∑ 𝑑(𝑣𝑖, 𝑣𝑗)𝑖≠𝑗  … Equation 13 
In Equation 13, 𝑙𝑁  is the average path length in the network, 𝑁, which is of size 𝑛, and 𝑑 is the shortest 
path between the nodes (or vertices), 𝑣.  
A measure to determine whether or not the network is indeed small-world is to validate the average 
path length against the criteria of Equation 14 (Yi & Choi, 2012): 
𝑙𝑛 < 1 + 𝑙𝑜𝑔100𝑛 … Equation 14 
7.3.2 Two-mode keyword-actor networks 
The keyword-actor networks were drawn using a two-mode network. Two-mode networks are also 
referred to as affiliation or bipartite networks (Borgatti & Everett, 1997) and involve two sets of nodes, 
with the ties between the nodes belonging to different sets. A common distinction made between the 
two sets of nodes is that one set of nodes is more responsible for creating the tie (primary nodes) than 
the other (secondary nodes) (Opsahl, 2013). In the keyword networks of this thesis, the primary nodes 
are the actors, and the secondary nodes are the keywords. Using a two-mode network in UCINet, 
actors were related to keywords if the actors and keywords appeared on the same publication. The 
resulting node matrix relating actors and keywords is not symmetric; both the actor-collaboration 
network of Chapter 5 and the keyword-only network (above) are built with a symmetric node matrix. 
In the keyword-actor network, the node matrix is of size 𝑛 × 𝑚, where 𝑛 is the number of actors and 
𝑚 is the number of keywords. In the actor-collaboration networks of Chapter 5 and the keyword 
networks described above, the node matrix of size 𝑚 × 𝑚, where 𝑚 was the actors and the keywords, 
respectively. The keyword-actor network illustrates the areas of orthopaedic device innovation in 
which actors are working, based on their publications.  
Popular keywords were used to draw two-mode actor networks, linking the actor to the area of 
interest. Popular keywords were those appearing with highest frequency in the data set. The two-
mode keyword-actor network is useful in determining the capacity of actors to contribute to the 
innovation domains of, and their relation to popular areas of interest in, the orthopaedic devices TIS.  
7.3.3 Collaboration-potential network 
The actor-collaboration networks (based on co-authorship as shown in Chapter 5) were redrawn to 
show edges between nodes as keywords, to illustrate the relationship between actors based on 
 
8 The average path length is also called the geodesic distance. The geodesic distance calculator in UCINet was 
used to calculate average path length.  
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common research areas. To draw the network, UCINet requires an input relationship matrix. The two-
mode keyword-actor matrix was converted to a one-mode matrix – [𝑁]𝑘𝑒𝑦𝑤𝑜𝑟𝑑𝑠 – in which actors 
were related by keywords. This is different from the conventional actor-collaboration network node 
matrix – [𝑁]𝑐𝑜−𝑎𝑢𝑡ℎ𝑜𝑟𝑠ℎ𝑖𝑝 – in which actors were related by co-authorship. The collaboration-potential 
matrix was calculated by Equation 15: 
[𝑁]𝐶𝑜𝑙𝑙𝑎𝑏𝑜𝑟𝑎𝑡𝑖𝑜𝑛−𝑝𝑜𝑡𝑒𝑛𝑡𝑖𝑎𝑙 = [𝑁]𝑘𝑒𝑦𝑤𝑜𝑟𝑑𝑠 − [𝑁]𝑐𝑜−𝑎𝑢𝑡ℎ𝑜𝑟𝑠ℎ𝑖𝑝 … Equation 15 
The collaboration-potential network highlights presently unutilised opportunities for collaboration in 
orthopaedic device development in South Africa, based on common areas of interest.  
7.4  Results 
Fourty of the 63 scientific publications, which had formed part of the scientific publication dataset of 
Chapter 5, had author-assigned keywords. Twenty-two of the publications did not have author-
assigned keywords, and keywords were assigned independently by the author and another researcher 
who had read the title and abstract of the publications. These assigned keywords were compared and 
reconciled by the author to determine a set of keywords for this set of publications. One publication 
did not have an abstract. The author read this publication and assigned keywords to it. As authors of 
the scientific publications would define a similar concept differently, keywords were standardised. For 
example, the term “prostheses and implants” encompass keywords described by authors as 
“biomechanical implants”, “cervical implant”, “implants”, “prostheses and implants” and “prosthesis”.   
A full list of the standardised keywords can be found in Appendix J. 
In total, 271 unique keywords were identified. After standardising, 205 keywords were retained for 
further analysis. From the standardised list, the popularity of a given keyword was determined based 
on its frequency of appearance on publications. Most keywords only appeared on one publication; of 
the 205 keywords, 42 appeared on two or more publications, and 18 appeared on three or more 
publications. These 18 keywords are referred to here as popular keywords.  
7.4.1 Keyword-only network 
The keyword-only network is presented in Figure 21. The network comprises 8 components; 167 
keywords, including all 18 popular keywords, appear in the main component. The clustering co-
efficient of the keyword network is 1.004, and the average path length (among reachable pairs) is 
3.804. The keyword network is of size 205 nodes, and the average path length is considered long in 
this network. To meet small-world length criteria, the average path length should have been smaller 
than 2.156 steps. The keywork network is therefore not a small-world network. It also has hierarchic 
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structure, and its dendrogram is presented in Appendix K. The keyword network therefore has the 
structural elements as described in Yan & Ding (2012). 
 
Figure 21:Keyword network drawn from keywords appearing in scientific publications on orthopaedic device development in 
South Africa. The nodes have been scaled to the degree centrality metric; edge thickness is unweighted. Only the labels of 
popular keywords have been included for legibility. 
The top five keywords by popularity, degree centrality and betweenness centrality are presented in 
Table 6. The high-ranking keywords are research areas typically associated with orthopaedic devices, 
including the arthroplasty of major joints (hips and knees), and “fixation” which has the highest 
betweenness centrality and is a cross-cutting research focus in orthopaedics. More recently, 
developments by some South African actors have been focussed on “customised design” of devices. 
In Table 6, “hydroxyapatite” had the third highest betweenness centrality but does not appear as a 
high-ranking popular keyword or high-ranking degree centrality keyword. Hydroxyapatite is used as a 
coating on hip and knee implants, as well as in bone grafting, as it encourages bone growth after 
surgery. Like “fixation”, it cuts across different orthopaedic applications.   
The agreement between degree and betweenness centrality is consistent with Choi et al. (Analysis of 
keyword networks in MIS research and implications for predicting knowledge evolution, 2011) who 
showed a strong correlation between these two metrics, but noted that the correlation is not typical 
of natural and artificial networks. In addition to highlighting the popular areas of interest of 
orthopaedic device development in South Africa, the connections between keywords can also be 
highlighted. In the keyword network, the strongest ties were between “knee arthroplasty” and 
“customised design”, the result of co-occurrence on four publications.  
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Table 6: Highest-ranked keywords by popularity, degree centrality and betweenness centrality 
Popularity  Degree Centrality Betweenness Centrality 
Keyword Value Keyword Value Keyword Value 
hip arthroplasty 8 hip arthroplasty 28 fixation 9180 
prostheses and implants 8 prostheses and implants 26 prostheses and implants 8868 
fixation  7 fixation 26 hydroxyapatite 5045 
customised design 7 customised design 26 hip arthroplasty 4492 
 knee arthroplasty 7 design 20 mechanical wear 4480 
 
7.4.2 Two-mode keyword-actor network 
A two-mode keyword-actor network based on the 18 popular keywords was drawn and is presented 
in Figure 22. The network is a single component network comprising 77 of the 99 actors. Stellenbosch 
University (SUN) and Stellenbosch MediClinic (SMC) have strong ties to “knee arthroplasty” and 
“customised design”. The University of Cape Town (UCT) has strong ties to “radiography” and 
“design”’. Even though “hip arthroplasty” and “prostheses and implants” are the most popular 
keywords, the biggest nodes in this network are “fixation” and “intramedullary nail”, indicating that 
more actors are involved in these areas. The two-mode keyword-actor network is useful in highlighting 
the areas of orthopaedic device development in which actors are publishing. Figure 22 is limited to 
actors involved in research areas described by popular keywords, for legibility of the network.  
Of the 22 actors absent from this network (shown on the left-hand side of Figure 22), only two are 
national actors. The other 20 are international actors, 12 of which are international universities. There 
was a total of 63 international actors in the scientific publication actor-collaboration network. This 
finding suggests that international actors bring new areas of interest into the orthopaedic device 






Figure 22: Two-mode actor-keyword network based on popular keywords of scientific publications of orthopaedic device 
development in South Africa.  The actors appearing on the left-hand side do not work in the areas described by the popular 
keywords. The nodes have been scaled to the degree centrality metric, and edge thickness has been scaled to tie strength.   
National actors appear to be involved in specific niche areas of orthopaedic device development and 
the fragmentation displayed in the actor-collaboration networks of Chapter 5 could be a result of 
these niche areas. This can be illustrated by considering the example of national university actors. 
SUN, for example, had focussed on the customised design of implants for knee and spine applications 
and a posture analysis tool. Tshwane University of Technology (TUT) had focussed on rehabilitative 
orthoses. The University of the Witwatersrand (WITS) and UCT were involved in many different 
developments, each collaborating with several actors in the network. WITS had focussed on hip 
implants, materials for hip implants and instrumentation for fatigue monitoring of biomechanical 
implants. UCT had focussed on surgical instrumentation, radiography for orthopaedic applications and 
software development with orthopaedic applications. 
7.4.3 Collaboration-potential network 
In Chapter 5, the actor-collaboration networks (Figure 9) had been presented in five-year moving-
window timeframes. In Figure 23, the actor network is drawn for the period 2000 to 2015. Network 
metrics of degree centrality are reported in Section 5.4.  
The scientific publication actor-collaboration network is sparse, with a density of 0.064, indicating that 
only 6.4% of all possible connections in the network have been made. The actor-collaboration network 
comprises nine components, with 74 actors present in the largest component. The most prominent 
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nodes (by degree centrality) are national research-intensive universities – UCT, WITS and SUN – and 
national healthcare actors – Charlotte Maxeke Johannesburg Academic Hospital (CMJAH), Groote 
Schuur Hospital (GSH) and Vincent Palotti Hospital (VPH). The strongest ties, i.e. the thickest edges in 
the network due to repeat collaborations between actors, was between the national universities and 
national healthcare facilities; examples include UCT and GSH (5 instances), UCT and VPH (3 instances), 
and WITS and CMJAH (3 instances). The other eight components in the network form isolated pockets 
of activity – five of these components have a national university actor present. Even within these 
isolated components, repeat collaborations occurred. The Six Degrees of Freedom (6DOF) component 
is due to two publications, largely from the same group of authors and the TUT component is due to 
three publications, with common authors across the three publications.  
 
Figure 23: Scientific publication actor-collaboration network for the period 2000 to 2015, where the links between nodes are 
indicative of a co-authorship event. Nodes are sized according to degree centrality. Thickness of edges have been weighted 
to tie strength. 
The nodes having the highest degree centrality are presented in Table 7. The three highest ranked 
nodes are national universities UCT, WITS and SUN, each of which are located at the centre of hubs 
within the main component. Each of these universities co-author publications with several other 
organisations in the actor-collaboration network, but not with each other. UCT, WITS and SUN are 
linked to each other through the activity of their collaborators.  
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Table 7: Actors having high degree centrality in the scientific publication actor-collaboration network for the period 2000 to 
2015 
Degree Centrality 
Rank Node Actor Sector Location Value* 
1. UCT University of Cape Town University Local 33 
2. WITS University of Witwatersrand University Local 30 
3. CMJAH Charlotte Maxeke Johannesburg 
Academic Hospital 
Healthcare Local 21 
4. GSH Groote Schuur Hospital Healthcare Local 20 
5. SUN University of Stellenbosch University Local 16 
*The degree centrality value is the weighted degree centrality, excluding self-reflecting ties. 
 
In Figure 24, the actor network for the period 2000 – 2015 is redrawn with the edges between nodes 
as keywords. The result is a highly connected network, with 97 of the 99 actors connected in the main 
component. The actors University of the Free State (UFS) and Roehampton University (RU) appear in 
the scientific publication actor-collaboration network for the development of materials for use in 
orthotics.; no other actors in the scientific publication actor-collaboration network had published in 
this research area. This network illustrates common areas of interest among actors, and shows that 
actors may in fact be more closely related to each other in terms of research interest than suggested 
in the actor-collaboration network based on co-authorship in Figure 23.   
 
Figure 24: Redrawn actor network for the period 2000-2015 where the edges between actors are keyword links. The nodes 
have been scaled to the degree centrality metric, and the edges are unweighted.  
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The collaboration-potential network, presented in Figure 25, has been derived by subtracting the 
scientific publication actor-collaboration network from the keyword actor network. The nodes have 
been scaled to the degree centrality metric. This network illustrates the potential that exists for 
collaboration based on common areas of interest. Figure 24 illustrates how closely actors are related 
in the cognitive dimension; Figure 25 highlights the connections that could be made should actors 
exploit their relationships in the cognitive dimension to establish relationships in the social dimension 
through collaboration.  
 
Figure 25:Collaboration potential of actors in the scientific publication network. Thickness of edges are unweighted.  
The ten actors shown on the left-hand side of Figure 25 are isolated in this network because they are 
either already connected to the actors via the actor-collaboration network (Figure 23), or they work 
in more specialised areas which sets them apart from the interests of the other actors. As an example, 
in the actor-collaboration network of Figure 23, Telecom Bretagne (TB), Institut Mines-Telecom (IMT) 
and University of Liege (UL) co-author a publication with UCT on an automated statistical shape model 
of the human scapula and humerus. The choice of keywords by the authors were “statistical shape 
model”, “scapula” and “humerus”. These keywords do not overlap with any other actors’ areas of 
interest. Of these ten actors, nine are international actors, further supporting the suggestion that 
international actors bring new ideas into the network.   
The highest-ranked actors in the collaboration potential network are presented in Table 8. The actors 
having the greatest collaboration opportunities are again national research-intensive universities 
(SUN, UCT and WITS) and national healthcare actors (TAH and VPH) that collaborate with them. These 
research-intensive universities have worked in many areas of innovation in orthopaedic device 
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development and can therefore connect with other smaller degree actors who are more closely 
related in the cognitive dimension. In Figure 23, national university actors UCT, WITS and SUN showed 
no social ties in the orthopaedic devices TIS, as these universities never co-authored any of the 
scientific publications in the dataset. Some opinions about this absence of social ties have been 
offered in the discussion of Chapter 5. Figure 25 shows direct links between these universities based 
on their cognitive distance, and supports the assertions made by Yan & Ding (2012) that real social 
connections are harder to establish than similarity approximations.  
Table 8:High-degree actors of the collaboration potential network 
Degree Centrality 
Rank Node Actor Sector Location Value 
1. SUN Stellenbosch University University Local 65 
2. UCT University of Cape Town University Local 50 
3. TAH Tygerberg Academic Hospital Healthcare Local 37 
4. WITS University of the Witwatersrand University Local 32 
5. VPH Vincent Palotti Hospital Healthcare Local 27 
 
7.5 Discussion 
The keyword network is useful in several ways. At the superficial level it shows the research areas in 
which South African organisations are pursuing scientific knowledge in orthopaedic device 
development. The keyword network highlights which areas are of greatest focus and how these 
research areas are connected. Most keywords only appear on one publication, indicating a vast array 
of areas of innovation in which actors are independently conducting research. At the other end of the 
scale, popular keywords are connected to many of these hapax keywords. This can be seen in the 
keyword network (Figure 21) where the 18 popular keywords are connected to 149 other keywords 
in the main component of the network. These popular keywords are typically associated with 
traditional research areas for orthopaedic devices (e.g. prostheses and implants, fixation, hip 
arthroplasty, etc.). On the one hand it appears that innovation continues and expands in these 
traditional research areas, while on the other hand, these traditional areas are being combined with 
new areas as shown by the lower-frequency keywords to which the popular keywords are connected. 
The two-mode keyword-actor network illustrated how key actors in the network are related to 
popular keywords. It is clear from Figure 22 that high-ranking actors are working in research areas 
described by popular keywords. However, it may also be true that the high-ranking actors are driving 
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the focus of the research making these research areas appear popular, at least in terms of the number 
of publications produced. UCT, WITS and SUN are linked to several popular keywords. 
In their study of the evolution of knowledge and research themes in five major journals, Choi et al. 
(2011) found a strong correlation between degree centrality and betweenness centrality in their 
keyword networks, which is uncharacteristic of most natural or artificial networks. In this study, 
keywords having high betweenness centrality also had high degree centrality. This suggests that the 
research areas connecting the network are also the research areas in which most knowledge is being 
produced. 
The collaboration potential network highlights links that could be made between actors based on their 
cognitive distance. This network presents an opportunity for actors who have weak social ties in the 
network, in that it reveals potential collaborators who are similar in the cognitive dimension.  
The approach presented responds to the recommendation by Yan & Ding (2012) to investigate hybrid 
network approaches when studying social and cognitive relations among actors in scientific 
knowledge production. The collaboration-potential network yields the same outcome as that of Vida 
(2018), i.e. determining the cognitive distance between actors, but with a simpler methodology. 
Author-assigned keywords on scientific publications can be retrieved with ease from scientific 
publication databases and combined with the two-mode network to link actors to keywords. In 
contrast, author bibliographic coupling through co-citation, suggested by Vida for the determination 
of cognitive distance, is time consuming and cumbersome with currently available bibliometric tools.  
7.5.1 Limitations of the study 
The keyword networks are based on author-assigned keywords and the keywords assigned by 
researchers in the present study to publications not having author-assigned keywords. The results are 
therefore somewhat subjective, i.e. the collaboration potential is only as good as the choice of 
keywords. The visibility of a publication is related to the choice of keywords. While keywords reflect 
the content of the publication, the choice by the author of a specific keyword could affect reach in the 
reader audience and encourage preferential attachment. Choosing keywords that are already 
prominent in orthopaedic device development, could connect a publication to an array of keywords 
already connected to that choice of keyword. In this way, authors may become more strongly 
associated with a research area. The keywords selected by authors in this set of scientific publications 
were highly specialised. None of the scientific publications have a keyword “orthopaedic device” or 
similar, and only three of the scientific publications had “medical device” as an assigned keyword. The 
keyword network is also sensitive to the generalised choice of keywords in the standardisation 
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process, which, moving from 271 keywords to 205 keywords, aimed not to miss new research areas 
or oversimplify existing ones. 
The approach to establish collaboration potential among actors in a network has been presented as 
an alternative to Vida’s (Distance on scientific collaboration networks, 2018) use of author 
bibliographic coupling to determine cognitive distance. Direct comparison in future studies of the Vida 
approach and the new approach presented here, would reveal the extent to which they yield similar 
results.  
7.6 Conclusion 
This study has identified the scientific research areas of interest in the orthopaedic devices TIS and 
illustrated the linkages between these research areas. It has shown that actors of the orthopaedic 
devices TIS may be closer in their cognitive distance than suggested by the actor-collaboration 
networks of Chapter 5. The study has proposed a new approach for determining the cognitive distance 
among actors in a social network. The new methodology has been applied to show the collaboration 
potential that exists between actors of the orthopaedics devices TIS, which could be exploited for the 
creation of ties to facilitate knowledge diffusion through the scientific network.  
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8. Institutions that impact orthopaedic device development in South 
Africa 
Institutions are considered to be the “rules of the game” in society; they are humanly devised 
constraints that shape human interaction (Hekkert, Negro, Heimriks, & Harmsen, 2011). Institutions 
may be formal or informal. Formal institutions are those rules that are codified and may be enforced 
by an authority, for example supportive legislation and technology standards, whereas informal 
institutions are shaped by the collective interaction of actors (ibid). The creation of a favourable 
ecosystem for the local medical device and diagnostics industries to flourish, requires government 
engagement and intervention (South African Medical Research Council and PATH, 2014; Trade & 
Industrial Policy Strategies, 2018).  It is therefore fitting to consider the institutions of government and 
how they impact on orthopaedic device innovation in South Africa.   
This chapter identifies institutions that impact orthopaedic device development in South Africa. It 
presents government institutions that support innovation as well as institutions that support the 
realisation of a medical device industry in South Africa. The chapter also presents institutions that 
shape actors’ roles in the innovation system. The performance of institutions is not assessed.  The 
discussion at the end of the chapter relates the institutions to the orthopaedic devices technological 
innovations system (TIS) in South Africa and highlights the role of the political context in the TIS. 
8.1 Methodology 
Formal (codified) institutions likely to affect the development of orthopaedic devices and therefore 
the orthopaedic devices TIS, were investigated. While informal institutions may have a strong 
influence on innovation dynamics, it is impossible to map them systematically (Hekkert, Negro, 
Heimriks, & Harmsen, 2011).In the scientific publication and patent actor-collaboration networks, a 
list of actors involved in orthopaedic device knowledge development within South Africa, was 
generated. This actor list is distinguished by location (national and international) and sector 
(university, healthcare, industry and science councils). For each of the four sectors, institutional 
documents relevant to those sectors and actors belonging to those sectors, were identified as 
described below. Furthermore, knowledge creation for orthopaedic device development may be 
influenced by other national and international governance structures. The following sections describe 
the approaches taken to identify relevant institutional documents.  
8.1.1 Government departments 
In the scientific publication and patent actor-collaboration networks, no South African government 
departments were identified as knowledge creators in the orthopaedic devices TIS. However, 
112 
 
government has the important role in enabling and facilitating the growth of the medical device 
industry in South Africa. Four government departments were identified either to be involved in 
medical device development or to contribute more broadly towards knowledge development and 
exchange. These are: 
1. Department of Science and Technology9 
2. Department of Health 
3. Department of Higher Education and Training 
4. Department of Trade and Industry 
The websites of these departments were searched for institutional documents (acts, bills, other 
legislation, annual reports and strategy documents) which may speak to knowledge development and 
exchange for (orthopaedic) medical device development in South Africa.   
8.1.2 Universities 
Different university institutions may support the creation, exchange and dissemination of knowledge 
to deliver and improve healthcare in South Africa.  For each identified university actor in the scientific 
publication and patent actor-collaboration networks, a search of its website was performed to 
capture: 
1. The vision and mission statements of the university. 
2. Policy and strategy documents that provide information on knowledge development and 
knowledge exchange in the scientific and technological domains, in general.  
3. Policy and strategy documents that provide information on knowledge development and 
knowledge exchange in the scientific and technological domains of medical device 
development.  
8.1.3 Healthcare 
Many of the authors and inventors affiliated with the healthcare sector were clinicians, including, 
among others, medical officers, orthopaedic surgeons and neurosurgeons. Clinicians subscribe to 
certain ethical institutions and practices, which were searched for on the websites of the Health 
Professions Council of South Africa (HPCSA) and the South African Orthopaedic Association (SAOA).  
In South Africa, the healthcare delivery system is divided into the public and private sectors. There are 
three large private hospital groups in South Africa, namely Netcare, Life Healthcare and Mediclinic. 
 
9 At the time of performing this institutional review, this was the name of the department. It has since changed 
to the Department of Science and Innovation.  
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The websites of public and private healthcare services providers were explored for relevant 
institutions.  
While actors identified in the actor-collaboration networks were knowledge creators for orthopaedic 
device development, the healthcare sector actors, at large, would be users of orthoapedic devices. 
The institutions searched for included those addressing both knowledge development and exchange 
and the procurement and use of devices.  
8.1.4 Industry 
Several of the identified industry actors were members of either, or both, the South African Medical 
Technology Industry Association (SAMED) and the Medical Device Manufacturers Association of South 
Africa (MDMSA)10. The websites of these organisations were searched for relevant documents.  
All actors who manufacture medical devices must have certain regulatory pathways in place, e.g. ISO, 
CE or FDA approval. In South Africa, medical device regulations were passed in December 2016, and 
are overseen by the South African Health Products Regulatory Authority (SAHPRA). ISO, CE, FDA and 
SAHPRA regulatory pathways were investigated. 
8.1.5 Science councils 
The websites of all the science council actors identified in the actor-collaboration networks were 
searched to identify relevant institutional documents.  
8.2 Results 
Most of the identified actors of the actor-collaboration networks do not exist for the sole purpose of 
developing and/or commercialising orthopaedic devices. Except for a few industry sectors actors who 
may be orthopaedics or medical device companies and specialist orthopaedic hospitals, the other 
actors offer a diverse spectrum of services. 
8.2.1 Government institutions 
An overview of the government institutions identified and presented here is shown in chronological 
order in Figure 26. During the review of the government institutions, it became apparent that the 
institutions of government departments were aligned to the National Development Plan Vision 2030 
(National Planning Commission, 2012), which are South Africa’s long-term socio-economic 
development goals - hereafter referred to as NDP2030. The NDP2030 was only published in 2012, and 
the more recent institutions refer to its goals. The NDP2030 identifies 11 focus areas, one of which is 
 




“Improving Health”. Government’s strategic plans are further communicated through the Medium 
Strategic Framework (MTSF); the MTSF provides a five-year framework for the alignment of other 
government plans at national, provincial and local level, and is intended to bring coherence and 
continuity to the country’s long-term plan. Institutions like the 1974 Health Professions Act, the 1988 
Scientific Research Act, and the 1991 South African Medical Research Act, established the Health 
Professionals Council, the Council for Scientific and Industrial Research and the South African Medical 
Research Council. They are described in their respective sector sections below. The rest of this section 
describes the government institutions chronologically.  
 
 
Figure 26: Government institutions that may impact the orthopaedic devices TIS in South Africa 
 
The White Paper on Science and Technology (Department of Arts, Culture, Science and Technology, 
1996), introduced the concept of a National System of Innovation (NSI). The NSI is the set of 
organisations and networks working towards the development and diffusion of new technologies that 
are economically useful. Within the NSI are certain public organisations, which are categorised into 
the funding bodies, science councils, universities, government departments, state-owned enterprises 
and regulators (Department of Science and Technology, 2017). Funding bodies include organisations 
that fund research and development activities, e.g. the SAMRC, the National Research Foundation 
(NRF) and the Technology Innovation Agency (TIA).  Science councils perform basic and applied 
research and development across the entire innovation chain and include organisations such as the 
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CSIR and (again) the SAMRC. Science councils may also perform research with the private sector or 
through contractual research and formal research training, however, the research activity of science 
councils is in line with their respective government department’s functions, i.e. research performed 
by the SAMRC would be in line with that of the NDoH. Universities operate in the same research space 
as science councils, however, universities have the responsibility of formal research training. 
Universities and science councils were established through individual legislation (Acts). Government 
departments, state-owned enterprises and regulators may also perform research in line with their 
mandates. The DST is the custodial co-ordinator for the development of the NSI and influences the 
NSI through strategies (Department of Science and Technology, n.d.(c)).  The 1996 White Paper 
presented a broad vision to maintain South Africa’s (then) areas of global competitiveness and address 
the needs of South Africans. It set forth the establishment of several organisations or bodies, including 
the National Advisory Council on Innovation (NACI), the NRF, the Innovation Fund and the National 
Facilities for Research. Among the objectives of the Innovation Fund, was the promotion of increased 
networking and cross-sectoral collaboration within the South African NSI. 
The National Biotechnology Strategy (Department of Science and Technology, 2001) and the Health 
Research Policy of South Africa (Department of Health, 2001) were both published in 2001. The aim 
of the National Biotechnology Strategy was the development of services and technologies to support 
science-based innovation in the health, industrial and agricultural sectors of South Africa. The purpose 
of the Health Research Policy in South Africa (Department of Health, 2001) was to provide an enabling 
framework to conduct research that improves health and wellbeing in South Africa. Among its 
objectives were: to develop a communication strategy that establishes mechanisms for the 
dissemination of research and to ensure that the benefits of research are systematically and 
effectively translated into practice; and to establish links, locally and internationally, between partners 
involved in health, health research, funders of research, research organisations and users of research 
in public and private sectors.  
South Africa’s National Research and Development Strategy (Department of Science and Technology, 
2002) was introduced in 2002 as an implement for publicly financed science and technology to create 
an enabling environment for the NSI. It was based on three pillars: (1) innovation; (2) science, 
engineering and technology (SET) human resources and transformation; and (3) creating an effective 
government science and technology system. The innovation pillar includes the establishment and 
funding of technology missions necessary for the promotion of economic and social development. 
These include technology platforms for biotechnology and information technology, and technology 
for manufacturing, indigenous resources, and poverty reduction. The NRF was identified as the key 
organisation for promoting this strategy as it links to the university sector.  
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The National Health Act, Act 61 of 2003, provides a framework for a structured uniform health system 
in South Africa. At national level, the Act gives the National Health Council (NHC) the role of advising 
the Minister of Health on the health technology development, procurement and use. It also gives the 
NHC the role of advising the Minister on the development of an integrated strategy for health 
research. The National Health Research Committee (NHRC) identifies, and advises the Minister on, 
health research priorities, considering the burden of disease and the cost-effectiveness of solutions 
aimed at reducing the burden of disease. At the provincial level, the general functions of the provincial 
health departments include conducting or facilitating research in health and health services. The 
Minister may also make any regulations concerning, and including, the development of an essential 
drug list and a medical and other assistive devices list, health technology, and health research.  
In 2008, three pieces of related legislature were introduced: The Ten-Year Plan for Science and 
Technology (Department of Science and Technology, 2008), the Intellectual Property Rights from 
Publicly Financed Research and Development Act11, Act 51 of 2008, and the Technology Innovation 
Act, Act 26 of 2008. The Ten-Year Plan for Science and Technology (Department of Science and 
Technology, 2008) was developed to transform South Africa from a resource-based economy towards 
a knowledge-based economy, where the production and dissemination of knowledge would lead to 
economic benefits in South Africa. The knowledge-based economy is underpinned by four 
interconnected and interdependent pillars, including innovation; economic and institutional 
infrastructure; information infrastructure; and education. Progress towards a knowledge-based 
economy would be driven by investment into four elements, including human capital development; 
knowledge generation and exploitation; knowledge infrastructure; and enablers to address the 
“innovation chasm” between research results and socio-economic outcomes. Attempts to address the 
“innovation chasm” have focused on connecting the knowledge generators (universities) more closely 
to the market (Department of Science and Technology, 2002). The Ten-Year Plan for Science and 
Technology introduced the establishment of TIA to address fragmentation of (the then) existing 
funding instruments and stressed the need to establish an Intellectual Property Management Office 
for the enhancement of intellectual property (IP) protection, and to develop capacity to manage 
technology licenses and commercialisation. The Intellectual Property Rights from Publicly Financed 
Research and Development Act provides for effective utilisation of IP arising from publicly financed 
research and development, to establish the National Intellectual Property Management Office 
(NIPMO), and to provide for the establishment of technology transfer offices (TTOs) at publicly 
 
11 “Publicly financed” or publicly funded means research and development performed using funds made 
available by the South African government, or an agency of the South African government as defined in the Act; 
this excludes bursaries and scholarship.  
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financed research organisations. The objective of the Act is to make provision for IP stemming from 
publicly financed research and development to be identified, protected, utilised and commercialised 
for the benefit of South Africans.  Twelve months after the Act came into effect, publicly financed 
research organisations were to establish and maintain a TTO. TIA was established through the 
Technology Innovation Act, Act 26 of 2008, with the intention to promote the development and 
exploitation of discoveries, inventions, innovations and improvement, which are of the public’s 
interest. TIA complements the National Intellectual Property Management Office (NIPMO) by actively 
promoting technology transfer and commercialisation by South African research organisations 
(Department of Science and Technology). TIA has health as a focus area. Its objectives in health include 
(Technology Innovation Agency, 2018): investing in the development of affordable and adaptable 
novel health technologies aimed at addressing the Southern African burden of disease; and 
strengthening the current portfolio of health technologies, developing point-of-care diagnostics for 
tuberculosis, and exploiting expertise in cardiac and orthopaedic devices in South Africa.  
The Bio-economy12 Strategy (Department of Science and Technology, 2013), introduced in 2013, 
aimed to coordinate innovation among different actors, to promote opportunities, resources and 
outcomes in agriculture, health, industry and the environment, and to guide research and investment 
in biosciences. South Africa’s Bio-economy Strategy builds on the foundation set by The National 
Biotechnology Strategy (Department of Science and Technology, 2001) and the Ten-year Plan for 
Science and Technology (Department of Science and Technology, 2008). Within its health scope, the 
Bio-economy strategy identifies medical device development as a key intervention to address the 
South African burden of disease. It mentions government’s approach in using the “quadruple helix” 
model to integrate actors from government, industry, universities and civil society into a coordinated 
system. In the quadruple helix model, government provides the framework to co-ordinate 
relationships; industry has a key role in production; universities generate new knowledge, innovation 
and technology; and civil society is consulted as co-innovators, end-users and holders of traditional 
knowledge. The NDoH sets the health research and innovation priorities for the Bio-economy Strategy. 
The Research Outputs Policy (Department of Higher Education and Training, 2015), revised in 2015, is 
aimed at sustaining current research strengths and promoting the kinds of research and knowledge 
outputs which would be required to meet the South African national development needs. The policy 
encourages research productivity and rewards research output from universities, through the 
 
12 “The term “Bio-economy” encompasses biotechnological activities and processes that translate into economic 
outputs, particularly those with industrial application”; it may include the “technological and non-technological 
exploitation of natural resources, such as animals, plant biodiversity, micro-organisms and minerals to improve 
human health, address food security and subsequently contribute to economic growth and improved quality of 
life” (Department of Science and Technology, 2013). 
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distribution of a research subsidy to universities based on their research outputs (journal and 
conference papers, and master’s and doctoral degrees). The research outputs subsidy has historically 
not recognised creative outputs, artefacts and patents. Innovations, such as patents, will be evaluated 
for the first time in 2020 and will receive equal weighting to journal articles and conference 
proceedings (Department of Higher Education and Training, 2018).    
In 2016, A South African Additive Manufacturing Strategy (Department of Science and Technology, 
2016) was introduced, and the 1965 Medicines and Related Substance Act, was amended. A South 
African Additive Manufacturing Strategy speaks explicitly to medical implants and the promotion of 
knowledge development and exchange among different stakeholders for the use of additive 
manufacturing (AM) platforms for medical implants. The AM strategy identifies products and future 
market opportunities where AM technology development might place South Africa in a competitive 
position in the global market. The AM Strategy recognises AM as having the potential to impact 
product manufacturing, especially in areas with mass customisation or relatively low volume 
production and to improve the competitiveness of the South African manufacturing sector. South 
Africa already has AM centres including the Vaal University of Technology South Gauteng Science and 
Technology Park and the Centre for Rapid Prototyping and Manufacturing at the Central University of 
Technology. The amended Medicines and Related Substances Act incorporates regulations relating to 
medical devices and invitro diagnostic medical devices. The South African Health Product Regulatory 
Authority (SAHPRA) was established in February 2018, with the responsibility of the regulation of 
medicines for human and animals, complementary medicines, medical devices, radiation emitting 
devices and radioactive nucleotides (South African Health Products Regulatory Authority, 2019). 
SAHPRA operates independently of the NDoH. Prior to the Amendment of the Act, there was no 
medical devices regulator in South Africa. However, there was a Medicines Control Council (MCC) 
which served as the national medicines regulatory authority with the aim of ensuring that medicines 
available in South Africa met quality, efficacy and safety standards (Medicines Control Council, 2012). 
The MCC transitioned to becoming SAHPRA, with additional role of regulatory oversight of medical 
devices and complementary medicines in South Africa. Prior to the establishment of SAHPRA, the sale 
and use of medical devices in South Africa were largely unregulated (Saidi, 2016), with only 
electromagnetic medical devices or radiation-emitting devices being subject to certain regulatory 
criteria under the Hazardous Substance Act, Act 15 of 1973.  
In 2017, the DHET released the “Draft Policy Framework for the Internationalisation of Higher 
Education in South Africa” 13 (Department of Higher Education and Training, 2017), which provides a 
 
13 In this DHET report, internationalisation refers to “cross-border movement of students and staff; international 
research collaboration; offering joint degrees by universities in different countries; establishment of campuses 
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national framework for internationalisation for higher education organisations, which comprises high-
level principles and guidelines, to which individual organisations may align their policies and 
strategies. The policy framework describes South Africa as being a “knowledge hub on the African 
continent”, where South Africa offers attractive research opportunities to international researchers 
and is a gateway to Africa (and the Global South) for researchers from other countries (Department 
of Higher Education and Training, 2017).  
A strategic objective of the Department of Trade and Industry (dti) is to grow manufacturing in South 
Africa towards industrial development, job creation, investment and exports. Current strategies for 
medical device development in South Africa by the dti are addressed in a series of annual documents, 
the Industrial Policy Action Plan (IPAP). In the Industrial Policy Action Plan 2014/15 – 2016/17  
(IPAP2014) (Department of Trade and Industry, 2014), the key opportunities and constraints of a 
potential medical devices sector was to be identified through a study of the medical devices sector, 
later published as (Deloitte, 2014). Key action programmes in the IPAP2014 was the development of 
a strategy for the medical device sector. The strategy would be developed with stakeholders in the 
South African medical device sector, the NDoH and the SAMRC. The absence of an internationally 
recognised South African Medical Devices Certification Authority was also highlighted as an 
impedance on South African exports. The Deloitte (2014) report found that the medical device sector 
will only develop if university, industry and government initiatives are aligned and these sectors co-
ordinate their growth plans and activities. The report further suggests that such collaboration will 
need to take place within a formalised structure. Another recommendation made in this report is for 
government to consider and analyse the potential effects of product designation14. This avenue could 
create demand in the domestic medical device market for locally produced medical devices. It is 
suggested that product designation via the Preferential Procurement Policy Framework Act, Act 5 of 
2000, may be an instrument to ensure demand for locally manufactured medical devices.   
Key opportunities identified in IPAP2015 (Department of Trade and Industry, 2015) for the medical 
device sector was expanding co-operation and exports of medical products to the Southern African 
Development Community (SADC) and other African markets. Two key action programmes were 
developed in IPAP2015: the development of an industrial strategy for the medical device sector; and 
optimising procurement of medical consumables in the public sector. An industrial strategy for the 
 
by universities outside of their home country; the growth of satellite learning and online distance education, 
including online educational institutions; arrangements between countries for the mutual recognition of 
qualifications; regional harmonization of qualification systems; and the increasing inclusion of international, 
intercultural and global dimensions in university curricula.” 
14 Product designation refers to the setting of specific requirements, such as designating a portion of government 
funds to be spent on locally manufactured products, which would encourage innovation by local manufacturers, 
and result in the demand for the procurement of local products.  
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medical device sector would be jointly developed by government, industry, labour, universities and 
NGOs. The strategy was expected to optimise manufacturing and trade in the medical devices sector, 
meet government’s health needs, as well as gradually decrease the sector’s trade deficit. The strategy 
would support the design of regulatory and economic measures to exploit the potential of the medical 
device and pharmaceutical industries in South Africa. 
The key action programmes in IPAP2016 (Department of Trade and Industry, 2016) for the medical 
devices sector include: the facilitation of the development of regulatory standards and certification in 
South Africa; and the facilitation of the development of support mechanisms to subsidise compliance 
to ISO13485.  These interventions would address challenges and opportunities in the sector, including 
quality assurance, and public and private procurement, which would promote exports and where 
possible, enable import substitution, which may result in increased capacity to access new and existing 
markets, and promote further investment in manufacturing in South Africa. In facilitating the 
development of support mechanisms to subsidise compliance to regulatory requirement of ISO13485, 
interventions would seek to address the challenges in adherence to this internationally recognised 
standard.  
IPAP2017 comprises two parts. Some of the key opportunities for the medical device sector identified 
in IPAP2017 (Department of Trade and Industry, 2017b) include developing improved health 
technology innovation capabilities, and leveraging South Africa’s geographic location in relation to the 
rest of Africa, and its BRICS status. The key action programme is the Medical Devices Supplier 
Development programme. This intervention calls for the investigation into local supplier development 
programmes, in collaboration with the private sector, to capture an increasing share of the private 
market, provided the correct mechanisms are put in place to meet the necessary requirements for 
supply into this sector of the economy. The intervention aims to facilitate increased local production 
of medical devices for the domestic as well as regional and international markets. Within IPAP2017 
(Department of Trade and Industry, 2017a) is the proclamation of six cluster development 
programmes, one of which is for the medical device sector.  
The key action plan for the medical device sector in IPAP2018 (Department of Trade and Industry, 
2018b) was the establishment of a Technology Innovation Cluster Programme (TICP) to promote 
collaborative initiatives between university, industry and government, to enable high-impact 
industrialisation in the medical device sector. The TICP brings together the TIA, CSIR, IDC, DST, dti and 
the MDMSA for this intervention to strengthen ecosystems using a cluster-based approach. The TIA-
TICP intends to establish a national initiative, the Medical Device and Diagnostic Technology 
Innovation Cluster (MDDTIC), to stimulate technology innovation and competitiveness in the medical 
device sector.   
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A new White Paper on Science, Technology and Innovation was put forth to develop new policy 
approaches to respond to an ever-changing innovation environment, as well as address some 
challenges which constrain the NSI in attaining the NDP2030 objectives. The new White Paper on 
Science, Technology and Innovation (Department of Science and Technology, 2019)  sets the medium- 
to long-term policy direction of government for science, technology and innovation policy; it will be 
implemented through a series of decadal plans to be developed with actors from government, 
universities, industry, and civil society. In selecting and supporting research focus areas, the new 
White Paper proposes that, among other factors, science, technology and innovation priorities should 
be based on the sustainable development goals (SDGs) and the objectives of the NDP2030. The new 
White Paper calls for sector and thematic co-ordination, where integrated science, technology and 
innovation planning for priority sectors will be adopted, resulting in sector science, technology and 
innovation plans. These plans will be used to co-ordinate research efforts across the university, science 
council and industry sectors, and to concentrate funding on priority initiatives. Universities are 
proposed to continue playing a central role; science councils, NGOs and state-owned enterprises may 
also have a role. Regarding medical device development, the new White Paper aims to provide a 
supportive legislative environment for new industries, for example, government procurement.  
8.2.2 Institutions of university actors 
This section is divided into three sub-sections: Innovation policy of university actors; Traditional 
universities; and Universities of technology. In the scientific publication and patent actor-collaboration 
networks presented in Chapters 5 and 6, respectively, 12 South African universities were identified as 
actors of the orthopaedic devices TIS. There are many commonalities among the institutional 
documents of university actors, and rather than presenting them individually, they are presented as a 
whole, with outliers mentioned or discussed where relevant, or specific universities discussed for 
illustrative purposes.   
Innovation policy of university actors 
All 12 South Africa universities identified in the scientific publication and patents actor-collaboration 
networks had an established TTO and an innovation or IP policy. IP policy covers the establishment of 
the TTO, IP advisory committees and their roles, IP as it relates to university employees, students and 
visitors, and technology development and commercialisation strategies. It also provides for the 
recognition of, and the provision of incentives for, contributions made by researchers, and supports 
more effective utilisation of IP. The university allocates an annual budget to its TTO; NIPMO also 
supports the TTO by providing rebates of fees associated with protecting university IP. TTOs may also 
offer seed and innovation funding, or rely on support from other agencies, such as TIA or the SAMRC, 
which have dedicated funding for technology transfer and commercialisation of technology out of the 
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university. The TTO serves as a liaison between the university and industry regarding IP protection and 
technology development, commercialisation and business development. 
The Department of Research Contracts & Innovation at the University of Cape Town (UCT) – the TTO 
of UCT - through NIPMO funding, is developing a series of booklets called Route to Market (R2M) 
which focusses on specific sectors or products and highlights key steps and consideration for bringing 
such a product to market in the South African context. The booklets are released under a Creative 
Commons license which will enable other organisations to customise the booklet for their own use. 
“Medical Devices: An Innovation Guide from Lab to Commercialisation” (University of Cape Town, 
2018) is one such booklet released in the series. In this guide, the innovation pipeline of publicly 
financed developments and can be illustrated, as in Table 15 in Appendix L, according to different 
technology readiness levels (TRL). TRLs are used to classify technology maturity as technology 
develops from TRL 1 – research initiation – towards TRL 9 – where the technology has been 
commercialised and has a market presence.  
Typically, the university is the default owner of the IP generated from research activity. This translates 
to the university being the “applicant” or “assignee” on a patent application; inventors – which may 
be university employees, students or visitors – are also formally associated with the patent. There are 
conditions where IP may be assigned to the funder. This usually results from a “full cost model”, where 
the funder pays for direct, indirect and, in some instances, a margin of the, project costs, which is 
declared and approved by NIPMO. There may also be instances of co-ownership of IP, resulting from 
collaborative research. The share of the IP is often determined and agreed upon through the terms 
set in the collaborative agreement, and/or may be based on the financial and intellectual contributions 
made by parties involved.  
Commercialisation of university IP is usually done on a case-by-case basis. University-owned IP can 
usually be accessed in one of three ways: exclusive license; non-exclusive license and assignment. 
Other arrangements include the formation of start-up and spin-out companies, occasionally with the 
inventors of the IP themselves. The university may also seek industry assistance and partnerships to 
access funding to support innovation through technology development, scale-up, piloting and 
marketing trials. The nature and conditions of license agreements are usually determined by the 
university, however, certain NIPMO preferences need to be considered. Exclusive licenses are not 
preferred and are only granted where the IP is commercialised in a manner that benefits South Africa; 
the State retains “walk-in rights” for IP related to health, security and emergency needs of South Africa 
(Research Contract and Innovation, 2014). All off-shore IP transactions must be approved by NIPMO. 
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A favourable scenario for product development is for the university to partner with an industry partner 
that already has the appropriate regulatory infrastructure, which is willing and able to develop the 
device, secure regulatory approval, and manufacture the device for the market (University of Cape 
Town, 2018). Due to the limited size of South African medical device industry, very few opportunities 
exist to map new products to companies with existing infrastructure (ibid). The creation of a company 
may be undertaken to take the device to market. However, this is usually done at a late stage in the 
innovation pipeline, once all risks have been identified and minimised. The cost associated with 
establishing a company for a device, and its potential in the market, must be weighed (ibid).  
Traditional universities 
Traditional universities offer formal and professional academic programmes in undergraduate and 
postgraduate degrees (Department of Higher Education and Training, 2019). Nine traditional 
universities were identified in the scientific publication and patent actor-collaboration networks. In 
their vision statements, six of the universities identified themselves as being an African university. 
Common threads running through these vision statements were to be an internationally recognised 
university, favouring engaged scholarship and social responsiveness, contributing to the development 
of social justice, creating knowledge and advancing knowledge in the service of society.   
The common threads in the mission statements of universities were excelling in innovative learning,  
teaching, scholarship and cutting-edge research which benefits society and the environment through 
knowledge and adding to the local, regional and global knowledge base; improved student success 
and well-being, and the opportunity for lifelong learning; advancing African scholarship through 
strategic partnerships on the continent, with the Global South and with the rest of the world; 
producing graduates and future leaders who were influential locally and globally; producing 
qualifications that are locally applicable and internationally acclaimed; producing qualifications 
underpinned by values of engaged citizenship, engaged scholarship and social justice; advancing the 
transformation within the university, its curriculum, and beyond; and nurturing an inclusive 
institutional culture that embraces diversity and redresses the disadvantages and inequality of the 
past. 
Universities of technology 
Universities of technology offer programmes (mainly undergraduate) that are career-focused 
(Department of Higher Education and Training, 2019) and usually have a work-integrated component. 
Universities of technology are distinguished by their focus on technology innovation and technology 
transfer (Bridge, 2020). Four universities of technology identified in the scientific publication and 
124 
 
patent actor-collaboration networks. Three of the four vision statements of the universities of 
technology spoke of “innovation” to different ends. These included being “at the heart of technology 
education and innovation in Africa”; being “an engaged university that focused on producing quality 
social and technological innovations for socio-economic development…”; and being “a university that 
leads in innovative knowledge and quality technology education.” The mission statements presented 
the aims in which the universities of technology would pursue their vision. The common threads 
running through the mission statements were to build  universities of technology that were 
sustainable and environmentally conscious; known for providing a high quality of education and 
fostering a scholarship of teaching and learning; known for having a relevant and competitive 
curriculum; creating a well-resourced living and learning environment for its students; enhancing and 
developing the quality and effectiveness of (relevant) research and knowledge production and 
promoting innovation, engagement and social enterprise for the African continent, and beyond; and 
investing in state-of-the-art technology and teaching methods. Each of these universities of 
technology had a health sciences faculty.  
In health technology innovation and medical device development, universities of technology are 
providing innovation and manufacturing platforms, and are involved in community based and SMME 
projects, often projects that focus on commercialisation of technology and provide platforms for 
technology transfer and spin-off technology companies.  A special mention here is the CRPM which 
was established 1997 as “a centre for commercial work as well as research using rapid prototyping, 
rapid manufacturing, rapid tooling and medical product development technologies” (Central 
University of Technology, 2010). It was realised that infrastructure at CRPM could benefit industry 
through offering rapid prototyping services, and in fulfilling one of CUT’s missions, the CRPM was able 
to introduce new technology to the South African manufacturing industry (Centre for Rapid 
Prototyping and Manufacturing, n.d.). The CRPM received ISO 13485 certification for 3D printing of 
medical devices making it the first accredited centre of its kind in Africa (ibid).  
8.2.3 Institutions of healthcare actors 
The Health Professions Act, Act 56 of 1974, established the Health Professions Council of South 
(HPCSA) and professional boards who provide control over the education, training, registration and 
practice of health professions. The mission of the HPCSA is to enhance the quality of healthcare for all 
South Africans by developing policy frameworks for effective and efficient co-ordination and guidance 
of the health professions (Health Professions Council of South Africa, 2018). The HPCSA guides the 
behaviour of healthcare professionals who may be involved in the research, development and 
commercialisation of medicines and medical devices, as well as their relationship with industry. A 
health professional may not be involved in any commercial activity (manufacture, promotion, sale, 
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etc.) related to medicines or medical devices (Health Professions Council of South Africa, 2016a). 
Furthermore, the health professional may not engage in or advocate for the preferential use of a 
medicine or medical device, except where, through valuable consideration by the health professional, 
the patient is provided with the clinically most appropriate or the most cost-effective option (ibid).  
The HPCSA has explicit guidelines for the involvement of health professionals in certain health 
technologies, including biotechnology (Health Professions Council of South Africa, 2008) and 
telemedicine (Health Professions Council of South Africa, 2014). The HPCSA also has a policy document 
to regulate business practices of healthcare professionals (Health Professions Council of South Africa, 
2016b). There are limitations in which private hospitals may not employ HPCSA healthcare 
professionals, because of the profit-driven motive of such organisations.  
Related to the institutions set by the HPCSA, are the institutions of the South African Orthopaedics 
Association (SAOA). The SAOA has “Principles of Medical Ethics” (South African Orthopaedic 
Association, 2019), which are not laws, but are standards of conduct for the behaviour of the 
orthopaedic surgeon, and are aligned with those guidelines of the HPCSA. The SAOA “Principles of 
Medical Ethics” details the orthopaedic surgeon’s involvement with industry, including any consulting 
services offered by the surgeon to industry. Surgeons acting as consultants to industry providing a 
genuine service can receive reasonable compensation for their services. Industry-sponsored health 
research was previously seen as inappropriate because of the bias it may have introduced. The SAOA 
“Principle of Medical Ethics” outlines sponsorship and remuneration details for health research 
involving researchers, research organisations and funding corporations.  
Twenty-one South African healthcare sector actors (all hospitals) were identified in the orthopaedic 
devices TIS in South Africa. Eight of these actors were from the public sector, all academic or tertiary 
hospitals. In the actor-collaboration networks, each of these eight hospitals were linked to university 
actors, the exception being Livingstone Hospital (LH) which appears in isolation in the patent actor-
collaboration network. The other 13 identified hospitals were from the private sector, largely from the 
Netcare, Life Healthcare and MediClinic groups, the exceptions being the Sports Science Orthopaedic 
Clinic (SSOC), and the Zuid-Afrikaans Hospital (ZAH).  
The webpages of all the public healthcare facilities were linked to their respective provincial 
Department of Health. Only Groote Schuur Hospital (GSH) and Steve Biko Academic Hospital (SBAH) 
also had their own websites. The websites of Netcare, Life Healthcare and MediClinic were patient-
centric and focussed on the services available to patients and related procedures, both clinical and 
administrative. The policies available on the websites of Netcare, Life Healthcare and MediClinic were 
largely related to quality assurance, procurement, transformation and employment equality, and the 
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environment. Each of these private healthcare service providers also had their own learning 
academies offering accredited training in nursing and healthcare sciences (examples include pharmacy 
and emergency medical response).  
8.2.4 Institutions of industry actors 
Twenty South African industry actors were identified in the scientific publication and patent actor-
collaboration networks. Denmyd Medical Equipment (Denmyd) is the only industry actor appearing in 
both networks. Several of the South African industry actors belong to one or both local medical 
industry associations SAMED or the MDMSA. SAMED members comprise local and multinational 
industry actors that are involved in the manufacture, import, selling, marketing and distribution of 
medical technologies in South Africa (South African Medical Technology Industry Association, 2018). 
The objectives of SAMED are to (South African Medical Technology Industry Association): 
1. Promote a balanced and harmonised policy environment – this is pursued by engaging with 
policymakers, regulators, politicians, health professional societies, funders and international 
organisations to develop and propose patient-centred policies and provide solutions that 
increase productivity and efficiency of healthcare systems.  
2. Provide membership services - SAMED comprises various committees dealing with issues such 
as regulations, government procurement processes, reimbursement, transformation, ethics, 
congresses and health policy. 
3. Promote ethical principles and practices.  
One of the SAMED committees, is the Orthopaedic Suppliers Committee, which is involved in elective 
orthopaedics, trauma and spinal applications. This committee works closely with SAOA, and engages 
with SAOA on congresses, venues, fair market value and fellowships (South African Medical 
Technology Industry Association).  
The MDMSA is an association of companies in South Africa that manufacture medical devices; it serves 
as a platform for manufacturers and others involved in the South African medical device sector to 
discuss matters that are important to industry, in support of the latter’s growth and sustainability 
(Medical Device Manufacturers Association of South Africa, 2015). The MDMSA has been instrumental 
in creating a strong partnership with the dti, towards continuous engagement on how to expand and 
grow the local medical technology manufacturing industry (South African Medical Technology Industry 
Association).  
Medical device regulations for industry actors 
The SAHPRA medical device regulations are to comply with the Essential Principles of Safety and 
Performance of Medical Devices and IVD Medical Devices (International Medical Device Regulators 
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Forum, 2018). The purpose of these guidelines is to provide harmonised essential principles for the 
design and manufacture of medical devices to ensure that devices are safe and perform as designed. 
The guidelines were written with reference to several available standards in medical device 
development, including ISO 13485 Medical Devices. 
The market in which the medical device is sold will have certain regulatory requirements and sets the 
regulatory compliance needed for the device to enter that market. There are many markets which 
accept the CE marking, or where work done for CE marking compliance is directly or partially 
applicable. Under European law, the CE regulations for medical device are Medical Device Directive - 
93/42/EEC – MDD.  
In terms of the new South African medical device regulations, all companies that handle medical 
devices must be licensed. The license requires that devices handled by the company be listed, that an 
authorised representative be appointed, and that a quality management system be in place at the 
company. A company whose name appears on the medical device (the legal manufacturer) is required 
to hold the regulatory approvals (University of Cape Town, 2018).  
SAHPRA is establishing capacity to approve devices under their regulations. This may take several 
years. In the interim, recognised regulatory approval such as CE markings and FDA approvals may be 
the quickest route to bring a product to the South African market (University of Cape Town, 2018). 
8.2.5 Institutions of science council actors 
The CSIR was formed under the Scientific Research Council Act, Act 46 of 1988. The work of the CSIR 
aims to support industrial development and to enhance government capabilities in the areas of service 
delivery, policy development and information management (Council for Scientific and Industrial 
Research, 2015).  Their focus area of Health Technology has objectives of addressing the South African 
burden of disease through developing cost-effective bio-therapeutic technologies and health 
infrastructure as well as medical devices, sensors and information systems. The CSIR has begun to 
investigate the establishment of an incubator for medical devices and diagnostics, to assist local 
medical device manufacturers (Council for Scientific and Industrial Research, 2018).  
The SAMRC is a public entity reporting to the NDoH and was established in terms of the South African 
Medical Research Council Act, Act 58 of 1991. The Intellectual Property Rights from Publicly Financed 
Research and Development Act, Act 51 of 2008, also informs the mandate of the SAMRC. The SAMRC 
has a mandate to improve health and quality of life through research, development and technology 
transfer. The SAMRC has four strategic goals which are aligned with the SDGs and the NDP2030 and 
contribute to the strategic objectives of the NDoH (South African Medical Research Council, 2018):  
1. Efficiently and effectively administer health research in South Africa. 
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2. Lead knowledge generation and facilitate knowledge translation into policy and practice for 
improved health.  
3. Support innovation to improve health. 
4. Build capacity for long-term sustainability of health research.  
Performance indicators of Goal 2 include the number of scientific publications published by the 
SAMRC’s divisions and bibliometrics associated with it (e.g. authorship, citation, etc.). A performance 
indicator of Goal 3 is the number of innovation and technology projects which are funded by the 
SAMRC to develop new health technologies. In its quest to achieve these strategic goals, the SAMRC 
is an actor whose objective it is to develop and translate (new) knowledge for health technology in 
South Africa.  
The SAMRC is the largest local funder of health research in South Africa. It also funds programmes 
focused on health innovation through strategic partnerships. Funding is directed at major health 
concerns that affect South Africa and the rest of the world.  
The SAMRC Strategic Health Innovation Partnership (SHIP), a partnership between the SAMRC and the 
DST, is a programme for health technology product innovation. SHIP funds and manages projects that 
focus on the development of new pharmaceuticals, treatments, vaccines, medical devices and 
prevention strategies. Through partnerships with local universities, science councils and industry, SHIP 
aims to facilitate the translation of research results into improved health outcomes and social benefit. 
The focus areas of research and development are those which are relevant to South Africa’s burden 
of disease, i.e.  HIV/AIDS, TB, malaria, non-communicable diseases and maternal and child health 
(South African Medical Research Council and PATH, 2014). SHIP, together with the SAMRC’s TTO, aims 
to enable technology transfer for the movement of new products to market.  
8.3 Discussion 
In this section, the main findings of the institutional review are discussed with reference to the 
scientific publication and patent actor-collaboration networks, to provide a comprehensive picture of 
the structure of the orthopaedics devices TIS. The discussion considers the TIS-contextual factors 
described by Bergek et al. (2015).  
The orthopaedic devices TIS is externally linked to the broader innovation system in South Africa, i.e. 
the National System of Innovation (NSI). The actors who work in the orthopaedics devices TIS, 
especially the public sector actors (science councils, universities and public healthcare actors), may be 
influenced by broader innovation policy, such as the Ten-Year Plan for Science and Technology and 
the White Paper on Science, Technology and Innovation. The NSI assigns roles to different classes of 
actors. Among the group of actors not previously identified in the scientific publications and patent 
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actor-collaboration networks are funding bodies, government departments, state-owned enterprises 
and regulators. While these actors do not explicitly develop knowledge in the TIS, they play a role in 
the facilitation of knowledge development and exchange among actors who do create knowledge in 
the TIS. Key among these are the regulators, such as NIPMO and SAHPRA, who have the authority to 
establish pathways for technology development (i.e. NIPMO) and regulate markets (i.e. SAHPRA). 
While regulators appear to have their roles in the later stages of the innovation pipeline, being 
cognisant of their regulations is important in the earlier phases of the innovation pipeline, as their 
regulations may determine market entry of developed devices, which directly relates to the success 
of the device. TIA plays a fundamental role in bridging the gap between knowledge created at 
universities and science councils from publicly funded research and its commercialisation, by funding 
technology development activity. TIA makes explicit contributions towards technology transfer for 
medical and orthopaedic devices, towards addressing the South African burden of disease and 
exploiting South Africa’s local expertise.  
Across government policy are examples of initiatives and strategies where the NSI learns, adapts and 
changes. Examples include the move towards a knowledge-based economy, the establishment of 
agencies to address the “innovation chasm” and playing to South African strengths by investing into 
focus areas where South Africa has competitive or comparative advantage.  The move from the 
National Biotechnology Strategy to the Bio-economy Strategy has reflected an emphasis on the 
medical device sector in the latter. A co-ordination strategy proposed for medical device innovation 
in the Bio-economy Strategy is the use of the quadruple helix model and assigning roles to actors - 
industry, government (including science councils), university and civil society. The Bio-economy 
Strategy does not explicitly mention who “civil society” is, but according to the model, civil society 
provides inputs as users of the innovations, holds traditional knowledge and are co-innovators 
through consultation. These are all characteristics of clinicians, healthcare professionals and others 
belonging to the healthcare sector. It may also be the characteristics of NGOs and NPOs. Leaving the 
definition of “civil society” broad has two consequences. The first is that it excludes the healthcare 
sector from being a recognised helix in the proposed innovation model, despite its crucial role in 
medical device innovation. The second is that the institutions of healthcare actors may not expand 
and adapt towards innovation policy or encourage innovation within the healthcare sector, causing a 
potential gap in the outcomes of the Bio-economy Strategy.  
The institutional review has highlighted certain sector-specific opportunities and challenges for the 
orthopaedics devices TIS, illustrating the way in which the TIS is structurally coupled to its context at 
both the sectoral and geographic levels. Universities are encouraged to be differentiated so that they 
make unique contributions towards knowledge production and national development by responding 
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to the needs of their immediate environment, the African region and are globally competitive. 
Traditional universities largely identified themselves as being African universities, and their vision 
statements spoke of being internationally recognised, having engaged scholarship and developing or 
advancing knowledge for the service of society. Research-intensive universities are important in 
developing countries to address issues of relevance in the developing world (Department of Higher 
Education and Training, 2013). South Africa is considered a gateway to the African continent. In the 
new White Paper on Science, Technology and Innovation, the importance of international 
engagement for the evolution of the NSI is emphasised. The new White Paper’s focus is on building 
African science, technology and innovation capacity, and acknowledges that the South African NSI will 
flourish as part of the innovation systems of the SADC and Africa as a whole. Africa is the biggest 
destination for medical device exports out of South Africa. Of the estimated domestic production of 
medical devices of around ZAR2.6 billion in 2014, more than ZAR1.5 billion was to African markets 
(Department of Trade and Industry, 2016). The African agenda, including its burden of disease, is 
therefore critical in developing the medical device market in South Africa. However, there is no 
evidence of collaboration with other African organisations in the scientific publication and patent 
actor-collaboration networks.  
Innovation is central to the mission of universities of technology. Universities of technology were 
found to be active in creating innovation and manufacturing platforms for technology development; 
these areas overlap with science council mandates. While the Higher Education Act encourages 
collaboration of universities, primarily for sharing resources, the effects of the current university 
funding framework, including the Research Output Policy – a major driver of knowledge production 
from the university sector - does not encourage collaboration. Collaborating South African universities 
must share Research Output Policy incentives, essentially diluting would-be-funding into the 
university. Scientific knowledge production in universities has been favoured over technological 
knowledge production, as previously, only scientific research outputs were incentivised in the policy. 
This may be a reason why such few South African universities have contributed towards the patent 
actor-collaboration network.  
The HPCSA guidelines steer the behaviour of healthcare professionals involved in research, 
development and commercialisation of medical devices, and influence their relationships with 
industry. The SAOA further builds on these guidelines as they would be appropriate to orthopaedic 
surgeons. These guidelines have resulted in healthcare professionals serving as consultants to 
industry. This is especially evident in the patent actor-collaboration network where surgeons co-invent 
devices with industry actors, suggesting that consulting to industry is a favourable pathway for getting 
innovations to market. The HPCSA also regulates business practices for healthcare professionals. One 
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such measure is that private hospital groups may not employ HPCSA healthcare professionals, because 
of the profit-driven nature of such organisations. In the patent actor-collaboration network it had been 
highlighted that inventors affiliated with private healthcare providers make a large contribution 
towards technological knowledge production in the TIS. There is an opportunity for private healthcare 
groups to facilitate or support knowledge development for individuals already active in the 
orthopaedics devices TIS who are resident in their facilities. 
The institutional review highlighted roles in medical device development of science councils (CSIR and 
SAMRC) which had not been considered in this research project before. Science councils are major 
funders of research and development activity, and fund knowledge exchange endeavours, such as 
local and international conferences. Science councils have also created innovation pathways for 
technology transfer from publicly financed research and development.  
Since 2014, the Industrial Policy Action Plans (IPAPs) of the Department of Trade and Industry (dti) 
have addressed the building of a medical devices sector in South Africa in their key action plans. These 
key action plans always involve partnerships with, or the inclusion of, actors from different sectors, 
including government, universities, science councils, NGOs, labour and industry. The IPAPs also 
address issues that directly impact the industry actors of the medical device sector. As an example, 
the key action plans of IPAP2016 were to facilitate the development of regulatory standards and to 
support certification in South Africa, and to facilitate the development of support mechanisms for 
compliance to the regulatory requirements of ISO 13485. These key action plans directly address 
challenges of industry where local manufacturers are not able to trade in certain areas in the South 
African market or they aren’t able to expand export markets, because they do not meet regulatory 
requirements. ISO 13485 is an expensive process and is beyond the reach of many local 
manufacturers. The dti response was therefore to investigate processes that would help support local 
manufacturers to comply with this well-established regulation.  
The institutional review has highlighted the desire of the South African government to create an 
environment for medical device development to prosper in South Africa. Such a conducive 
environment would result in institutions that structurally couple the TIS to its political context. The 
first steps came as recognition of the potential shown by existing actors in the field. Government 
strategies like the Bio-economy Strategy and the South African Additive Manufacturing Strategy put 
forward mechanisms for different stakeholders to participate in the innovation chain in a formal, co-
ordinated way. The Strategies also draw strongly on skills, capabilities and competitive/comparative 
advantages of actors who participate in the innovation chain. Several other government initiatives 
targeting medical devices have emerged to support the medical device sector over the past few years, 
including medical device regulations and the establishment of SAHPRA as a body to regulate medical 
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devices. Other larger strategies have medical devices as streams and aim to accelerate the sector. 
These include medical device platforms in TIA, key action plans from the dti, a medical device cluster 
programme, and initiatives and platforms created by both the SAMRC and the CSIR. These initiatives 
and interventions are still in early stages of implementation and are facing challenges, one of which is 
not having the (human resource) capacity to fulfil the ambitious tasks that lie ahead.  
8.3.1 Limitations of the study 
A limitation of this study is that only formal codified institutions were reported on. Informal 
institutions, due to the impracticality of mapping such institutions, have not been considered at all. 
Additionally, it proved impractical to assess all formal institutions from all organisations who 
contribute towards the knowledge base of the TIS. Institutional documents such as annual reports and 
audits, for instance, were largely omitted from this exercise. This institutional review extended to 
South African organisations involved in knowledge development and exchange for orthopaedic device 
development in South Africa. Limiting the review to South African organisations may have led to the 
omission of drivers for international organisations to be involved in orthoapedic device development 
in South Africa. 
8.4 Conclusion 
This institutional review has identified actors that facilitate knowledge development and exchange 
within the orthopaedic devices TIS in South Africa, which had not been identified in the scientific 
publication and patent actor-collaboration networks. Further roles of those actors that had previously 
been identified in the orthopaedic devices TIS have been highlighted. The institutional review also 
highlighted how the orthopaedic devices TIS is related to its context, both externally linked and 
structurally coupled to the political contexts, and structurally coupled to the sectoral and geographical 
contexts. Strategies relating to medical device development address the burden of disease and focus 
on the capabilities of actors and the competitive/comparative advantage of actors in the NSI. Finally, 
the institutional review has shown inter-relationships between, and co-existence of, three well 
accepted and documented innovation frameworks, i.e. the NSI, the TIS and the quadruple helix model, 
in South Africa.   
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9. Case studies: Knowledge development and knowledge diffusion 
through networks in the orthopaedic devices TIS 
This chapter presents case studies designed to investigate how knowledge is developed and 
exchanged among actors of the orthopaedic devices TIS, and through actor experiences, how the 
knowledge functions are influenced by TIS-contextual factors. 
Yin (2003) defined a case study as an “empirical enquiry that investigates a contemporary 
phenomenon within its real-life context, where the boundaries between the phenomenon and context 
are clearly not evident, and in which multiple sources of evidence are used.” Eisenhardt (1989) defined 
a case study as “a research strategy which focussed on understanding the dynamics present within 
single settings”.  
9.1 Methodology 
The case study design for this study has been influenced by the case study design theory presented in 
Eisenhardt (1989), Yin (2011) and Gibbert (2015), and the case study design of Lander (2014). The case 
study design is broken down below.  
9.1.1 Case selection 
The case selection was based on descriptors for the functions “knowledge development” and 
“knowledge diffusion through networks” of the orthopaedic devices TIS in South Africa. The findings 
of the scientific publication and patent actor-collaboration networks presented in Chapters 5 and 6 
inform the case selection, as do theories of knowledge development and exchange presented in the 
literature. Two cases – translational collaboration and author-inventors – were examined. 
9.1.1.1 Translational collaboration 
Translational collaboration occurs when the orthopaedic device developed resulted from the 
collaboration between actors from the university, healthcare and industry sectors. This type of 
collaboration has been presented by the Academy of Medical Sciences (2010), and investigated by de 
Jager et al. (2017). These sectors serve the public in different ways, and organisations in these sectors 
have different mandates; their motives for participating in the orthopaedic devices TIS may be 
different. Each of these sectors also brings capital to the collaboration, which may benefit other 
sectors depending on the needs of the latter. The translational collaboration case is explored because 
it involves different actors that are assumed to provide complementary skills and resources. In the 
scientific publication and patent actor-collaboration networks, if the scientific publication or patent 
resulted from the co-authorship or co-inventorship of actors from these three sectors, that 
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collaboration was considered to form part of the population for this case. The co-authors and co-
inventors who appear in these publications were invited to participate in the study.  
The unit of analysis in this case is the interviewed individual (co-author or co-inventor). By inviting 
individuals of different sectors to participate in the study, the sample of participants would cover 
experiences from individuals from all three sectors. Actors from different sectors may offer contrary 
evidence or views.  
9.1.1.2 Author-Inventors 
Author-inventors are individuals who had contributed to both the scientific publications and patents 
in the datasets of the networks. The author-inventor case explores cases where the same actors 
produce different types of knowledge, working in scientific discovery as well as technological 
application. The unit of analysis is the individual. Investigating author-inventors was expected to 
reveal development dynamics in both the scientific and technological dimensions, as well as 
knowledge translation dynamics between the scientific and technological domains.  
9.1.2 Data sources 
The primary data source for the case studies were semi-structured interviews with individuals who 
met case criteria. Approval for the case studies was obtained from the Human Research Ethics 
Committee of the Faculty of Health Sciences at the University of Cape Town (HREC 860/2015).     
Secondary data gathering techniques included a review of the institutional documents of actors 
creating knowledge in the orthopaedic devices TIS (see Chapter 8), published literature, and the 
analysis of other documents from the respondent’s organisational websites. The findings of the 
scientific publication, patent and keyword networks were used as additional data sources.   
9.1.3 Field data collection 
For each respondent, a resource pack was created. Each pack included: 
1. An informed consent form. 
2. The scientific publication(s) and/or patent(s) to which the individual had contributed, and 
which had formed part of the scientific publication or patent actor-collaboration network.  
3. Collected data about the respondent’s career path and publications.  
4. The scientific publication and patent actor-collaboration networks for the period 2000-2015. 
5. The interview protocol. 
The questions used in the semi-structured interviews were derived from the diagnostic questions for 
analysing the “knowledge development” and “knowledge exchange” functions of the TIS, presented 
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in Hekkert et al. (2011, p. 10). To test the appropriateness of the questions and to expose the author 
to interviewing practice, a set of preliminary interviews was conducted. 
9.1.3.1 Preliminary interviews 
Invitations were sent to 10 individuals from the University of Cape Town known to be working in either 
orthopaedic device development or innovation management, and who did not meet the criteria for 
the case selection described above. Four individuals agreed to be interviewed, and a researcher who 
had experience in case study research agreed to a meeting discussing the proposed interview 
protocol.  
The preliminary interviews were conducted in the same way the case interviews were planned to take 
place. In three of the interviews, a researcher with interviewing experience was present. The author 
asked the questions, and after all questions had been asked, the second researcher raised additional 
questions that he thought were relevant. Once the interview was over and the interviewee had left, 
the author and the researcher discussed the interview, the topics discussed, the respondent’s 
interpretation of the questions, the achievements and gaps of the interview, and strategies for 
improving future interviews.  
9.1.3.2 Interviews 
Each respondent was asked to sign an informed consent form and permission was sought to record 
the interview. The interview was divided into three parts. The first part aimed to collect demographic 
data of the interviewee including educational background and career path choices of the respondent. 
It included questions like “Can you tell me about your tertiary education?” and “What is your current 
role(s) at your organisation(s)?”. The questions were broad and open-ended to allow for the 
interviewee to provide an account of their career in orthopaedic device development, and how they 
came to their current role in their current organisation. The second part of the interview was a 
discussion on the scientific publication and patent actor-collaboration networks, and how the 
interviewee formed part of the network. The questions in this part of the interview reflected how well 
knowledge development and diffusion activity had been captured in the scientific publication and 
patent actor-collaboration networks.  The third part of the interview addressed the respondent’s 
perceptions about “knowledge development” and “knowledge diffusion through networks” within the 
orthopaedic device development TIS in South Africa. An interview protocol, presented in Appendix M, 
was developed, and contains the list of questions developed for the interview. The protocol served as 
a guide on topics to be covered, rather than rigid questions to be posed.  
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9.1.4 Data analysis 
The data analysis followed a similar path to that presented in Yin (2011), and comprised the following 
five phases: 
1. Assembly – the compilation and assembly of data into a database.  
2. Disassembly – iterations of coding to disassemble the data. 
3. Reassembly – identification of emerging patterns from disassembled data.  
4. Interpretation – interpretation of the reassembled data, which forms the key analytic portion 
of the study.  
5. Concluding – drawing conclusions from the study. 
Validity of the data analysis has also been considered, as discussed later.  
9.1.4.1 Assembling, disassembling and reassembling data 
NVivo software (QSR International Pty Ltd, 2015) was used in the assembly, disassembly and 
reassembly of data. Codes were developed to capture the functions of the TIS framework, with a 
special focus on the “knowledge development” and “knowledge diffusion through networks” 
functions, and their relation to specific contextual conditions. As coding progressed, concepts not 
captured by the TIS functions gave rise to additional codes. The codes were reassembled and formed 
the basis for the theory developed in the study. Theory refers to an account of how a phenomenon 
operates and why it operates in the way that it does (Johnson, 1997); it is based on a collection of 
concepts which may be assembled in some logical order about the events that have been studied (Yin, 
2011). The study’s findings should demonstrate whether and how the results support or challenge the 
theory (Yin, 2011).  
In developing theory, within-case data analysis, cross-case patterns and the development of 
hypotheses, described by Eisenhardt (1989), were considered. Within-case data analysis allowed the 
author to become familiar with each case. It allowed for unique patterns to emerge from each case 
before the author moved to generalisation across cases. Cross-case patterns were explored by 
examining the data in divergent ways. Three methods are discussed by Eisenhardt. The first is category 
or dimension selection, where within-group similarities and inter-group differences are determined 
on a set of categories or dimensions. The second method involves comparing a pair of selected cases 
and examining the subtle similarities and differences between them. The third method involves 
dividing cases according to the data source. In this chapter, only within-group similarities and inter-
group differences are compared across cases.  The cases are not designed to illustrate differences 
which may exist between them; both cases explore the development of knowledge for orthopaedic 
device development in the TIS. The translational collaboration case explores knowledge development 
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for orthopaedic device development under pre-defined conditions. Theory may be generated when 
within-case analysis, cross-case analysis and overall impressions reveal emergent themes and 
concepts.  
9.1.4.2 Interpreting and concluding 
The interpretation phase connects the ideas of interest, which may be supported by literature, to the 
reassembled data (Yin, 2011). In this study, the interpretation phase links the reassembled data to the 
broader TIS framework, and explicitly addresses the TIS-contextual factors. Interpretation takes the 
form of developing theory, where context-specific findings may be linked to the objectives of the 
thesis. Interpretation is supported by the available literature; in the absence of available literature, it 
adds to the body of TIS literature for medical device development in/and developing country contexts.  
In interpreting findings, there is a possibility that others might interpret the findings differently, thus 
alternatives to the findings and their explanations, which may be less compelling, are also considered 
(Yin, 2011). 
9.1.4.3 Validity 
A valid study is one that has properly collected data and has interpreted the data in a way that the 
conclusions accurately reflect and represent the studied setting (Yin, 2011). Research validity is a 
criterion that denotes qualitative research that is credible, plausible, trustworthy and defensible 
(Johnson, 1997).   
There are different strategies to promote validity in qualitative research, as described by Johnson 
(1997) and discussed below. Among them is triangulation, which is the cross-checking of information 
and conclusions using multiple methods or sources; “corroboration” occurs when the different 
methods or sources agree. When using methods triangulation, more than one research method is 
used in a single study. In this definition, the term method is used broadly to describe different methods 
of research as well as different procedures of collecting data. The purpose of triangulation is to 
combine different methodologies that have strengths and weaknesses that do not overlap, so that in 
their combination, “the whole is better than its parts”. Data triangulation refers to using multiple data 
sources in a single method. As an example, if an interview method is used, multiple interviews would 
be the multiple sources of data. In this research project, triangulation is performed at both levels. For 
methods triangulation, the scientific publication, patent and keyword networks, as well as the 
institutional review, are sources employed to triangulate the developed theory. For data triangulation, 
each interview serves as a standalone source of data, so that several interviews could triangulate 




In the translational collaboration case, 21 e-mail invitations were sent to individuals from South 
African organisations who met the inclusion criteria. In the author-inventor case, 11 e-mail invitations 
were sent to individuals from South African organisations meeting the inclusion criteria. Nine positive 
responses were received for 32 invitations, translating to a 28% response rate. The interviews for the 
translational collaboration case were conducted before those for the author-inventor case. 
9.2.1 Interview transcription and coding of transcripts 
Interviews were recorded and uploaded to a secure drive. All interviews were professionally 
transcribed by a third party. All interview transcripts were confirmed against the audio by the author. 
Interview transcripts were coded using NVivo software; a database was created for each case. Prior 
to coding the first transcript, the author identified codes based on the TIS framework. Initially, there 
were seven codes corresponding to the seven functions of the TIS framework. As coding progressed, 
concepts not captured by the seven functions gave rise to additional codes. Coding was performed 
according to an iterative cycle, presented in Appendix N, which produced a total of 14 codes based on 
themes derived from interview responses. A brief explanation of each of these codes is presented in 
Table 9; these codes were used in both cases. As this study is concerned with the functions “knowledge 
development” and “knowledge diffusion through networks”, the areas of interest in the interviews 
were those coded by either “knowledge development” or “knowledge diffusion through networks”, 
those coded simultaneously by “knowledge development” and “knowledge diffusion through 
networks”, or where any of the other codes are coded simultaneously with either “knowledge 
development” or “knowledge diffusion through networks” or both. While the primary focus of the 
study was the knowledge functions, relationships between the knowledge functions and the other five 










Table 9:Descriptions of codes used in interview transcripts for the translational collaboration and author-inventor cases 




All events or activities described by interviewees dealing with the 
commercialising of the technology. 
F2: Knowledge development All events or activities described by interviewees where learning took place, 
i.e. where knowledge was acquired. Learning may occur in several forms, 
including the STI and DUI modes.  
F3: Knowledge diffusion 
through networks 
All events or activities described by interviewees where learning occurred 
through the exchange of information, or interactions between individuals or 
with the technology.   
F4: Guidance of the search All events or activities described by interviewees that affect the visibility of 
specific objectives or goals of the users of the technology.  
F5: Market formation All events or activities described by interviewees that were pursued to form a 
market for the technology.  
F6: Resource mobilisation All events or activities described by interviewees that were undertaken to 
access and secure resources, including human, financial and infrastructural 
resources.  
F7: Counteract resistance to 
change OR Legitimacy 
creation 
All events or activities described by interviewees that were undertaken to 
promote acceptance of a technology.   
Extension of knowledge or 
technology 
All events or activities described by the interviewee that moved the 
technology beyond its intended use. This includes events or activities that 
showed the diffusion of the technology outside the networks displayed in this 
project.   
Innovation in allied fields All events or activities described by interviewees involving innovation or 
technology development in fields associated with orthopaedic device 
development. This code has similarities to the function “development of 
positive externalities” described by Bergek et al. (2008b). This function 
emphasises the “collective dimension” of innovation and illustrates how 
externalities amplify the other functions. 
Innovation in other fields All events or activities described by interviewees involving innovation or 
technology development not associated with orthopaedic device 
development.  
Network familiarity Interviewees’ familiarity with other actors in the actor-collaboration network. 
This extends only to the scientific publication and patent actor-collaboration 
networks which were presented to interviewees in the interview.  
Network limitations Occasions highlighted by the interviewee where the scientific publications 
and patent actor-collaboration networks presented to the interviewee failed 
to capture relationships among actors.  
South African context Factors described by interviewees that were specific to South Africa.  
Success factors This code resulted from the question “If you were part of a successful 
collaborative project, how would you go about replicating those factors that 
made that project successful?”. It codes factors described by interviewees 
that were necessary in collaborative projects for the technology to be 
successful.  
*In the table, F refers to function, and “F1” refers to function 1 of the functional approach to the TIS framework as described 
by Hekkert et al. (2007). 
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9.2.2 The translational collaborations case 
Five interviews were conducted in person in December 2017 and January 2018: three at the 
interviewee’s office or board room at their place of work; one at a coffee shop in a business park 
where the interviewee’s office was located; and one at the home of the interviewee. Basic 
demographic data of the interviewees are presented in Table 10. The interviewee responses will 
henceforth be referred to using their allocated pseudonym, P1, P2, P3, P4 and P5, where P1 was the 
first individual interviewed, P2 the second individual interviewed, and so forth.  There are also some 
relations between the interviewees. P1 and P5 are co-inventors of a patent in the patent actor-
collaboration network, and P2 and P3 are co-authors of a scientific publication in the scientific 
publication actor-collaboration network.  














P1 PhD Engineer Managing 
Director 
Industry 31 years in medical 
device industry 
P2 MSc Engineer Chief 
Executive 
Officer 
Industry 23 years in medical 
device industry 
P3 MSc, MBA Engineer Founder/ 
Director 
Industry 7 years in medical device 
industry 
P4 DSc Scientist Retired Industry Over 40 years in medical 
device industry 






Over 50 years in medicine 
and 40 years in medical 
device development 
 
All interviewees held post-graduate qualifications. Three of the interviewees were engineers, one was 
a scientist, and one was an orthopaedic surgeon. Four of the five interviewees were from the industry 
sector, however, the fifth served also served as a consultant to industry. Before joining the medical 
device industry, P2 had been employed as a university lecturer. P4 also lectured at a university and P5 
had been a university-affiliated clinician.  The interviewees had worked in medical device development 
for periods ranging from 7 years to over 40 years.  
As the interviewees were identified using scientific publications and patents, discussions initially 
focussed on experiences in the development phase of orthopaedic devices, and how knowledge is 
created and exchanged among actors. However, in these experiences, many lessons were revealed by 
the interviewees about the manufacture and commercialisation of devices. 
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9.2.2.1 Knowledge development 
Interviewees were involved in the development of an array of orthopaedic devices, including 
orthopaedic software, instrumentation, biomaterials, plates, and prostheses of major and minor 
joints. P4 and P5 were the only interviewees who spoke of research in basic sciences. Industry actors 
rarely co-authored scientific publications, and patents only reflect a portion of their device 
development activity. Patenting is an expensive exercise and was only pursued where developments 
showed promise and needed early-stage protection in sought-after economies. Provisional patent 
applications were also exploited to capitalise on development time; provisional patents establish the 
priority date and expire after twelve months, as per the Paris Convention (Southern African Research 
and Innovation Management Association, 2018), and result in a “patent pending” designation.  
Patenting did not always have a favourable outcome. P3 said that the company “didn’t win” anything 
out of the patent; patenting was done because it was encouraged by peers as the device showed 
clinical promise. P4 highlighted that margins on medical devices were low, and the return on 
investment took many years from the time of the initial patent application. Patenting in South African 
universities is also a relatively new concept. P4 shared experiences of faculty peers at the university 
who were intent on publishing research (in journal articles and presenting at conferences), in which 
opportunities to potentially protect IP were missed; faculty had to be educated on the value of IP and 
were encouraged to give the university the opportunity to explore IP protection.   
The interviewer enquired about scientific publication decisions that were made. P1 pointed out that 
much of medical device development work of his company was presented at conferences and 
congresses, which would not be reflected in the scientific publication actor-collaboration networks15. 
P3 indicated that he was not really interested in authorship other than promoting the product.  
After clinical introduction of the device, research continued into the clinical performance of devices, 
i.e. time saved in surgery, reduction of hospital stays, blood loss, etc. While one interviewee (P3) 
indicated that none of this clinical data had been published, he did mention that clinical data were 
initially used to motivate the use of the device by surgeons to medical insurance companies. Some 
devices developed were used for purposes other than those initially intended. For example, a plate 
developed by P5 saw dental, maxillo-facial and veterinary applications by other clinicians and 
researchers.  
 
15 While conference proceedings have been captured in the scientific publication actor-collaboration network, 
the coverage by Scopus and Web of Knowledge (WoK) may not be comprehensive. Conferences, especially those 




Knowledge development occurred alongside innovations in allied fields. These included process 
innovations which fed back to product innovation. Examples include innovations in 3D printing and 
additive manufacturing. Another example is the development of materials, especially polymers, which 
directly impacted the development of prostheses for arthroplasty. Knowledge development was also 
hampered because of limitations in allied fields. P5 had worked in orthopaedic device development 
since the late 1970s, and at that time standards for using biomaterials were not available; material 
selection was a learning process, by trial and error. P2 spoke of a novel hip implant that had been 
patented, and for which funds had been raised for research and development, yet the device never 
reached the market because, at that stage, the biomaterials available were not suitable for the device.  
9.2.2.2 Knowledge diffusion through networks 
Interviewees shared many stories of orthopaedic devices being developed from collaboration 
between engineers/technicians and clinicians (e.g. orthopaedic- and neurosurgeons); however, the 
knowledge exchange described differed among the interviewees. P1 spoke of taking researched ideas 
from engineers to surgeons to provide insight about the practical implementations of the engineer’s 
ideas. P3 spoke of the surgeon identifying a gap and developing the specifications for the device, and 
then passing those ideas to the engineers for calculations and conceptual designs. P5 identified the 
clinical need, developed a simple prototype of a device in his home garage and requested a 
biomechanical engineer to build prototypes for cadaver and animal studies. In these cases, the 
developments arose from the interaction between the engineer and the surgeon. Arenas for (tacit) 
knowledge exchange were mechanical workshops and operating theatres. P1 also mentioned that 
biomedical engineers must be in the operating theatre to explain the use of the device and experience 
its challenges first-hand. Three of the interviewees highlighted the significance of the 
biomedical/biomechanical engineer in orthopaedic device development. P2 considered the 
biomedical engineer to be the interface between a traditional engineer (mechanical, electrical, 
material, metallurgical, etc.) and the surgeon.   
When presenting the networks to the interviewees, two interviewees indicated that the networks did 
not truly reflect their contributions to orthopaedic device development in South Africa. These 
interviewees were familiar with the other actors in the network, and highlighted links between 
themselves and other actors which were not reflected in the networks. Among the ways in which the 
industry actors shared knowledge with the orthopaedic community, was attending and speaking at 
conferences/congresses, and inviting surgeons to their facilities.  
The interviewer enquired about the way in which the collaborations, reflected in the scientific 
publication and patent networks, had come about. P1 and P5 were co-inventors of a patent, and P5 
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was a consultant to P1’s company, working on many other developments. P2 and P3 were co-authors 
on the same scientific publication and had worked with each other intermittently for almost ten years. 
They had been introduced through a surgeon, who was also a co-author on the scientific publication. 
P4 indicated that a university-affiliated surgeon had visited him at his (then) place of work, and 
presented the problem to him, which resulted in their joint work on the project. The two had never 
interacted before, and the surgeon only knew of him because he (P4) was a specialist in his research 
field. 
Four of the interviewees indicated development of orthopaedic devices in the absence of university 
actors. The reasons given for the absence of university partners was that universities have a long turn-
around time in development, and that universities were unable to attach reasonable fees to the 
services provided. Other issues highlighted were burdensome university administrative processes and 
IP ownership barriers. When asked whether university actors were necessary in the orthopaedic 
device innovation chain, P1 acknowledged that universities had expertise or specialised equipment 
that was otherwise out of reach of their companies. P2 indicated that certain (false) boundaries exist 
between industry and universities, and that as an industry actor he was aware of the specialised 
facilities of the university but felt that he could not access them. Interviewees also accessed expertise 
at universities outside South Africa. P1 mentioned that collaborations with universities were in fact 
collaborations with clinicians associated with universities who had approached the industry actor and 
needed assistance in practical implementation of their ideas. In the patent network, P5 is a university-
affiliated clinician. In his earlier developments (from the late 1970s), he used university research 
facilities (workshops, cadavers from anatomy department and animal research centre). Publications 
generated from the research were published with the university affiliation. P5 and the university 
received royalties from the patented device. Lack of resources at the university drove P5 away from 
doing research at the university.  
Even though some developments occurred in the absence of university actors in the translational 
collaboration case, P2 mentioned that all the actors (referring to the network diagram) had some 
academic background and some sort of link to the university. Two of the interviewees mentioned that 
they served as external examiners of theses, and two interviewees were guest lecturers at universities. 
P2 gave the example of a university actor who is consulting him concerning mechanical testing of 
prostheses.  
P3 explained his design philosophy for the orthopaedic software that he had a part in developing. The 
software was designed to measure certain parameters of implants once implanted. This resulted in a   
baseline establishment of the parameters, and the parameters could be measured over time in follow-
up visits. By establishing these parameters, interventions could be pursued earlier, possibly in the 
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planning phase of an arthroplasty. P3 posed that the idea of the establishment of a baseline, and 
knowing where errors were made, was not well received by surgeons to whom the software had been 
promoted. P3 attributes this to the difference in operating modalities between engineers and 
surgeons.  
Knowledge exchange also occurred across geographic boundaries. Four of the interviewees presented 
work at international conferences/congresses. Research and development of a device would occur in 
South Africa with the intent of taking the product to international markets or selling the IP to big 
international corporations. Knowledge exchange between South African and international industry 
actors sometimes occurred to enable clinical trials of devices in that country, and commercialisation 
in those markets. International surgeons also visit local industry actors to do surgeries and experience 
the local devices.  
In addition to knowledge exchange described above, one interviewee was also instrumental in starting 
an international electronic magazine for his speciality, the aim of which was to develop a 
communication channel between members of an international organisation who hold a conference 
once every three years.  This electronic magazine, published quarterly, would ensure communication 
on a more regular basis. Two of the interviewees were reviewers for scientific journals and two of the 
interviewees served in administrative roles in either the Medical Device Manufacturers of South Africa 
(MDMSA) or the South African Medical Technology Industry Association (SAMED).  
9.2.2.3 Links between knowledge functions and other TIS functions 
In the translational collaboration case, the “knowledge development” and “knowledge diffusion 
through networks” functions were coupled to three of the other five TIS functions – F5: Market 
formation, F6: Resource mobilisation and F7: Legitimacy creation. These links are illustrated in Figure 
27. While links between the other five functions were discovered in the case studies, they have not 
been presented here, because these links would be incomplete as the interview questions were not 
designed to address them all. Only the links between the knowledge functions and the other functions 




Figure 27: Connections between the knowledge functions and other TIS functions in the translational collaboration case; arrows indicate direction of relationship.
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F2: Knowledge development ➔ F7: Legitimacy creation  
Knowledge development was driven by the desire to create legitimacy for devices. P1 had been part 
of the development of a novel implant, at a time where there was still controversy around this class 
of implant. The knowledge created by P1 and his peers over the years created legitimacy (or 
acceptance) of the implant by demonstrating its abilities. This ultimately translated to codified sources 
of knowledge, including patents and scientific publications, driven by the clinician on the team, who 
addressed challenges associated with the implant, including basic kinematics, medium and long-term 
outcomes, etc. Knowledge development also occurred with the aim of producing good science, i.e. 
statistically meaningful results.  
In the past, a surgeon could write a motivational letter to a medical insurance company motivating 
the use of a specific device, and this motivational letter would be sufficient for the medical insurance 
company to settle payment. In the present environment, a motivation is assessed by the medical 
insurance company, which determines if the device is relevant. A formal process for receiving a 
National Pharmaceutical Product Index (NAPPI16) code for a device ensues, requiring proof of 
regulatory approval (ISO, CE or FDA) and clinical evidence of performance. Clinical evidence would be 
collected on the device’s performance mainly to demonstrate to a medical insurance company the 
device’s capability; if the device does not have regulatory approval, then medical insurance companies 
will not finance its use.   
F2: Knowledge development ➔ F6: Resource mobilisation 
The resource mobilisation function describes activities to access or secure resources, including human, 
financial and infrastructural resources. Lack of resources negatively affected knowledge development 
in orthopaedic device development – clinical performance of devices remained unpublished and 
aesthetics of the product were compromised. Lack of resources at the university also drove 
researchers away from the university. While many products of the industry actors were privately 
funded by the company, where the device showed promise, funding was sought through venture 
capitalists and a local funding agency, the Industrial Development Corporation. P5 described 
difficulties associated with applying for external funding, including burdensome administration, pre-
trial proofs, and late financing of projects. While P1’s company had a wide portfolio of orthopaedic 
devices, he mentioned that they could do much more had they the money and resources to do so.  
 
16 A NAPPI code is a unique identifier that enables electronic transfer of information related to a product through 
the healthcare delivery system (MediKredit, 2009). 
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F3: Knowledge diffusion through networks ➔ F6: Resource mobilisation 
Interviews illustrated access to resources as a barrier to knowledge diffusion through networks. In 
university-industry interaction, universities expect funding for the research that students would 
perform. This is not attractive to industry as they could perform research and development inhouse 
at university rates, with a shorter turn-around time. P2 shared that inventors were utilising resources 
at local universities and local industry, with the aim of taking the developments to international 
companies; the intention of these inventors was not to develop devices to be manufactured locally, 
even though local resources were used in their development.  
F3: Knowledge diffusion through networks ➔ F5: Market formation 
The market formation function describes initiatives undertaken by interviewees to create a market 
presence for the device. Market formation strategies discussed included after-sales services, tapping 
into the network of private hospital groups, committing instrumentation sets to hospitals, and 
developing and sharing (including selling) IP with international collaborators to extend the market to 
other countries.  In building a market presence for a medical device, many medical device companies 
have sales representatives or sales engineers who go out to clinicians to promote and sell the device. 
Engineers also visit operating theatres to explain instrumentation sets and envisaged clinical 
procedures of the implant. P2 had mentioned that his company did not have the resources to pursue 
this line of marketing.  
P3 mentioned that having a well-known surgeon’s name associated with a device, gives the device 
traction in establishing a market. It was also the practice of big international companies to have key 
surgeons endorse or demonstrate a product to build a market for a device. 
Endorsements/demonstrations were often presented at congresses and conferences, which were an 
arena to promote technologies.  
P2 also highlighted some limitations of clinicians in the commercialisation of devices. In the past, 
clinicians could be involved in the running of medical devices companies and other commercial 
ventures. This has changed, and in the current environment, clinicians can only consult to medical 
devices company and earn royalties on IP.  
9.2.2.4 Relating knowledge functions to TIS-contextual factors 
The findings presented above are grouped according to the TIS-contextual factor categories of Bergek 
et al. (2015) in Table 11. “Knowledge development” and “knowledge diffusion through networks” 
were most strongly influenced by the sectoral context (activities taking place in other sectors) driven 
by developments between the engineer and surgeon, and the various arenas for knowledge exchange. 
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Knowledge functions were also linked to the embedded TIS (activities taking place in related TISs) and 
geographical contexts (activities taking place internationally). No political contextual factors were 
raised by the interviewees concerning in the interviews the knowledge functions.   
Table 11: Knowledge development and knowledge diffusion through networks grouped according to the TIS-contextual 
factors of Bergek et al. (2015) in the translational collaboration case 




occurs alongside innovation in 
allied fields, e.g. biomaterials 
and additive manufacturing, 
which are embedded TISs that 
influence the development of 
orthopaedic devices.   
Industry actors seldom 
participate in scientific 
publications.  
Clinical trials for FDA approval 
of a device were performed in 





 Industry actors present their 
developments at conferences 
and congresses, which are 
academic venues.  
Developments presented at 
international conferences. 
 Orthopaedic devices are 
developed by collaborating 
surgeons and engineers. 
Locally developed devices are 
taken to international 
markets, or IP is sold to 
international manufacturers.  
 Arenas for tacit knowledge 
exchange include mechanical 
workshops, operating 
theatres, conferences and 
congresses, industry facility 
visits, and lecturing.  
 
 Arenas for codified knowledge 
exchange include thesis 





9.2.3 The author-inventor case 
Four interviews were conducted in person in March 2018. All four interviews were conducted in the 
interviewee’s office at their place of work. Basic demographic data of the interviewees are presented 
in Table 12. These interviewees are not related to each other in the networks as was the case with 
interviewees in the translational collaboration case. The interviewee responses will henceforth be 
referred to using their allocated pseudonyms, P6, P7, P8 and P9.   

















26 years in biomedical 
research; 15 years in 
medical device industry 
P7 PhD Engineer University 
Lecturer 
University 10 years in biomedical 
research 
P8 DSc Engineer Chief 
Executive 
Officer* 
University 32 years in biomedical 
research; 20 years in 
medical device industry 
P9 PhD Engineer University 
Associate 
Professor 
University 12 years in biomedical 
research 
*In the scientific publication and patent actor-collaboration networks, P8 had been a university professor and affiliated with 
the university sector. He has since moved to industry where he is a CEO of medical devices company.  
All the interviewees in the author-inventor case held doctoral qualifications. All the interviewees had 
in the actor-collaboration networks been affiliated with the university sector, and P6 had additionally 
been affiliated with the industry sector. Interviewees worked in application areas including in medical 
imaging, neurology, cancer, leprosy, and sports and exercise technology. This included knowledge 
development in both basic and applied science. They were involved in the development of an array of 
orthopaedic devices, including diagnostic equipment, braces, cages, customised implants, software, 
instrumentation and prostheses of various joints. 
9.2.3.1 Knowledge development 
Two modes of knowledge development were described in the author-inventor case. The first was of 
developments arising out of post-graduate student projects. The second was the establishment of 
specialised laboratories or facilities at the university or associated facilities.  
Patenting and publishing 
In the author-inventor case, the interviewer enquired when interviewees chose to publish and when 
they chose to patent: “Patent first, publish after, that’s the rule here” – P7.  This sentiment was 
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expressed by all the interviewees. The project through which P7 was identified in the actor-
collaboration network had a conference proceeding and a journal article stemming from a patent. 
Patenting was done when a quick commercialisation of the device could be seen, and the patent 
offered design protection before the product went to the market, as going to the market could be a 
slow process. P8 mentioned that both publishing and patenting were important. P9 explored a more 
commercial route to research rather than a scientific one; much of the work done in his laboratory 
remains unpublished.  
Creating specialised laboratories and facilities 
All four interviewees described involvement in the creation of specialised laboratories or facilities in 
the university sector, not necessarily at their home university. P6 had been part of the establishment 
of a new manufacturing facility for medical implants. P8 contributed to setting up a research 
laboratory, and later started a research unit that had ties to the research laboratory, but whose 
research focus was different to that of the research laboratory.  
P9, in conjunction with a clinician at his university’s academic hospital, started a laboratory focussing 
on prostheses development. Rather than focusing on designing a new prosthesis, the laboratory 
initially focussed on basic science around design, including understanding design parameters.  
9.2.3.2 Knowledge diffusion through networks 
The interviewer enquired about how the actors involved in the patent or scientific publication had 
come together. Regarding the scientific publication P6 had been part of, the co-authors had different 
interests or roles in the project. The instigator of the project was a university professor who wanted 
to start a centre of excellence. P6 had an orthopaedic implant company, was keen on using a facility 
of that kind, and his company contributed financially to its establishment. A third co-author was an 
international university professor who was a specialist in the technology. Together they developed an 
implant that was the first of its kind in South Africa.  
P7’s patents and scientific publications stem from his PhD research. The project came about because 
his co-supervisor, a clinician, was having to fit standardised implants into patients, which was not ideal, 
while the clinician wanted to be involved in the development of custom implants. P7’s PhD research 
led to research questions for another PhD project, the focus of which was to develop a pipeline for 
commercialisation of the technology.  
The first scientific publication to which P8 contributed, was co-authored with a post-graduate student 
and a clinician. The clinician had previously been a student of P8’s and approached P8 to work on a 
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device. The research focus areas of the student, P8 and the clinician all aligned towards development 
of the device.  
All four interviewees spoke positively about the role of the university in orthopaedic device 
development in South Africa. While perceived challenges raised by interaction with other sectors were 
acknowledged, intra- and inter-sectoral collaboration was a regular occurrence, and in many 
instances, delivered positive outcomes. P9 mentioned that inter-sectoral collaboration was almost 
non-existent when he had arrived at his current university in 2011. P8 felt that inter-sectoral 
collaboration was improving and that there is a recognition among actors that inter-sectoral 
collaboration is necessary in orthopaedic device development. He referred to meetings held by 
healthcare and university actors to facilitate discussion among all sectors involved in research, 
development and commercialisation.  
University-university interaction 
Interviewees indicated that the disconnect between universities highlighted in the actor-collaboration 
networks, specifically within the scientific publication actor-collaboration network, were not a fair 
reflection of collaboration activity between those organisations. All four interviewees highlighted past 
and on-going collaborations between the universities, including joint supervision of post-graduate 
students, curriculum advice, examination of theses, joint workshops and training, joint conferences, 
and mutual access to laboratory facilities. These types of collaborative activities are localised and 
mostly tacit in nature, and rarely result in codified knowledge.  Furthermore, P7 highlighted that the 
scientific publication actor-collaboration network depended on the affiliations the authors had listed. 
One of the co-authors on P7’s publications always listed himself as being affiliated with a private 
healthcare actor, omitting his appointment as an honorary professor at the same university as P7. 
P7 had mentioned visiting a national university with the aim of connecting to, and collaborating with, 
its biomedical engineering group; it has since resulted in external examinations of post-graduate 
students with no real research collaboration between the two groups. P9 mentioned that while it is 
easy for research units within a university to collaborate, barriers still exist to collaboration with other 
universities, in the form of researchers being unwilling to collaborate and the cultural differences that 




Interactions between universities and their associated academic hospitals included accessing facilities, 
mechanical workshops17 and motion laboratories. Interviewees, who were all engineers, reported 
accounts of collaboration with both public and private healthcare sector actors. However, many of the 
interactions are with university-affiliated clinicians. Some university-affiliated clinicians also have a 
private medical practice, and research and efforts from clinicians often include activity in their private 
capacity as well as activity from the university side.  One interviewee served in both a biomedical 
engineer role at the academic hospital and was appointed as a lecturer at the university. This shows 
that engineers may also be affiliated concurrently with the university and healthcare sectors.   
P6 shared that, in the operating theatre, he learns the surgical technique, and how he can update 
designs based on a generic surgical technique. He shares this knowledge with his students and 
mentees.  
Some of the challenges arising out of co-invention between different parties is IP ownership. P9 
pointed out that it could be unclear who owns a solution when a surgeon brings an idea or problem 
and an engineer develops the idea or solves the problem. In the university patenting process, the fact 
that the university “owns” the patent, discourages some clinicians from participating in collaborative 
research. P9 suggested a perception among clinicians that the university will profit from the patent, 
to the clinician’s detriment. P9 emphasised that clinicians need to be educated on the role of the 
university in the patenting process; beyond the cost of the patent, which is borne by the university, 
much time is invested by technology transfer office staff in the patenting process. In the patent actor-
collaboration network, two patents in the dataset belonged to clinicians who patented in their own 
capacity, despite being affiliated concurrently with a university and a healthcare facility.  
P9 expanded his research collaborations by tapping into the clinician network of his clinical 
collaborator. This fostered new collaboration, in that the network of clinicians started collaborating 
with colleagues of P9, who were also involved in other (engineering-based) research areas. Interacting 
with more clinicians resulted in more research directions; however, a commonality was the aim of 
improving surgical experiences.  
The interviewer asked P9 how one could measure what is learnt between the engineer and the 
surgeon. He replied, “by the amount of time we spend together.” This time is a reflection of the 
 




collaboration. Beyond patenting and publishing, day-to-day needs are met, including 3D printing and 
visualisation and advisory meetings, which are not documented.  
The absence of a clinical collaborator could be a barrier to device development. P9 mentioned that his 
first venture in orthopaedic commercialisation had failed because there was no clinician to champion 
the device. In P6’s first exposure in orthopaedic device development in the late 1990s, P6 developed 
a tool for a clinician, who then left South Africa while the tool was still in the development phase, with 
the result that development stopped.  
P9 speaks of the “operating barrier” which exists between the researcher and the surgeon. The 
surgeon is almost instantaneous in providing a solution “…they open up a body, they fix the body, 
close the body, they go in, they finish it, they come out…” The researcher works on a substantially 
longer timescale. Thus, the clinician must be educated on how engineering design is done, and the 
biomedical engineer has to learn how to communicate with the clinician.  
University-Industry interaction 
University and industry interacted in various ways, including industry accessing university resources 
and university actors supporting the national medical device industry. P8 did the latter through helping 
to start-up companies in the medical device industry. P6’s company was approached by a different 
university from his home university, to assist in financing a specialised facility at that university. 
Because P6’s company was keen to use such a facility, they contributed towards machinery costs. 
Research between P6 and the other university continued, resulting in mutual access to facilities, 
including facilities of P6’s home university.  
As a university actor, P7 would like to work with industry in developing student projects which industry 
may not have time to work on. In turn, industry could fund those student projects. P7 had mentioned 
that such discussions do happen at networking events but are rarely realised. The interviewer shared 
with P7 responses from industry sector actors, including, universities have a long turnaround time as 
they are tied to an academic cycle, and that universities do not know what to charge for services 
offered. P7 was not aware of this barrier perceived by industry but acknowledged that that was a fair 
comment.  
One interviewee mentioned that the industry actor is not necessary for the development of a device; 
one can protect the idea and licence it to a manufacturer.  
Technology transfer offices and spin-off companies 
Three of the four interviewees spoke about their interactions with their respective universities’ TTOs. 
P6 had eight patents, all owned by the university and commercialised through his spin-off company. 
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The relationship between P6 and the university is mutually beneficial. P6 saw spin-off companies as 
an expansion of the university’s boundaries and a solution to commercialising university IP. The TTO 
at P7’s university examines project proposals that faculty believe may have commercial promise. The 
TTO offered to do prior art searches, identify gaps and give advice in steering the project towards 
outputs that might be suitable for commercialisation.  
Other modes of knowledge exchange 
Inter-organisational knowledge exchange occurred in student exchange programmes, visiting 
professorships, and sabbaticals spent at other universities. This results in collaborative research and 
joint publications. Intra-organisation knowledge exchange occurred at strategy meetings of 
collaborating departments, and in mechanical workshops between engineers and technicians. 
Teaching responsibility at the university also enabled knowledge development and exchange. P8 
introduced a new course at an international university at which he was lecturing, which introduced 
students to principles of IP. Part of the course involved spending an afternoon with patent lawyers to 
learn and share experiences. P9 has lectured (by invitation) biomechanics to orthopaedics registrars.  
Location 
The location of specialised facilities and departments of the university further enabled certain 
channels for knowledge exchange. An example given, was university departments having a research 
base in sports performance centres. As other individuals and centres also reside at the sports 
performance centre, including specialist orthopaedic centres, further collaboration between these 
centres and universities could arise.  
9.2.3.3 Links between knowledge functions to other TIS functions 
The knowledge functions were linked to three of the five other TIS functions – F1: Entrepreneurial 
experimentation and production, F4: Guidance of the search and F6: Resource mobilisation. The 
relationships are illustrated in Figure 28, which is a summary of the discussion presented in the rest 




Figure 28: Connections between the knowledge functions and the other TIS functions in the author-inventor case, arrows indicate the interrelation between functions. 
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F2: Knowledge development → F1: Entrepreneurial experimentation and production 
Knowledge is developed through entrepreneurial experiences when establishing companies and 
commercialising the product. Through experiential learning, actors have moved from customised to 
modular implants.  
F3: Knowledge diffusion though networks → F1: Entrepreneurial experimentation and production 
Knowledge is diffused through the network from the university where developments are 
commercialised.  Innovation in academia is limited to the ideation and proof of concept phases. After 
those phases, companies and entities must be started which would have to do the technology 
development and commercialisation of university IP. This includes selling and licensing IP. University 
actors have sought DUI (doing, using and interacting) partnerships with established manufacturers 
who have necessary infrastructure to build devices and served as consultants to established 
manufacturers, creating links between STI and DUI learning modalities.  
F6: Resource mobilisation → F2: Knowledge development  
In the author-inventor case, financial resources were the enabler to build infrastructure which was 
not available, and ensure a stream of human resources to perform research and development 
activities. All interviewees shared experiences of raising funds, domestically and internationally, for 
building research and manufacturing spaces. The availability of funding enabled the recruitment of 
researchers and post-graduate students to work on projects. South African organisations funding 
research and development discussed in these endeavours were the National Research Foundation, 
South African Medical Research Council, and the Industrial Development Corporation. International 
funding organisations included the National Institute of Health and the Wellcome Trust.  Funding was 
also sought from collaborators, and through writing joint funding applications with collaborators.  
Lack of funding also drove innovation and knowledge development. P6 and P9 shared experiences on 
the need to develop devices because the options available were so expensive it had motivated them 
to develop alternatives. P9 further mentioned that limited funding resulted in more responsible 
choices of research projects to pursue, focusing on projects which would result in greater per capita 
returns, rather than “blue-sky” projects.  
F6: Resource mobilisation → F3: Knowledge diffusion through networks 
Funding enabled visiting professorships and sabbaticals, which were means of knowledge diffusion. 
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9.2.3.4 Relating the knowledge functions to TIS-contextual factors 
The findings presented in this section were grouped according to the TIS-contextual factor categories 
of Bergek et al. (2015) as presented in Table 13. “Knowledge development” and “knowledge diffusion 
through networks” was most strongly influenced by the sectoral and geographical contexts. As in the 
translational collaboration case, no findings were categorised as political factors.  
Table 13: Knowledge development and knowledge diffusion through networks functions grouped according to the TIS-
contextual factors of Bergek et al. (2015) in the author-inventor case 
 Sectoral context Geographical context 
Knowledge 
development 
University actors have a limited role in the 
orthoapedic devices TIS.  
National and international funding agencies 
support the establishment of facilities, 
device development, and knowledge 




University actors create partnerships with 
manufacturers to commercialise devices. In 
this way they create STI-DUI partnerships.  
Collaboration with international universities 
enables access to specialists to establish 
local facilities.  
University and industry actors collaborate 
to establish specialised facilities.  
Collaboration with international universities 
is based on common research areas. 
University and healthcare actors collaborate 
in post-graduate student projects. 
Healthcare actors are usually co-supervisors 
and provide access to resources.  
 
Universities usually own IP in collaborative 
projects; this discourages collaboration with 
other sectors. 
 
There are operating barriers between 
engineers and surgeons in collaboration. 
Education on how actors from other sectors 






9.2.4 Analysis of the South African context 
In this section, findings that were coded as “South African context” are reported as themes related to 
factors that influence the TIS which may be specific to South Africa. The responses were largely drawn 
from four questions posed to interviewees in part three of the interview about their perceptions of 
knowledge development and exchange in the orthopaedic devices TIS in South Africa. The questions 
were: 
1. Are the types of devices South African organisations focussing on addressing the needs of the 
country?  
2. Is there enough inter-sectoral collaboration in orthopaedic device development in South 
Africa? 
3. Is there adequate knowledge exchange across geographical borders? Whom are we learning 
from? Whom are we influencing? 
4. What is your opinion about the quality of work produced by South African actors in 
orthopaedic device development with whom you have worked? Are there South African 
actors with whom you wish to work? Are there international actors with whom you wish to 
work?  
9.2.4.1 Addressing the South African burden of disease 
There were varying responses from interviewees about their perception of South African organisations 
addressing the orthopaedic burden of disease in South Africa. Those interviewees who were of the 
opinion that South African organisations are addressing the South African burden of disease, indicated 
that locally developed and manufactured devices were of good quality and were sold at a fraction of 
the cost of imported devices. One interviewee from the university sector pointed out that, while the 
need may be addressed, the solution is rarely implemented: “…there’s always a need and we identify 
and we really try to find a solution for the need. The issue is, it never gets to the people, it’s always in 
the academic exercise - the person finishes his masters and that’s where it stops … we rarely build on 
projects … We never actually take whatever they found, whether bad or good and do another run of 
iterations and refine and get a product out … it never gets to that point where we actually implement 
what we are doing.” 
Those interviewees who agreed that South African organisations were not addressing the orthopaedic 
burden of disease offered some insights. These include that developments from industry actors were 
focussed on earning and export potential, and that locally developed devices had limited acceptance 
in the domestic market.  
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9.2.4.2 Inter-sectoral collaboration for orthopaedic device development in South Africa 
The following emerged from the interviewees’ responses on inter-sectoral collaboration. 
1. Actors recognise that inter-sectoral collaboration is necessary for orthoapedic device 
development in South Africa.  
2. While inter-sectoral collaboration has not always been present in orthopaedic device 
development in South Africa, it is improving.  
Actors from different sectors may have different expectations which limit or discourage collaboration 
for orthoapedic device development. One way to overcome these is through education and setting 
realistic expectations in collaborative research. 
9.2.4.3 International collaboration for orthopaedic device development in South Africa 
P1, P7 and P8 indicated that there was enough international collaboration. P1 indicated that South 
African professionals in other countries were a valuable resource and an opportunity to develop 
devices and introduce products into those markets. The interviewee responses suggest that 
collaboration with international partners is taking place, at a sufficient scale. 
9.2.4.4 Quality and stigma of South African developments  
While the quality of South African developments was reported to vary, the introduction of medical 
device regulations is expected to regulate and standardise the industry. Several interviewees were 
proud of the good quality work done by their organisations as well as fellow South African 
organisations; there was however some concern over quality control and stigma attached to South 
African developments – of products not being well researched and being produced in facilities of big 
international organisations. 
Beyond these four questions, there were other instances that were coded as “South African context”. 
Only South African contextual factors related to “knowledge development” and “knowledge diffusion 
through networks” have been discussed here. Interviewees mentioned the weak South African 
currency (the Rand) and its attraction for local device development and import substitution, as well as 
South Africa as an attractive destination for development, due to lower costs than in other parts of 
the world.  
9.3 Development of theory 
Some of the findings from the interviews suggests that multiple perspectives exist. In other instances, 
the results of the interviews converge towards a single perspective. The development of theory from 
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the cases presented and strengthened by triangulation with the findings presented in the earlier 
chapters. The propositions of the theory, along with supporting evidence, are summarised in Table 14, 
and discussed later in this section. 
Table 14:Propositions and evidence showing that “knowledge development” and “knowledge diffusion through networks” 
of the orthopaedics devices TIS are influenced by TIS-contextual factors 









Interviews • Interviewees acknowledged that inter-sectoral collaboration is 
necessary for orthoapedic device development in both cases. 
Networks • In the scientific publication actor-collaboration network, the 
sectorisation index shows a preference of national actors to 
participate in inter-sectoral collaboration with other national 
actors.  
• In the patent actor-collaboration networks, the sectorisation 
index shows a preference of national actors to participate (almost 
exclusively) in inter-sectoral collaboration with other national 
actors.  
Literature • Lander & Atkinson Grosjean (2011) and Lander (2013) illustrated 
the importance of inter-sectoral collaboration in the biomedical 
innovation chain.  
• Chimhundu et al. (2015) and de Jager et al. (2017) illustrated inter-
sectoral collaboration in cardiovascular medical devices and 





limited role, in 
the orthopaedic 
devices TIS. 
Interviews • Results from translational collaboration case interviews illustrate 
absence of university actors in device development.  
• In the author-inventor case, interviewees described the limited 
role of the university actor in orthopaedic device development: 
scientific discovery, initial research and prototyping, and the 
protection of IP.  Partnerships with DUI partners are created for 
technology development and commercialisation of devices.  
Institutional 
review 
• The TTO and TTO institutions may limit university involvement 
beyond the research and development phase. 
Networks • National research-intensive universities had key positions (high 
degree and betweenness centrality) in the scientific publication 
actor-collaboration network.  
Literature • Lander (2013), Chimhundu et al. (2015) and de Jager et al. (2017) 
showed that university actors were key actors, having high degree 
and betweenness centrality, in their respective biomedical 
innovation networks.  
3. The 
healthcare 




Interviews • Interview results confirm that development occurs in 
collaboration with healthcare actors.  
Networks • Healthcare actors are present in the scientific publication and 
patent actor-collaboration networks.  
Literature • Healthcare sector actors are present in development networks for 
cardiovascular devices (Chimhundu et al. (2015) and medical 
devices more broadly (de Jager, Chimhundu, Saidi, & Douglas, 
2017) in South Africa. 
• Hicks & Katz (1996) identified hospitals as an application site 







• The Bio-economy Strategy does not explicitly include the 
healthcare actor in the quadruple helix model. 
• Other healthcare related institutions may promote or hinder 
healthcare actor participation in biomedical innovation. As an 
example, HPCSA regulations limit the role of the healthcare 










Interviews • Knowledge is developed on clinical performance of novel implants 
on for devices to be accredited by medical insurance companies.  




• Knowledge development is necessary for devices to comply to 
medical device regulations, national and international, including 
FDA, CE and SAHPRA. 
• Medical insurance companies require evidence for approval of 




• Research evidence is included in information relating to what 
knowledge is required for regulatory approval (FDA, CE) from 
respective websites. 
• NAPPI registration requires regulatory approval and clinical 
evidence of performance  (www.medikredit.co.za). 
5. Affordability 
of available 




Interviews • Innovations are sometimes a response to options available on the 
market being too expensive.  
Institutional 
review 
• National Health Act promotes cost-effective solutions to deliver 
healthcare. 
• Initiatives of SAMRC/PATH and TIA to support the development of 






Interviews • Advances in process innovations (3D printing and additive 
manufacturing) have given rise to advances in orthoapedic device 
development.  




• The South African Additive Manufacturing Strategy supports 
orthoapedic device development.  
Literature • Bergek et al’s (2008b) discussion on “development of positive 
externalities” presents a TIS function that captures the dynamics 
between innovation in related research fields.  
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Proposition 1: Inter-sectoral collaboration supports orthopaedic device development  
While there are differences in the types of inter-sectoral collaboration described by interviewees, 
there is acknowledgement that successful innovation in orthopaedic device development arises from 
collaboration across sectors, particularly between engineers/technicians and surgeons. The arenas 
where inter-sectoral knowledge exchange takes place were at conferences and congresses, operating 
theatres and mechanical workshops. Other knowledge exchange modalities include thesis 
examination and lecturing. These knowledge exchange modalities are largely tacit in nature.  
In the scientific publication and patent actor-collaboration networks presented in earlier chapters, the 
sectorisation index reveals the preference of national actors to participate in inter- or intra-sectoral 
collaboration with other national actors. In the scientific publication actor-collaboration network, all 
national sectors prefer inter-sectoral collaboration, to varying degrees. The healthcare and industry 
actors showed preference for inter-sectoral collaboration across all timeframes. The university sector 
largely showed preference for inter-sectoral collaboration but did show preference for intra-sectoral 
collaboration in some of the timeframes. In the patent actor-collaboration networks, of the national 
actors who do participate in collaboration, actors from the university, healthcare and industry sectors 
prefer inter-sectoral collaboration.  
Lander & Atkinson-Grosjean (2011) and Lander (2013) put forward that the “biomedical innovation 
system” relies on public sector institutions, including universities and hospitals, as well as the private 
sector industry. Lander (2013) showed that in the infection and immunity network in Vancouver, 
Canada, innovation is dominated by interactions between universities and hospitals, both non-
commercial sectors. Chimhundu et al. (2015) found inter-sectoral collaboration between the 
university and healthcare sector to be the most prominent type of collaboration in scientific 
knowledge production for cardiovascular medical device development in South Africa. de Jager et al. 
(2017) identified organisations and sectors active in medical device development in South Africa and 
quantified the extent of intra- and inter-sectoral collaboration. They found the university and 
healthcare sectors collaborated extensively both intra- and inter-sectorally.  
Both cases reported orthopaedic device development in the absence of a specific sector. In the 
translational collaboration case, developments occurred in the absence of university actors; in the 
author-inventor case, developments occurred in the absence of industry actors. In both cases 
however, the healthcare actor was highlighted as being a significant actor in the development of 
orthopaedic devices. Approximately 15% of the publications in the publication and patent actor-
collaboration networks emanated from translational collaboration, which suggest orthopaedic device 
development can take place in the absence of translational collaboration across three sectors.  
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There is however evidence in the actor-collaboration networks of knowledge being developed by one 
actor (self-reflecting ties), and therefore one sector, in a small number of cases. There are also 
instances where scientific publications and patents arose from intra-sectoral collaboration only. There 
are also barriers to inter-sectoral collaboration, which include unmatched expectations from partners 
in collaboration, different perspectives on IP ownership, and burdensome university administrative 
processes. Education on the roles and limitations of each sector in the collaborative partnership is 
necessary to address these barriers.  
Proposition 2: The university sector has an important, but limited, role in the orthopaedic devices 
TIS 
In the translational collaboration case, interviewees described device development in the absence of 
university actors. Universities do have their place in orthopaedic device development, in providing 
access to infrastructure that industry could not afford to build. Interviewees in the author-inventor 
case pointed out the limited role that universities play in orthoapedic device development. Much 
university-based work towards orthopaedic device development never reaches implementation.  
The institutional review presented the typical innovation pipeline for medical device development 
emanating from universities (Appendix L), which often ends at research or early-stage development, 
with TTOs playing a role in liaising with industry to further develop and commercialise the technology.  
Universities were found to be key actors in the scientific publication actor-collaboration networks and 
were instrumental in developing knowledge and diffusing it through the network. The industry actors 
who collaborate with university actors towards scientific knowledge production are largely 
multinational corporations, and South African entities running local operations of the multinational 
corporations. This suggests that national university actors are attractive collaborators for 
multinational corporations for scientific knowledge production. As these multinational corporations 
do not appear in the patent actor-collaboration network, it suggests that national university actors 
are sought for their early phase research and development discoveries, i.e. national universities are 
STI partners. In the patent actor-collaboration network, only seven national universities are 
represented, and the creation of spin-off companies to develop and commercialise technology is 
evident. This evidence from the scientific publication and patent actor-collaboration networks 
illustrates that the university has an important role in the knowledge development and exchange in 





Proposition 3: The healthcare sector has an important role in knowledge development 
In addition to identifying clinical needs, healthcare actors conceive design ideas, and offer ideas on 
the practical implementation of device design and surgical techniques. Healthcare actors also have 
specialised resources and infrastructure, including operating theatres and access to patients.  
In the scientific publication and patent actor-collaboration networks, healthcare actors account for 
approximately 40% of the actors. In the scientific publication actor-collaboration network, healthcare 
actors having high degree centrality were academic hospitals with close ties to research intensive 
universities. In the patent actor-collaboration network, many healthcare actors were private sector 
clinicians who patent in isolation. Chimhundu et al. (2015) and de Jager et al. (2017) found the 
healthcare sector to be significant contributor to cardiovascular medical device development and 
medical device development, respectively, in South Africa. Hicks & Katz (1996) found hospitals to be 
a site of application for biomedical research in the UK research system; hospitals made a more 
substantial contribution than industry to the science base in the biomedical innovation system.  
While the important contribution the healthcare sector makes towards knowledge development in 
health technology has been shown, in the South African medical devices ecosystem presented in Bunn 
(2018), the healthcare sector was not regarded as an innovator in the innovation ecosystem. The role 
of healthcare actor in the South African medical device ecosystem appears to be limited to identifying 
the local needs in medical device innovation and being the users of medical devices. As presented in 
the institutional review, the Bio-economy Strategy recommends a “quadruple helix” model of 
innovation in medical device development to address the South African burden of disease, which does 
not explicitly include healthcare as one of the helices in the innovation model. The patent actor-
collaboration networks and the institutional review have highlighted underutilisation of innovation 
potential in the healthcare sector, showing that opportunities exist for private healthcare groups to 
exploit and promote the knowledge already being created by individuals within their healthcare 
facilities.  
The actor-collaboration network analyses have shown that orthopaedic device development also 
takes place in the absence of healthcare actors. 
Proposition 4: Knowledge development and exchange create legitimacy to support the acceptance 
of developed devices  
Legitimation is the socio-political process of creating legitimacy for a technology through the actions 
of actors; it includes formation of the actors’ expectations and visions and extends to compliance with 
relevant institutions and social acceptance (Bergek, Jacobsson, & Sanden, 2008b). Legitimacy is 
necessary for resource mobilisation, demand creation, and attainment of political strength by actors 
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in the TIS (Aldrich & Fiol, 1994). Legitimacy is required for the formation of new industries and new 
TISs, and for having new technologies accepted as alternatives to existing ones  (Bergek, Jacobsson, & 
Sanden, 2008b).  
In the interviews, four scenarios were reported which illustrated that knowledge was developed 
and/or exchanged to create legitimacy for orthopaedic devices. These are: 
1. Knowledge was created on the clinical performance of the device for reimbursement by 
medical insurance companies.  
2. Knowledge was created to show acceptable clinical performance of novel implants.  
3. Knowledge was created through clinical trials for Food and Drug Administration regulatory 
approval, so that the device could be sold in the American (and other international) markets.  
4. Knowledge was developed and exchanged by key orthopaedic surgeons to endorse or 
demonstrate a device; this was often shared at conferences/congresses which were an arena 
to promote the technology, an example of expert legitimation as described by Bergek et al. 
(2008b).  
The market in which the medical device is sold has certain regulatory requirements for the device to 
enter the market. South African medical device regulations were passed in December 2016; and the 
South African Health Product Regulatory Authority (SAHPRA) is still establishing capacity to review and 
approve medical devices. This may take several years. In the interim, recognised regulatory approval 
such as CE markings and FDA approvals may be the quickest route to bring a product to the South 
African market (University of Cape Town, 2018). Both the CE and FDA systems clearly require 
knowledge development on the device for it to receive its regulatory approval, a key form of 
legitimacy.  
Proposition 5: Affordability of available devices a driver of knowledge development  
In the interviews, there were two instances – both in the author-inventor case – which illustrated that 
knowledge development and exchange occurred due to the options available on the market not being 
affordable and alternatives being developed that were cost effective.  
The institutional review showed that innovation in medical device development, and health research 
in general, directed at cost-effective solutions, is encouraged or incentivised. This is evident in the 
National Health Act, Act 61 of 2003, which mandates that the cost-effectiveness be considered of 
interventions aimed at reducing the burden of disease. The SAMRC has an agreement with PATH which 
involves activities for the promotion of access to affordable and appropriate medical devices, 
diagnostics and vaccines in South Africa through research and development, technology transfer, and 
local manufacture (South African Medical Research Council and PATH, 2014). Under the health focus 
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of TIA, the objectives include investing in projects that focus on the development of affordable health 
products that address the South African burden of disease. This evidence from the institutional review 
illustrates how government and its agencies are promoting cost-effective solutions in health 
technology research. Espoused support for medical device innovation by government institutions 
can’t be assumed to be causative factors for the findings of the case studies; the presence of 
supportive institutions has however been noted. 
The finding of affordability of available devices as a driver of knowledge development exists alongside 
available resources as an enabler of knowledge development, which is an accepted feature of TISs and 
for which evidence was shown in the interviews.  
Proposition 6: Knowledge development is enhanced by innovation in allied fields 
The code “Innovation in allied fields” has similar elements to that described by the function 
“development of positive externalities” of Bergek et al. (2008b). In their framework, two or more 
emerging TISs are related if they share structural elements (actors, networks, technology or 
institutions). Bergek et al. explain that the related TISs may mutually benefit from functions moulding 
these elements. This means that the strengthening of one TIS function may result in positive 
externalities that promote the development of the structural elements of another (related) TIS.  
In the interviews two points were raised which highlighted that knowledge created in the orthopaedic 
devices TIS was enhanced by innovations in allied fields: 
1. Advances in 3D printing and additive manufacturing resulted in advances in orthopaedic 
device development.  
2. Advances in biomaterials made certain implants more realisable.  
Additive manufacturing is a process innovation, the implementation of which is expected to yield 
product gains through better performing production processes. Additive manufacturing has made 
patient-specific orthopaedic implants realisable.  
The orthopaedic devices TIS and the additive manufacturing TIS share two structural elements: actors 
and institutions. As an institution, A South African Additive Manufacturing Strategy (Department of 
Science and Technology, 2016) speaks explicitly to medical implants, including orthopaedic 
applications, and to the promotion of knowledge development and exchange among different 
stakeholders for the use of additive manufacturing platforms for medical implants. South Africa 
already has an additive manufacturing centre which has ISO 13485 quality assurance to manufacture 
medical implants at the Centre for Rapid Prototyping and Manufacturing (CRPM) at the Central 
University of Technology.  
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One of the authors of A South African Additive Manufacturing Strategy, Professor Deon de Beer, is 
also a co-author on two articles in the scientific publication actor-collaboration network. Professor de 
Beer has been a knowledge creator in rapid prototyping/3D printing/additive manufacturing with 
focusses on final parts manufacturing, new material development, impact and economic aspects, as 
well as foundry, casting and medical industry focusses (Oxford, 2015). He, an actor, is therefore 
evidence of a shared structural element between the two TISs. The point made here is that, while 
Professor de Beer is an actor in orthopaedic devices, his academic profile lies more broadly in additive 
manufacturing theory and applications, and this academic profile may have enhanced his contribution 
to orthopaedic device innovation.  
9.4 Limitations of the study 
Each of the interviewees brought their career experience to the interviews. Their unique experiences 
and contributions towards knowledge development and exchange in the orthopaedic devices TIS adds 
to the findings, interpretations and conclusions drawn in this study. The response rate to the call for 
participation into the case studies was low. More interviewee experiences would certainly have added 
richness to the findings presented here. Additionally, only one interviewee was from the healthcare 
sector.  
The interviewees highlighted how the actor-collaboration networks did not truly capture knowledge 
development and exchange activity of the orthopaedic devices TIS. Since interviewees were drawn 
from the pool of individuals identified through the scientific publications and patents which inform 
the actor-collaboration networks, those actors who do participate in creating knowledge in the TIS 
outside of what is captured by these two codified indicators, may have been missed. 
9.5 Conclusion 
This chapter has presented two case studies exploring aspects of knowledge development and 
diffusion in the orthopaedic devices TIS and have proposed theory that captures the findings from the 
case studies and from earlier chapters. The chapter has shown that inter-sectoral collaboration 
supports knowledge development in the TIS and highlighted the roles of actors from different sectors, 
particularly those of university and healthcare actors. Knowledge development was highlighted as 
being an important process, particularly in creating legitimacy for the device. Within the South African 
context, innovation in the orthoapedic devices TIS was found to have been driven by the affordability 
of available devices, and positively influenced by innovation in the additive manufacturing TIS.   
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These findings have provided an understanding of the way in which knowledge is developed and 
diffused through networks and of the processes and contexts that affect knowledge development and 





This thesis hypothesised that “knowledge development” and “knowledge diffusion through networks” 
of the orthopaedic devices technological innovation system (TIS) are influenced by TIS-contextual 
factors. While the hypothesis is broad, the objectives provide a narrower focus. In addressing the 
objectives of the study, evidence has been found to support the hypothesis. The project identified 
knowledge creators using codified knowledge indicators and related them in a social network analysis 
through co-authorship and co-inventorship to examine knowledge diffusion through networks in the 
orthopaedics devices TIS. A keyword network analysis was performed, which identified research focus 
areas in the TIS and related the actors based on their cognitive distance, highlighting collaboration 
potential in the actor-collaboration network.  The institutions that impact the TIS were reviewed, 
completing the structural analysis of the TIS. A set of case studies, in which actors of the TIS were 
interviewed, investigated knowledge development and diffusion to determine contextual factors that 
may influence TIS development. This chapter concludes the thesis by illustrating how the objectives 
of the research have been achieved and linking the objectives to propositions developed in the case 
studies. 
10.1 Objective 1: Nature of relationships among actors 
The first objective of this thesis was to identify the actors that develop knowledge in the orthopaedic 
devices TIS and to characterise the relationships between them. The actors were identified, and the 
relationships between them were determined using analysis of scientific publication and patent actor-
collaboration networks.  
Creators of scientific knowledge, as determined by analysis of scientific publications, were found to 
be largely from the university and healthcare sectors; industry and science council actors played a 
lesser role. Key actors in the actor-collaboration network were largely research-intensive national 
universities and their associated academic hospitals. Scientific knowledge production was shown to 
be collaborative; knowledge diffusion through the network, however, was shown to be limited and 
localised to components of the network dominated by national universities. The TIS was largely 
internationalised, becoming more nationalised over time. The shift towards a nationalised TIS was 
attributed to national actors becoming more established and being able to create knowledge among 
themselves. This positive shift could facilitate development focussed on national interests.  
Technological knowledge, as determined by analysis of patenting activity, was found to be produced 
largely by South African actors, in almost equal shares by university, healthcare and industry actors. A 
few actors patented many inventions, while many inventors only filed one patent. The patent actor-
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collaboration network showed that actors, particularly private healthcare actors, patent in isolation 
resulting in highly fragmented networks, with many inventors patenting in their personal capacity. 
There was evidence that knowledge translation occurs between the scientific and technological 
domains in the TIS, with the presence of patent-paper and author-inventor pairs.  
In the case studies (Chapter 9), several interviewees indicated that the scientific publication and 
patent actor-collaboration networks did not truly capture knowledge development and exchange 
activity in the orthopaedic devices TIS, based on absent links between themselves and other actors. 
Other knowledge development and exchange activities include: the supervision of post-graduate 
students; curriculum advice, lecturing and teaching responsibilities; student exchange programmes; 
visiting professorships and sabbaticals; examination of theses; workshops and training; hosting, 
attending and presenting at conferences; accessing laboratories of other universities; consulting; 
creating media; inviting surgeons to industry facilities; the interaction of surgeons and 
engineers/technicians in mechanical workshops and operating theatres; participation in industry 
associations; and day-to-day interactions.  
The institutional review of Chapter 8 identified actors that facilitate knowledge development and 
exchange in the TIS and highlighted further roles of actors already identified in the orthopaedic devices 
TIS through patent and publication actor-collaboration networks. The institutional review has 
presented a set of institutions intended to support medical device innovation in South Africa, which 
may influence the behaviour of actors of the TIS. The case studies have enriched the network analysis 
presented in the earlier chapters, by providing a more holistic picture of knowledge development and 
exchange in the TIS. The case studies also showed that beyond research and development activity, 
knowledge development and exchange create legitimacy to support acceptance of developed devices 
(Proposition 4). 
10.2 Objective 2: Research focus areas  
The second objective of the project was to establish the focus areas of orthopaedic device 
development in South Africa. The research areas of scientific knowledge development were identified 
in the keywork networks presented in Chapter 7. The actors create knowledge in a wide range of 
orthopaedic applications, in both traditional and new orthopaedic research areas, including 
orthopaedic software, instrumentation, diagnostic equipment, biomaterials, braces, cages, plates, 
prostheses for major and minor joints, and customised implants.  
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10.3 Objective 3: Drivers and barriers 
The third objective of the project was to provide insight into what drives and hinders “knowledge 
development” and “knowledge diffusion through networks” in the orthopaedic devices TIS in South 
Africa.  
The drivers of knowledge development and exchange were found to be: inter-sectoral collaboration 
(Proposition 1); the availability of resources; affordability of available devices (Proposition 5); and the 
positive externalities of allied TISs (Proposition 6).  
Actors from different sectors have different and defined roles in inter-sectoral collaboration 
(Propositions 2 and 3), and successful developments arise where partners are aware of each other’s 
mode of operation and have reasonable expectations from the collaboration. Funding enables 
knowledge development and exchange; it can translate into resources of other kinds, including human 
resources and infrastructure, which further advance knowledge development and exchange. The 
affordability of available devices stimulates innovation in a different way, resulting in more 
responsible use of resources with cost-effective solutions (Proposition 5).  
Progress in the additive manufacturing TIS positively influenced knowledge development and 
exchange in the orthopaedic devices TIS. Even though the TISs may exist and mature separately from 
each other, they have become mutually enabling, with shared structural elements. Thus, knowledge 
development is enhanced by innovation in allied fields (Proposition 6). 
The main barrier to knowledge development and knowledge diffusion through networks of the 
orthopaedic devices TIS were barriers to inter-sectoral collaboration. These include unmatched 
expectations from partners in collaboration, different perspectives on IP ownership, and burdensome 
university administrative processes. 
10.4 Objective 4: Contextual factors 
Bergek et al. (Technological innovation systems in contexts: Conceptualizing contextual structures and 
interaction dynamics , 2015) explained that technologies develop differently in different contexts. 
Through the explicit consideration of context, an increased understanding of the peculiarities of 
individual TISs is achieved and provides a basis for a classification, generalisation and transfer of 
findings, which is important for TIS-based policy making. The aim here was not to generalise findings 
but to highlight the way in which knowledge development and exchange in the orthopaedic devices 
TIS is influenced by its contextual factors.  
The findings of the case studies revealed that the TIS is influenced by the embedded TIS and sectoral 
contextual factors. Evidence has been found to support the hypothesis of this thesis, that “knowledge 
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development” and “knowledge diffusion through networks” of the orthopaedic devices TIS are 
influenced by TIS-contextual factors. The knowledge functions were shown to be structurally coupled 
to the embedded and sectoral contexts, and externally linked and structurally coupled to the political 
context.  
The orthoapedic devices TIS in South Africa was shown to be structurally coupled to the additive 
manufacturing TIS in South Africa. The horizontal linking between these TISs has shown that the 
maturation of each of these TISs positively enhances that of the other.  
Sectoral dynamics are certainly at play in the TIS. In both forms of knowledge production, science 
council actors were found to play a lesser role in creating knowledge, but were however shown to be 
funders of medical device development and knowledge exchange initiatives, as well as creators of 
innovation pathways to facilitate technology transfer from publicly financed research. The 
bureaucratic nature of universities, accompanied by burdensome administration, dependence on an 
academic cycle, and unrealistic costs of research, discourage inter-sectoral collaboration. While 
healthcare actors are central to orthopaedic device development, they lack supportive institutions. 
This may be a deterrent to innovation by clinicians; however, a favourable pathway for healthcare 
actors to get their product to market – by serving as consultants to industry – was identified.  
The orthopaedic devices TIS is part of the broader national system of innovation (NSI) in South Africa 
and is affected by innovation policy from various government departments. On the political front, 
government policy and initiatives in innovation, and specifically in medical device innovation, have 
been introduced with the intention of promoting knowledge development and exchange. However, 
clear causal pathways from these policies and initiatives, to the development of the orthopaedic 
devices TIS, cannot be concluded, as an analysis of policy implementation was beyond the scope of 
the study.  Nonetheless, an effect of the Intellectual Property Rights by Publicly Financed Research 
Act, Act 51 of 2008, on behaviour change by university actors, was suggested in the patent actor-
collaboration networks of Chapter 6.  Patenting by universities is further expected to increase with 
the Department of Higher Education and Training rewarding patents with equal weighting to journal 
articles in its revised Research Output Policy.   
South Africa’s NSI comprises a wide variety of institutions and organisations playing complementary 
roles in scientific and technological knowledge production in the country (Manzini, 2012). Success of 
the TIS lies in having institutional alignment between those policies that steer actor behaviour in the 
NSI, and specific policies geared towards the TIS. While government strategies are attempting to co-
ordinate engagement among actors from different sectors, healthcare actors must be recognised as 
knowledge creators in the innovation chain, and attempts should be made to allow for institutional 
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alignment of the healthcare sector to those of the government strategy (the Bio-economy Strategy as 
an example). Geographical factors played a lesser role. While international actors have a strong 
presence in terms of the number of actors contributing towards the actor-collaboration networks, 
many only appear on one publication. Their presence, however, is noted with the contribution of 
bringing new ideas into the network. Of concern is that, in both publication and patent actor-
collaboration networks, there is no evidence of co-authorship and co-inventorship with actors from 
other African countries, despite government policies having been written with the African and SADC 
agenda in mind and national universities identifying themselves as being African universities.  
10.5 Limitations and recommendations 
Co-authorship as a proxy for collaboration has been used extensively in SNA studies. In this study, co-
authorship was used to characterise the relationships among actors who produce scientific 
publications for orthopaedic devices in and with South African organisations.  Co-authorship of 
publications captured activity from a very specific tier of knowledge generation. Within this tier, 
funding detail was not captured, and citation analysis was not performed to explore broader 
knowledge diffusion than that captured within the network. Co-inventorship as a proxy for 
collaboration has been used less extensively in SNA studies. The lack of bibliographic detail available 
in patent data, limits the use of patents. An objection raised against co-inventorship to illustrate 
knowledge exchange among inventors, is that inventorship only reflects a small subset of the 
knowledge exchange that takes place for technological development. The case studies revealed that 
the scientific publication and patent networks did not truly capture knowledge development and 
exchange activity in the orthopaedic devices TIS. Furthermore, the institutional review identified 
actors who are able to facilitate knowledge development and exchange in the TIS. It is important to 
acknowledge here that the scientific and patent networks, based on co-authorship and co-
inventorship, are not sufficient on their own to capture knowledge development and diffusion through 
networks.  
Knowledge networks that aim to capture innovation in developing countries should be based on 
appropriate indicators. Kebede & Mitsufuji (2017) proposed an approach to distinguish between 
research and development-based TISs and diffusion-based TISs, using knowledge indicators that 
would be suited to developing countries. These knowledge indicators inlude feasablity studies, market 
assessments, and technology adapted from developed economies. This research has revealed some 
sources of such indicators for the orthopaedic devices TIS in South Africa; these include national 
conferences of importance to the orthopaedic community, joint meetings involving different 
stakeholders, and activity in mechanical workshops and operating theatres. Future studies on TIS 
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knowledge development and exchange for orthopaedic device development in South Africa, would 
benefit from an exploration of knowledge indicators derived from these sources, and from the 
development of approaches for their analysis.  
In the patent actor-collaboration network, more than 10% of the retained patents had incomplete 
affiliation data and were omitted from further analysis. Strategies to link inventors to their 
organisational affiliations in a formal and robust manner would aid more comprehensive analyses. In 
the absence of a more robust system of establishing affiliations from patent bibliographic data, the 
methodology presented in Chapter 4 is a start to understanding these collaborative activities at an 
organisational level. Further work in this area is recommended.  
Chapter 7 has presented a methodology for the analysis of keyword networks to highlight 
collaboration potential among actors in a network based on their cognitive distance, as an alternative 
to the co-citation analysis presented by Vida (2018).  Comparative studies would reveal the relative 
strengths and weaknesses of the two approaches.  
The institutional review of Chapter 8 presented formal (codified) institutions that impact the 
orthopaedic devices TIS. An analysis of how these institutions have been put into practice and their 
performance was beyond the scope of the project; such analysis in future work would provide 
understanding of how the espoused government support for medical device innovation translates 
into, or hinders, innovation. 
The response rate for the case studies was poor and resulted in nine interviews. Only one of these 
interviews was with an actor from the healthcare sector.  Given that the research has highlighted the 
important role of the healthcare sector in the orthopaedic devices TIS, greater representation from 
the healthcare sector would have enhanced the case studies.  
10.6 Original contribution and implications 
This thesis makes two methodological contributions. First, it extends the spatial indices presented by 
Binz et al. (2014) to sectoral indices to capture preferences among actors who participate in intra- and 
inter-sectoral collaboration. Second, it builds on keyword network methodologies to add a new 
approach for analysing social relationships among actors through cognitive distance.  
This thesis adds to the body of knowledge on the application of the TIS framework in the developing 
country context, by examining a new setting and a new technological field. Previous studies using the 
functional approach of the TIS framework in a developing country setting have applied the framework 
to renewable energy applications.  
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The findings of the research suggest that certain contextual factors play a role in the orthopaedic 
devices TIS, as captured in the propositions derived in Chapter 9. Thus, evidence has been found to 
support the hypothesis that “knowledge development” and “knowledge diffusion through networks” 
of the orthopaedic devices TIS are influenced by TIS-contextual factors. In addition, the neglect of the 
role of healthcare actors as innovators has been highlighted. 
The findings presented in this thesis may inform strategies towards the promotion of knowledge 
development and exchange for orthopaedic device innovation that are relevant to the South African 
context. Specifically, this thesis has highlighted the roles of the university and healthcare actors in 
creating knowledge in the orthopaedic devices TIS. It has also highlighted barriers to inter-sectoral 
collaboration, especially those stemming from universities. In a co-ordinated National System of 
Innovation, actors have defined roles and established pathways for collaboration. By highlighting the 
roles that different actors play and the barriers they experience in collaboration, the findings of this 
study address limitations in the current conceptualisation of medical device innovation in South Africa 
and may inform national strategies such as the Bio-economy Strategy, as well as university strategies 
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APPENDIX A – Search phrases for the scientific publication actor-
collaboration network 
The following search phrase was used to extract scientific publications from Scopus. 
(AFFILCOUNTRY (south africa) AND TITLE-ABS-KEY (biomechanical OR bone OR joint OR muscle OR 
tendon OR ligament OR muscul* OR skelet*) AND TITLE-ABS-KEY (replacement OR arthroplasty* OR 
device OR tool OR instrument OR apparatus OR implement OR implant OR prosthe* OR orthotic OR 
orthoses OR machine OR appliance OR software OR material OR design* OR develop* OR concept*) 
AND NOT TITLE-ABS-KEY (dental OR orthodont* OR archaeolog* OR immunolog* OR pharmacolog* 
OR metaboli* OR evolution*)) AND PUBYEAR > 1999 
The following search phrase was used to extract scientific publications from Thomson Reuters Web of 
Knowledge: 
CU=(South Africa) AND PY=(2000-2015) AND SU=(Orthopedics OR Surgery OR Sports Sciences OR 
Engineering,Biomedical) AND TS=((joint OR bone OR tendon OR muscle OR ligament OR muscul* OR 
skeleton OR skeletal OR biomechanical) AND (arthroplast* OR medical device OR device OR tool OR 
instrument OR apparatus OR implement OR implant OR machine OR appliance OR prostheses OR 
prosthetic OR orthotic OR orthoses OR software OR material OR design OR concept* OR develop* OR 
replacement) NOT (pharmacolog* OR immunolog* OR metaboli* OR dental OR orthodont* OR 





APPENDIX B – Search phrase used for the patent actor-collaboration 
network 
The following search terms were used to extract patent data from LexisNexis TotalPatent.  
((biomechanical OR bone OR joint OR muscle OR tendon OR ligament OR muscul* OR skelet*) AND 
(replacement OR arthroplast* OR device OR tool OR instrument OR apparatus OR implement OR 
implant OR prosthe* OR orthotic OR orthoses OR machine OR appliance OR software OR material OR 
design* OR develop* OR concept*) AND (Inventor-Res(South Africa) OR Inventor-Nat(South Africa) OR 




APPENDIX C – Actors of the scientific publication network 
Abbreviation Organisation Location 
 University sector  
CPUT Cape Peninsula University of Technology National 
CUT Central University of Technology National 
IMT Institut Mines Telecom International 
JGU Johannes Gutenburg University International 
LMU Ludwig Maximillian University International 
LU Loughborough University International 
MSU Michigan State University International 
MU Massey University International 
MUI Medical University of Innsbruck International 
NWU North Western University National 
PSG PSG Tech International 
PSTDV Pole Scientifique Et Technologique de Vlizy  International 
QTU Qinglao Technological University International 
RU Roehampton University International 
SFIT Swiss Federal Institute of Technology International 
SSSA Scualo Superiore Sant’Anna International 
TB Telecom Bretagne International 
TUHH Hamburg University of Technology International 
TUT Tshwane University of Technology National 
UBRI University of Bristol International 
UCAL University of California International 
UCD University College Dublin International 
UCL University College London International 
UCT University of Cape Town National 
UDP University de Pisa International 
UFS University of the Free State National 
UKZN University of KwaZulu Natal National 
UL University of Liege International 
ULEED University of Leeds International 
UM University Mainz International 
UP University of Pretoria National 
UPEC University of Paris East Central International 
USA University of South Australia International 
SUN University of Stellenbosch National 
UVSQ University de Versailles Saint-Quentin-en-Evelines International 
UWC University of the Western Cape National 
UWIS University of Wisconsin International 
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VITU VIT University International 
VU Vrije University International 
VUT Vaal University of Technology National 
WITS University of the Witwatersrand National 
YU Yale University International 
 Healthcare sector  
2aCO 2a Clinical Ortopedica International 
AODP Azianda Ospedaliera di Padova International 
BUH Balgrist University Hospital International 
BGMC BG Medical Centre International 
BRI Bristol Royal Infirmary International 
CMJAH Charlotte Maxeke Johannesburg Academic Hospital National 
CTOF Centro Traumalogico Ortopedico Firenze International 
CHBAH Chris Hani Baragwanath Academic Hospital National 
DH Davis Hospital International 
EGH Epsom General Hospital International 
EMH Eugene Marais Hospital National 
FH Freeman Hospital International 
GH Greys Hospital National 
GSH Groote Schuur Hospital National 
GMC Grosshadern Medical Centre International 
HMA Hand and Microsurgery Associates International 
KGH King George Hospital National 
KW Klinikum Worms International 
LTM Learning Trauma Med International 
LPC Linksfield Park Clinic National 
MMC Morningside MediClinic National 
NYPH New York Presbyterian Hospital International 
OSC Orthoone Speciality Clinic International 
OCC Orthopaedic Care Centre International 
RNOHT Royal National Orthopaedic Hospital Trust International 
SM Sint Maartenskliniek International 
SSOC Sports Science Orthopaedic Clinic National 
SPC Springs Parkland Clinic National 
SMC Stellenbosch MediClinic National 
SBAH Steve Biko Academic Hospital National 
TAH Tygerberg Academic Hospital National 
UKHM Unfalkrakenhaus Meidling International 
UHB University Hospital Berlin International 
UHL University Hospital Leuven International 
UMC University Medical Centre International 
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VPH Vincent Palotti Hospital National 
VP VogtlanklinikumPlauen International 
WH Wrightington Hospital International 
 Science Councils sector  
AOCID AO Clinical Investigation and Documentation International 
CSIR Council for Scientific and Industrial Research National 
FNIHMR French National Institute for Health and Medical Research International 
ITL Ithemba Labs National 
NIRDTP National Institute of Research and Development for Theoretical 
Physics 
International 
NECSA Nuclear Engineering Council of South Africa National 
SAMRC South Africa Medical Research Council National 
 Industry sector  
3DEG 3 Degree Research and Consulting (Pty) Ltd National 
6DOF 6 Degrees of Freedom National 
AO Advanced Orthopaedics National 
AAG Aesculap AG International 
DePuy DePuy International Ltd International 
HE Howmedica Europe International 
Denmyd Denmyd Medical Pty (Ltd) National 
LC Lima Corporate International 
LODOX Lodox National 
MRA Marcus Riley Associates Ltd International 
MEDT Medtronic International 
ORTHO Orthomedics Pty Ltd National 
TI Tornier Inc International 
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APPENDIX D – Evolution of scientific publication actor-collaboration 
networks over all 12 timeframes 
Each image presented in this appendix is an actor-collaboration network of the actors involved in the 
scientific publication network, in a five-year window over the period 2000-2015.  
 
Figure 29: Actor-collaboration network based on scientific publication data for the period 2000 – 2004 
 




Figure 31: Actor collaboration network based on scientific publication data for the period 2002 – 2006 
 




Figure 33: Actor-collaboration network based on scientific publication data for the period 2004 - 2008 
 




Figure 35: Actor-collaboration network based on scientific publication data for the period 2006 - 2010 
 
 




Figure 37: Actor-collaboration network based on scientific publication data for the period 2008 - 2012 
 




Figure 39: Actor-collaboration network based on scientific publication data for the period 2010 - 2014 
 
Figure 40: Actor-collaboration network based on scientific publication data for the period 2011 - 2015 
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APPENDIX E – Evolution of the 2-clan networks over all 12 timeframes 
Each figure in this appendix is a 2-clan drawing of actors collaborating in the scientific publication 
network, in a five-year window over the period 2000-2015. In each diagram, national actors are drawn 
below the diagonal and international actors are drawn above the diagonal. International actors are 
grouped according to their country of origin. Overlap of subgroups can be seen where nodes belong 
to more than one 2-clan group. Isolated actors shown in the top left-hand corner form part of the 
timeframe network, but do not belong to any 2-clans. 
 




Figure 42: 2-clan subgroups for the period 2001-2005  
 




Figure 44: 2-clan subgroups for the period 2003-2007 
 




Figure 46: 2-clan subgroups for the period 2005-2009 
 




Figure 48: 2-clan subgroups for the period 2007-2011  
 




Figure 50: 2-clan subgroups for the period 2009-2013 
 





Figure 52: 2-clan subgroups for the period 2011 - 2015
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APPENDIX G – Actors of the patent actor-collaboration network 
Abbreviation Full name Location 
 Healthcare sector  
CMJAH Charlotte Maxeke Johannesburg Academic Hospital National 
GUH Ghent University Hospital International 
GSH Groote Schuur Hospital National 
JH Jakaranda Hospital National 
KPOU Klinik und Poliklinik fur Orthopadie und Unfallchirurgie International 
LH Livingstone Hospital National 
LWH Life Wilgeleugen Hospital National 
LOC Lyon Ortho Clinic International 
MMC Morningside MediClinic National 
OSC Ortho One Sports Clinic International 
OSV OrthoSport Victoria International 
ParklandsH Parklands Hospital National 
PH Pinehaven Hospital National 
QE2HSC Queen Elizabeth 2nd Health Sciences Centre International 
SBAH Steve Biko Academic Hospital National 
 
SH Sunshine Hospital International 
SSOC Sports Science Orthopaedic Clinic National 
SMC Stellenbosch MediClinic National 
Unitas Unitas Hospital National 
VPH 
 
Vincent Palotti Hospital 
 
National 
ZAH Zuid Afrikaans Hospital National 
 Industry sector  
ATTRI ATTRI National 
BBOP Bradley Beckerleg Orthotic & Prosthetics National 
CMO Custom Med Orthopaedics (Pty) Ltd National 
DenMyd Denmyd Medical Equipment National 
DesDall Desmond Dall National  
D4SBV Design4Spine BV International 
ESS Elite Surgical Supplies National 
ESUSA Elite Surgical USA International 
KVP Kearny Venture Partners International 
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OrthoSol Ortho-Sol Pty Ltd National 
PAB Pressure Air Biofeedback CC National 
reSCRIBE reSCRIBE National 
Saspine Saspine National 
SmartCrutch smartCRUTCH National 
SI Southern Implants (Pty) Ltd National 
SM Southern Medical (Pty) Ltd National 
SMI Spinal Motion Inc International 
TI Tornier Inc International 
Wismed Wismed National 
 
Science Council sector 
 
CSIR Council for Scientific and Industrial Research National 
 University sector  
GU Ghent University International 
LTU La Trobe University International 
LU Loughborough University International 
NWU North-West University National 
PSTDV Pole Scientifique Et Technologique de Volzy International 
SUN Stellenbosch University National 
TUT Tshwane University of Technology National 
UVSQ Universite de Versailles Saint-Quentin-en-Evelines International 
UB University of Bath International 
UCT University of Cape Town National 
UM University of Manchester International 
UMIN University of Minnesota International 
UP University of Pretoria National 
UPEC Universite Paris East Central International 
WITS University of Witwatersrand National 
VUT Vaal University of Technology National 
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APPENDIX H - Patent actor-collaboration networks 
Each image presented in this appendix is an actor-collaboration network of in a five-year window over 
the period 2000-2015.  
 





Figure 54: Actor-collaboration network based on patent data for the period 2001-2005 
 




Figure 56: Actor-collaboration network based on patent data for the period 2003-2007 
 




Figure 58: Actor-collaboration network based on patent data for the period 2005-2009 
 




Figure 60: Actor-collaboration network based on patent data for the period 2007-2011 
 




Figure 62: Actor-collaboration network based on patent data for the period 2009-2013 
 




Figure 64: Actor-collaboration network based on patent data for the period 2011-2015 
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APPENDIX I – Patents 
Richter, P.W. and Thomas, M.E. 2000. Implant including a body of non-resorbable bioactive material. 
ZA200001247A. 
Roesch, T.G. 2000. Suture anchor. ZA2000/1282.  
Roesch, T.G. 2002. A method of feeding a suture element. ZA200208423A. 
de Villers, M. 2002. Arthroplasty implant. ZA200207516. 
de Villiers, M. and Hahnle, U.R. 2002. Intervertebral prosthesis. ZA200207517. 
Walker, R.M. 2003. An intervertebral prosthesis. ZA200309312A. 
de Villiers, M. and Hahnle, U. 2003. A method for assembling a prosthetic disc for intervertebral 
insertion. US60473802.  
de Villiers, M. and Hahnle, U. 2003. Intervertebral prosthetic disc. US60473803. 
de Villiers, M. and Hahnle, U. 2004. Prosthetic disc for intervertebral insertion. WOUS04016789. 
de Villiers, M. and Mennen, U. 2004. Digital joint arthroplasty. ZA2004/4961. 
de Villiers, M.; Hahnle, U. and Hovda, D. 2004. Intervertebral prosthetic disc with metallic core. 
US903913.  
Botha, P. J. 2004. Joint prosthesis component. US60610563P. 
de Villiers, M.; Hovda, D. and Shapiro, J. 2005. Intervertebral prosthetic disc with shock absorption. 
US11051513. 
Dall, D.M. and Miles, A.W. 2005. Configurable bone fixation system. GB0505505. 
de Villiers, M. 2005. Spinal fusion device. ZA2005/02948. 
de Villiers, M. 2006. Lower arm arthroplasty. ZA200607160A.  
Kairinos, N. 2006. Orthopaedic pin isolator. ZA2006/04593. 
de Villiers, M. and Hovda, M. 2006. Posterior spinal device and method. US60744710.  
de Villiers, M. and Hovda, D. 2006. Spinal prosthesis with offset anchors. US60820769. 
Solomons, M.W. 2006. Trapezium prosthesis. ZA2006/05686. 




de Villiers, M. and Hovda, D. 2007. Spinal prosthesis with multiple anchors. US11829056A. 
Hovda, D.; Arramon, Y.; Jansen, N. and de Villiers, M. 2008. Dynamic spacer device and method for 
spanning a space formed upon removal of an intervertebral disc. WOUS08080804. 
van der Merwe, W.M. and Wilson, D.A.J. 2008. Surgical drill aimer. ZA2008/07781.  
Albertyn, C.P. 2008. Crutch. ZA2008/6795. 
Oorthuizen, C.R. 2008. Orthopaedic prosthesis. ZA200805596. 
Arramon, Y.; Jansen, N. and de Villiers, M. 2008. Polyaryletherketone artificial intervertebral disc. 
US61050455. 
Jansen, N. and de Villiers, M. 2009. Artificial intervertebral disc placement system. US12504033.  
de Villiers, M.; Jansen, N. and Arramon, Y. 2009. Artificial intervertebral disc with lower height. 
US12400221.  
Arramon, Y.; de Villiers, M. and Jansen, N. 2009. Intervertebral prosthetic disc with shock absorbing 
core formed with disc springs. US12358716. 
de Villiers, M. and Jansen, N. 2009. Posterior prosthetic intervertebral disc. US12504042.  
Scheffer, C.; van den Heever, D.J.; Erasmus, P.J. and Dillon, E.M. 2009. A method of designing a knee 
prosthesis. ZA200903924A. 
Honiball, J.R. 2009. A positioning guide and a femur bone cutting guide system. ZA200904421. 
Honiball, J.R. 2009. A positioning guide and a bone cutting guide system. ZA200904421. 
John, L. R. 2009. Non-invasive deep muscle electromyography. ZA200905309.  
Campbell, R.I. and de Beer, D.J. 2010. Articulating prosthesis. ZA201005077A. 
de Villiers, M. and Jansen, N. 2011. Prosthetic intervertebral disc with moveable core. US13094131.  
Plugmacher, R.; Becker, G, and van Asselt, P.G.H. 2011. Surgical instrument for spreading bone. 
EP11167493.  
Dymond, I.W.D. and Dymond, G.F.D. 2011. A retractor for use in surgery. ZA201100153. 
Oosthuizen, C.R. 2011. A tibial component. ZA201107123. 
Vicatos, G.; Ginsberg, S.I. and Parsons, A.T. 2011. An endoprosthesis. ZA201104740. 
Honiball, J.R. 2011. An orthopaedic apparatus. ZA201107190.  
Pienaar, A.W. 2011. Device of medical readjustment. DE202011 107911. 
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Gerhardt, T. 2012. Bone distractor. ZAF2012/00870. 
Gerhardt, T. and Pieterse, R.K. 2012. Flexible drive assembly and bone distraction apparatus in which 
the drive assemble is used. ZA201204176. 
Honiball, J.R. 2012. A positioning guide for positioning a bone cutting guide assembly and a bone 
cutting guide system. ZA20121993.  
Honiball, J.R. 2012. A surgical tool guide. ZA201205808. 
Brijlal, Y.; John, L.R. and Sivarasu, S. 2012. Hand exoskeleton. ZA201208238.  
Wisniewski, P. 2012. Precision use enabling forceps. US61796731.  
Vicatos, G. 2012. Rotating hinge knee prosthesis. ZA2012/01641. 
Faure, E.; Goubet, N.; Dejour, D.; Erasmus, S.; Arendt, E.; Feller, J. and Almqvist, F. 2012. Set of femoral 
implants for a knee prosthesis. FR12055798. 
Honiball, J.R. 2012. A bone cutting guide and a bone cutting guide system. ZA20121998. 
Patnaik, S. and Sivarasu, S. 2013. Anatomical support facilitating medical imaging of the hip, leg and 
knee. GB1319689.  
Birkholtz, F.F. and Beckerleg, B.J. 2013. Foot supporting device. ZA201306674A. 
Monacelli, E.; Djouni, K.D.A; Gregory, U.N. and Hamam, Y. 2014. Mechatronic system for assisting an 
individual in obtaining a standing position. ZA201402346.  
Tenim, S. and Vicatos, G. 2014. Underactuated prosthetic hand. GB1412034.  
Nel, L.J. and Becker, G.S. 2015. Pedicle mountable retractor system. ZA2015/04028. 
Verbeek, R. and O’Toole, B. 2015. Inter-body spacer. US62114742.  
Patnaik, S. and Sivarasu, S. 2015. Accessory for conducting patella surgery. GB1511597.  
Theunissen, H.B. 2015. A fastening device. ZA201506500. 
Badenhorst, D.L.R.H.S.; and Davis, J.H. 2015. Cervical spine traction apparatus. ZA201508967.  
Grobler, G.P. and Dower, B.J. 2015. Femoral head measurement device. ZA201502483. 
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APPENDIX J – Standardised keywords of the keyword networks 
The following steps were taken to standardise keywords:  
1. If any of the arthroplasty terms appeared alongside the term “surgery”, the term “surgery” 
was removed, as arthroplasty is the surgical replacement of the respective joint. Therefore, 
the term “surgery” does not appear in the list of keywords. The respective arthroplasty term 
was thought to better represent the research area of interest of the author than a generic 
“surgery” term.  
2. Where keyword lists had both “medical” and “devices” listed, these terms were replaced by a 
single term “medical device”.  
3. The keyword term “new products” was removed as it was redundant. 
4. The term “custom implant” was replaced by both “customised design” and “prostheses and 
implants”. 
5. The terms “customised soft tissue modelling” and “subject-specific musculoskeletal model” 
were each replaced by both “customized design” and “modelling”.  
6. The term “implant wear” was replaced by both “prostheses and implants” and “mechanical 
wear”. 
Standalone keywords Consolidated keywords  
3D reconstruction arthritis includes arthritis and osteoarthritis 
abnormalities bone cement includes bone cement; calcium phosphate bone 
cement and cementation 
absorptiometry customised deign includes customised design; custom implant; 
customised soft tissue modelling; patient-specific and subject-
specific musculoskeletal model 
accelerometer design includes design; design innovation; design methodology; 
equipment design and mechatronic design 
accuracy device migration includes device migration and migration 
acetabular cup orientation digital arthroplasty includes finger reconstruction and proximal 
interphalangeal joint replacement 
adaptive coupled oscillators exoskeleton includes exoskeleton and robotic exoskeleton 
additive manufacturing failure includes failure criteria; failure prediction and material failure 
adolescent fixation includes circular external fixation; fixation; joint fixation and 
tibial fixation 
adult spondylolisthesis fracture includes fracture and radius fracture 
aluminium step wedge hip arthroplasty includes hip arthroplasty and total hip arthroplasty 
amorphous glass-covered microwires hydroxyapatite includes hydroxyapatite and plasma sprayed HA 
coatings 
ArmeoSpring intramedullary nailing includes intramedullary nail and 
intramedullary nailing of long bones 
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arthroscopy kinematics includes kinematics and 3D kinematics 
bacteriocins knee includes knee; knee geometries; knee joint and patella 
battery-less monitoring knee arthroplasty includes knee arthroplasty; patellofemoral 
arthroplasty; total knee prosthesis; total knee replacement and 
unicompartmental knee replacement 
benign bone lesions measurement includes 3D measurement; measurement and stress 
measurements 
bilateral imaging mechanical wear includes adhesion wear; cup wear; implant wear; 
plastic flow and wear 
biocompatible scaffolds medical device includes device; medical devices; medical equipment 
and medical scanners 
bioconductive coating metal-on-metal bearings includes metal-on-metal bearings and 
metal-on-metal hip joint 
biological tissues modelling includes modelling; musculoskeletal computational 
model; subject-specific musculoskeletal model and customised soft 
tissue modelling 
biomechanics osteolysis includes osteolysis; acetabular osteolysis and pelvic 
osteolysis 
body weight prostheses and implants include biomechanical implants; cervical 
implants; implants; prostheses and implants and prosthesis 
bone radiography includes CT; digital radiography; radiographic devices; 
radiography; x-ray and x-ray computed tomography scanners 
bone ingrowth repeatability of results includes repeatability and repeatability of 
results 
bone mineral mass shoulder arthroplasty includes hemiarthroplasty and shoulder 
arthroplasty 
bone replacement spinal arthroplasty includes cervical total disc arthroplasty; lumbar 
total disc arthroplasty and spinal arthroplasty 
bone substitutes spine includes cervical spine; intervertebral disc; spinal cord and 
spine 
bone transport trauma includes multiple injuries; multiple trauma and trauma 

























































fast terminal sliding mode control 
 
fatigue monitoring sensor 
 
femoral transverse movement 
 












































































































































radiographic image enhancement 
 


































shock absorbing pylon 
 






















sternal cable system 
 





































APPENDIX K - Keyword network dendrogram 
 
Figure 65: Keyword network hierarchical dendrogram.  The dendrogram does not produce legible information in terms of the 
keywords that make up this network at this scale. It is presented here to show the hierarchical structure of the network.  
 
Figure 66: Keyword network hierarchical cluster diagram.  The cluster diagram does not produce legible information in terms 
of the keywords that make up this network at this scale. It is presented here to show the hierarchical structure and node 
clustering of the network.  
236 
 
APPENDIX L – Medical device innovation pipeline for publicly financed developments 
Table 15: TRL medical device innovation pipeline, adapted from (University of Cape Town, 2018) 
Level TRL 1 TRL 2 TRL 3 TRL 4  TRL 5  TRL 6 TRL 7 TRL 8 TRL 9 
 
Basic research Pre-clinical research Late pre-clinical 
research 
Possible clinical trials and clinical investigations 














































validated on full 








the full range of 
mission 
conditions.  
Phase Research Translation/Development Commercialisation 
 
Table 15 is an adaptation of the process developed by UCT’s Department of Research Contract & Innovation, and how it may apply to the medical device 
innovation pipeline.  
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APPENDIX M - Interview questions 
1. Basic Demographic questions: 
a. Can you tell us about your tertiary education? 
▪ Need to establish highest qualification 
b. What is your current role(s) at your current institution(s)? 
▪ This should tell us to what extent the author/inventor is (still) involved in 
orthopaedic device development.  
2. The networks. The network to which the author/inventor would be part of is printed and the 
“case” which we are exploring is shown to the author/inventor. The network diagram is fully 
explained to the author, i.e. how it is drawn, betweenness and degree centrality, etc. The 
contribution of the author/inventor is then pointed out and discussed: 
a. Do you feel that this representation reflects your contribution to the orthopaedic 
device development network in South Africa? If yes, how? If no, then why not? Are 
there contributions which we may have missed? 
b. We have assigned you as belonging to the (insert sectoral and geographic 
classification here). Would you say that this is a fair assignation? 
c. In the project leading to this paper/patent, what was your role? 
d. How do you fit among the other authors/inventors on this publication/patent? DO 
you know their educational background? qualifications?  capacity? 
e. Who funded this project/patent? What resources were provided by your 
organisation? 
f.  Did this device reach the market? What is its market presence? 
3. Section three deals with knowledge creation and knowledge diffusion 
a. Are the types of devices South African organisations focussing on addressing the 
needs of the country?  
b. Is there enough cross-sectoral collaboration in orthopaedic device development in 
South Africa? 
c. Is there sufficient knowledge exchange across geographical borders? Who are we 
‘learning’ from? Or who are we influencing? 
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d. What is your opinion about the quality of work produced by South African actors in 
orthopaedic device development that you have worked with? Are there South African 
actors who you wish to work with? Are there international actors who you wish to 
work with?  
e. If you were part of a successful collaborative project, how would you go about 
replicating those factors that made that project successful? 





APPENDIX N – Iterative coding cycle of interview transcripts 
 
Figure 67: Iterative coding cycle of the interview transcript 
